0001654954-21-011107.txt : 20211015 0001654954-21-011107.hdr.sgml : 20211015 20211015060615 ACCESSION NUMBER: 0001654954-21-011107 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20211015 DATE AS OF CHANGE: 20211015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Loop Industries, Inc. CENTRAL INDEX KEY: 0001504678 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 272094706 STATE OF INCORPORATION: NV FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38301 FILM NUMBER: 211324725 BUSINESS ADDRESS: STREET 1: 480 FERNAND POITRAS CITY: TERREBONNE STATE: A8 ZIP: J6Y 1Y4 BUSINESS PHONE: 781-821-6600 MAIL ADDRESS: STREET 1: 480 FERNAND POITRAS CITY: TERREBONNE STATE: A8 ZIP: J6Y 1Y4 FORMER COMPANY: FORMER CONFORMED NAME: FIRST AMERICAN GROUP INC. DATE OF NAME CHANGE: 20101101 10-Q 1 loop_10q.htm FORM 10-Q loop_10q.htm

 

 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended August 31, 2021

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from ___________ to __________

 

Commission File No. 000-54768

loop_10qimg1.jpg

Loop Industries, Inc.

(Exact name of Registrant as specified in its charter)

 

Nevada

27-2094706

(State or other jurisdiction of

 incorporation or organization)

(I.R.S. Employer

 Identification No.)

 

480 Fernand-Poitras Terrebonne, Québec, Canada J6Y 1Y4

(Address of principal executive offices zip code)

 

Registrant’s telephone number, including area code (450) 951-8555

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

LOOP

Nasdaq Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No ☒

 

As at October 13, 2021, there were 47,160,164 shares of the Registrant’s common stock, par value $0.0001 per share, outstanding.

 

 

 

 

LOOP INDUSTRIES, INC.

 

TABLE OF CONTENTS

 

Page No.

PART I. Financial Information

Item 1.

Financial Statements

F-1

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

3

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

17

Item 4.

Controls and Procedures

18

PART II. Other Information

Item 1.

Legal Proceedings

19

Item 1A.

Risk Factors

20

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

20

Item 3.

Defaults Upon Senior Securities

20

Item 4.

Mine Safety Disclosures

20

Item 5.

Other Information

20

Item 6.

Exhibits

21

 

 

 

 

 

Signatures

22

 

 
2

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Loop Industries, Inc.

Three and Six months ended August 31, 2021

Index to the Unaudited Interim Condensed Consolidated Financial Statements

 

Contents

Page(s)

Condensed consolidated balance sheets as at August 31, 2021 and February 28, 2021 (Unaudited)

F-2

Condensed consolidated statements of operations and comprehensive loss for the three and six months ended August 31, 2021 and 2020 (Unaudited)

F-3

Condensed consolidated statement of changes in stockholders’ equity for the three and six months ended August 31, 2021 and 2020 (Unaudited)

F-4

Condensed consolidated statement of cash flows for the six months ended August 31, 2021 and 2020 (Unaudited)

F-6

Notes to the condensed consolidated financial statements (Unaudited)

F-7

 

 
F-1

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

August 31,

2021

 

 

February 28,

2021

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$65,561,362

 

 

$35,221,951

 

Sales tax, tax credits and other receivables (Note 3)

 

 

1,343,417

 

 

 

1,763,835

 

Prepaid expenses and deposits (Note 4)

 

 

972,149

 

 

 

609,782

 

Assets held for sale (Note 5)

 

 

3,411,037

 

 

 

-

 

Total current assets

 

 

71,287,965

 

 

 

37,595,568

 

Investment in joint venture (Note 10)

 

 

1,500,000

 

 

 

1,500,000

 

Property, plant and equipment, net (Note 6)

 

 

4,818,028

 

 

 

3,513,051

 

Intangible assets, net (Note 7)

 

 

871,050

 

 

 

794,894

 

Total assets

 

$78,477,043

 

 

$43,403,513

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities (Note 9)

 

$5,234,367

 

 

$8,124,865

 

Current portion of long-term debt (Note 11)

 

 

915,432

 

 

 

938,116

 

Total current liabilities

 

 

6,149,799

 

 

 

9,062,981

 

Long-term debt (Note 11)

 

 

3,322,596

 

 

 

1,516,008

 

Total liabilities

 

 

9,472,395

 

 

 

10,578,989

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

 

 

Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding

 

 

-

 

 

 

-

 

Common stock par value $0.0001: 250,000,000 shares authorized; 47,160,164 shares issued and outstanding (February 28, 2021 – 42,413,691) (Note 13)

 

 

4,717

 

 

 

4,242

 

Additional paid-in capital

 

 

149,008,231

 

 

 

113,662,677

 

Additional paid-in capital – Warrants (Note 18)

 

 

30,356,938

 

 

 

8,826,165

 

Accumulated deficit

 

 

(110,211,750)

 

 

(89,661,970)

Accumulated other comprehensive loss

 

 

(153,488)

 

 

(6,590)

Total stockholders' equity

 

 

69,004,648

 

 

 

32,824,524

 

Total liabilities and stockholders' equity

 

$78,477,043

 

 

$43,403,513

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-2

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

 

 

Three Months Ended August 31

 

 

Six Months Ended August 31

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development (Note 14)

 

 

5,284,797

 

 

 

2,749,222

 

 

 

13,922,632

 

 

 

4,229,810

 

General and administrative (Note 15)

 

 

3,116,226

 

 

 

2,049,241

 

 

 

6,276,797

 

 

 

4,002,323

 

Depreciation and amortization (Notes 6 and 7)

 

 

140,770

 

 

 

302,587

 

 

 

272,770

 

 

 

558,561

 

Interest and other financial expenses (Note 19)

 

 

33,102

 

 

 

(58,905)

 

 

63,689

 

 

 

67,871

 

Interest income

 

 

(8,413)

 

 

(18,039)

 

 

(18,174)

 

 

(58,386)

Foreign exchange loss (gain)

 

 

(174,066)

 

 

103,618

 

 

 

32,066

 

 

 

180,259

 

Total expenses

 

 

8,392,416

 

 

 

5,127,724

 

 

 

20,549,780

 

 

 

8,980,438

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

 

(8,392,416)

 

 

(5,127,724)

 

 

(20,549,780)

 

 

(8,980,438)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

(353,713)

 

 

402,812

 

 

 

(146,898)

 

 

232,400

 

Comprehensive income (loss)

 

$(8,746,129)

 

$(4,724,912)

 

$(20,696,678)

 

$(8,748,038)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

$(0.19)

 

$(0.13)

 

$(0.47)

 

$(0.22)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

 

44,132,872

 

 

 

39,928,047

 

 

 

43,282,989

 

 

 

39,922,443

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-3

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

 

 

Three Months Ended August 31, 2020

 

 

 

Common stock

par value $0.0001

 

 

Series A preferred stock

par value $0.0001

 

 

 
Additional

 

 

Additional
Paid-in

 

 

 

 

Accumulated Other

 

 

Total

 

 

 

Number of Shares

 

 

Amount

 

 

Number of Shares

 

 

Amount

 

 

Paid-in Capital

 

 

Capital - Warrants

 

 

Accumulated Deficit

 

 

Comprehensive (Loss)

 

 

Stockholders' Equity

 

Balance, May 31, 2020

 

 

39,916,905

 

 

$3,993

 

 

 

1

 

 

$-

 

 

$83,306,794

 

 

$9,870,241

 

 

$(57,169,761)

 

$(558,861)

 

$35,452,406

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

18,305

 

 

 

1

 

 

 

-

 

 

 

-

 

 

 

(1)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

553,540

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

553,540

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

312,390

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

312,390

 

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

402,812

 

 

 

402,812

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,127,724)

 

 

-

 

 

 

(5,127,724)

Balance, August 31, 2020

 

 

39,935,210

 

 

$3,994

 

 

 

1

 

 

$-

 

 

$84,172,723

 

 

$9,870,241

 

 

$(62,297,485)

 

$(156,049)

 

$31,593,424

 

 

 

 

Three Months Ended August 31, 2021

 

 

 

Common stock

par value $0.0001

 

 

Series A preferred stock

par value $0.0001

 

 

Additional

 

 

Additional
Paid-in

 

 

 

 

Accumulated Other

 

 

Total

 

 

 

Number of Shares

 

 

Amount

 

 

Number of Shares

 

 

Amount

 

 

Paid-in Capital

 

 

Capital - Warrants

 

 

Accumulated Deficit

 

 

Comprehensive (Loss)

 

 

Stockholders' Equity

 

Balance, May 31, 2021

 

 

42,433,320

 

 

$

4,244

 

 

 

1

 

 

$-

 

 

$

113,663,032

 

 

$

8,826,165

 

 

$

(101,819,334)

 

$

200,225

 

 

$

20,874,332

 

Issuance of common shares and warrants for cash, net of share issuance costs (Note 13)

 

 

4,714,813

 

 

 

471

 

 

 

-

 

 

 

-

 

 

 

34,622,383

 

 

 

21,461,450

 

 

 

-

 

 

 

-

 

 

 

56,084,304

 

Issuance of warrants for financing facility (Notes 11 and 18)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

69,323

 

 

 

-

 

 

 

-

 

 

 

69,323

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

12,031

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

(2)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

343,653

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

343,653

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

379,165

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

379,165

 

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(353,713)

 

 

(353,713)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,392,416)

 

 

-

 

 

 

(8,392,416)

Balance, August 31, 2021

 

 

47,160,164

 

 

$

4,717

 

 

 

1

 

 

$-

 

 

$

149,008,231

 

 

$

30,356,938

 

 

$

(110,211,750)

 

$

(153,488)

 

$

69,004,648

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-4

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

 

 

Six Months Ended August 31, 2020

 

 

 

Common stock

par value $0.0001

 

 

Series A preferred stock

par value $0.0001

 

 

Additional

 

 

Additional
Paid-in

 

 

 

 

Accumulated Other

 

 

Total

 

 

 

Number of Shares

 

 

Amount

 

 

Number of Shares

 

 

Amount

 

 

Paid-in Capital

 

 

Capital - Warrants

 

 

Accumulated Deficit

 

 

Comprehensive (Loss)

 

 

Stockholders' Equity

 

Balance, February 29, 2020

 

 

39,910,774

 

 

$3,992

 

 

 

1

 

 

$-

 

 

$82,379,413

 

 

$9,785,799

 

 

$(53,317,047)

 

$(388,449)

 

$38,463,708

 

Warrant issued for services (Note 18)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

84,442

 

 

 

-

 

 

 

-

 

 

 

84,442

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

24,436

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

(2)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,110,435

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,110,435

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

682,877

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

682,877

 

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

232,400

 

 

 

232,400

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,980,438)

 

 

-

 

 

 

(8,980,438)

Balance, August 31, 2020

 

 

39,935,210

 

 

$3,994

 

 

 

1

 

 

$-

 

 

$84,172,723

 

 

$9,870,241

 

 

$(62,297,485)

 

$(156,049)

 

$31,593,424

 

 

 

 

Six Months Ended August 31, 2021

 

 

 

Common stock

par value $0.0001

 

 

Series A preferred stock

par value $0.0001

 

 

Additional

 

 

Additional
Paid-in

 

 

 

 

Accumulated Other

 

 

Total

 

 

 

Number of Shares

 

 

Amount

 

 

Number of Shares

 

 

Amount

 

 

Paid-in Capital

 

 

Capital - Warrants

 

 

Accumulated Deficit

 

 

Comprehensive (Loss)

 

 

Stockholders' Equity

 

Balance, February 28, 2021

 

 

42,413,691

 

 

$4,242

 

 

 

1

 

 

$-

 

 

$113,662,677

 

 

$8,826,165

 

 

$(89,661,970)

 

$(6,590)

 

$32,824,524

 

Issuance of common shares and warrants for cash, net of share issuance costs (Note 13)

 

 

4,714,813

 

 

 

471

 

 

 

-

 

 

 

-

 

 

 

34,625,825

 

 

 

21,461,450

 

 

 

-

 

 

 

-

 

 

 

56,087,746

 

Issuance of warrants for financing facility (Notes 11 and 18)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

69,323

 

 

 

-

 

 

 

-

 

 

 

69,323

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

31,660

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

(4)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

892,971

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

892,971

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(173,238)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(173,238)

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(146,898)

 

 

(146,898)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(20,549,780)

 

 

-

 

 

 

(20,549,780)

Balance, August 31, 2021

 

 

47,160,164

 

 

$

4,717

 

 

 

1

 

 

$-

 

 

$

149,008,231

 

 

$

30,356,938

 

 

$

(110,211,750)

 

$

(153,488)

 

$

69,004,648

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-5

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Six Months Ended August 31,

 

 

 

2021

 

 

2020

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net loss

 

$(20,549,780)

 

$(8,980,438)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization (Notes 6 and 7)

 

 

272,770

 

 

 

558,561

 

Stock-based compensation expense (Note 16)

 

 

719,733

 

 

 

1,877,754

 

Accretion and accrued interest expenses (Note 19)

 

 

43,967

 

 

 

36,949

 

Loss on revaluation of foreign exchange contracts (Note 19)

 

 

-

 

 

 

11,482

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Sales tax and tax credits receivable (Note 3)

 

 

436,236

 

 

 

169,018

 

Prepaid expenses (Note 4)

 

 

(365,769)

 

 

(824,675)

Accounts payable and accrued liabilities (Note 9)

 

 

(2,957,577)

 

 

(304,438)

Net cash used in operating activities

 

 

(22,400,420)

 

 

(7,455,787)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

Investment in joint venture (Note 10)

 

 

-

 

 

 

(650,000)

Deposits on machinery and equipment (Note 4)

 

 

-

 

 

 

(1,305,010)

Additions to property, plant and equipment (Notes 5 and 6)

 

 

(5,010,982)

 

 

(1,116,744))

Additions to intangible assets (Note 7)

 

 

(90,591)

 

 

(160,484)

Net cash used in investing activities

 

 

(5,101,573)

 

 

(3,232,238)

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from sale of common shares and warrants, net of share issuance costs (Note 13)

 

 

56,087,746

 

 

 

-

 

Proceeds from issuance of long-term debt (Note 11)

 

 

1,894,877

 

 

 

-

 

Repayment of long-term debt (Note 11)

 

 

(27,740)

 

 

(26,836)

Net cash (used) provided by financing activities

 

 

57,954,883

 

 

 

(26,836)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes

 

 

(113,479)

 

 

125,433

 

Net increase (decrease) in cash

 

 

30,339,411

 

 

 

(10,589,428)

Cash, beginning of period

 

 

35,221,951

 

 

 

33,717,671

 

Cash, end of period

 

$65,561,362

 

 

$23,128,243

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information:

 

 

 

 

 

 

 

 

Income tax paid

 

$-

 

 

$-

 

Interest paid

 

$19,720

 

 

$19,441

 

Interest received

 

$18,174

 

 

$30,497

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-6

Table of Contents

  

Loop Industries, Inc.

Three and Six Months Ended August 31, 2021 and 2020

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

 

1. The Company, Basis of Presentation

 

The Company

 

Loop Industries, Inc. (the “Company,” “Loop Industries,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber.

 

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2021, filed with the SEC on June 1, 2021. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.

 

Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 28, 2021, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and six-month periods ended August 31, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, for the fiscal year ending February 28, 2022, or for any other period.

 

2. Summary of Significant Accounting Policies

 

Use of estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards and the judgment in the assessment.

 

The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.

 

 
F-7

Table of Contents

 

Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.

 

Stock-based compensation

 

The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.

 

The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.

 

The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.

 

The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.

 

Research and development expenses

 

Research and development expenses relate primarily to process development and design, testing of preproduction samples, purchases of machinery and equipment for the small-scale production facility, compensation, and consulting fees, and are expensed as incurred. Total research and development expenses recorded during the six-month periods ended August 31, 2021 and 2020 amounted to $13,922,632 and $4,229,810, respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.

 

Assets held for sale

 

Assets are classified as held for sale when they met the criteria set out in ASC 360-10-45-9 Long-lived assets classified as held for sale:

 

 

·

Management, having the authority to approve the action, commits to a plan to sell the asset;

 

·

The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;

 

·

An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;

 

·

The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;

 

·

The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and

 

·

Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

   

When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.

 

 
F-8

Table of Contents

 

Foreign currency translations and transactions

 

The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.

 

For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.

 

Net earnings (loss) per share

 

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the six-month periods ended August 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at August 31, 2021, the potentially dilutive securities consisted of 1,587,081 outstanding stock options (2020 – 1,587,081), 4,170,278 outstanding restricted stock units (2020 – 4,313,750), and 11,684,418 outstanding warrants (2020 – 4,884,331).

 

3. Sales Tax, Tax Credits and Other Receivables

 

Sales tax, research and development tax credits and other receivables as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Sales tax

 

$599,706

 

 

$1,155,504

 

Research and development tax credits

 

 

588,843

 

 

 

435,467

 

Other receivables

 

 

154,868

 

 

 

172,864

 

 

 

$1,343,417

 

 

$1,763,835

 

 

4. Prepaid Expenses and Deposits

 

Prepaid expenses as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Deposits on machinery and equipment

 

$733,586

 

 

$379,395

 

Other

 

 

238,563

 

 

 

230,387

 

 

 

$972,149

 

 

$609,782

 

 

 
F-9

Table of Contents

 

Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received.

 

During the six-month period ended August 31, 2020, the Company made non-refundable cash deposits on machinery and equipment of $1,305,010 which were classified as a cashflow from investing activities in the statement of cash flows as costs of machinery and equipment were previously capitalized. Starting in the third quarter of fiscal 2021, the Company treats costs of machinery and equipment as research and development expenses in the period they are incurred.

 

5. Assets held for sale

 

On May 27, 2021, we acquired land in Bécancour, Québec for cash of $4.8 million (CDN $5.9 million). The site is part of our planning for an Infinite Loop™ manufacturing facility. We plan on using a portion of the land in connection with the construction of our Infinite Loop TM manufacturing facility and selling the excess land. The portion of the land we are committed to selling meets all criteria under ASC 360 Property, plant and equipment to be classified as an asset held for sale.

 

The total purchase cost of the land has been allocated between the portion of land held for sale and the land to be used for the planned Infinite Loop™ manufacturing facility based on surface area.

 

Description

 

Balance sheet line item

 

Cost

 

Land held for sale

 

Assets held for sale

 

$3,411,037

 

Infinite Loop™ manufacturing facility

 

Property, plant and equipment, net

 

 

1,410,858

 

 

 

 

 

$4,821,895

 

 

 

6. Property, Plant and Equipment

 

Property, plant and equipment as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

As at August 31, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,964,878

 

 

$(235,410)

 

$1,729,468

 

Land

 

 

1,653,737

 

 

 

-

 

 

 

1,653,737

 

Building and Land Improvements

 

 

1,921,952

 

 

 

(666,509)

 

 

1,255,443

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

295,474

 

 

 

(116,094)

 

 

179,380

 

 

 

$12,350,293

 

 

$(7,532,265)

 

$4,818,028

 

 

 

 

As at February 28, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,954,345

 

 

$(201,589)

 

$1,752,756

 

Land

 

 

241,578

 

 

 

-

 

 

 

241,578

 

Building and Land Improvements

 

 

1,804,872

 

 

 

(474,114)

 

 

1,330,758

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

292,946

 

 

 

(104,987)

 

 

187,959

 

 

 

$10,807,993

 

 

$(7,294,942)

 

$3,513,051

 

 

 
F-10

Table of Contents

 

During the six-month period ended August 31, 2021, the Company acquired a parcel of land in Bécancour, Québec for $4.8 million (CDN $5.9 million). The Company intends to use a portion of the property for the construction of a commercial facility to manufacture Loop™ branded PET resin using its Infinite Loop™ technology. The excess land is classified as held for sale, as described in Note 5.

 

Depreciation expense for the three- and six-month periods ended August 31, 2021 amounted to $121,733 and $236,790, respectively (2020– $291,498 and $539,697, respectively), and is recorded as an operating expense in the consolidated statements of operations and comprehensive loss.

 

7. Intangible Assets

 

Intangible assets as at August 31, 2021 and February 28, 2021 were $871,050 and $794,894, respectively.

 

During the six-months periods ended August 31, 2021 and 2020, we made additions to intangible assets of $90,591 and $160,484, respectively.

 

Amortization expense for the three- and six-month periods ended August 31, 2021 amounted to $19,036 and $35,980, respectively (2020 - $11,088 and $18,864, respectively), and is recorded as an operating expense in the unaudited condensed consolidated statements of operations and comprehensive loss.

 

8. Fair value of financial instruments

 

The following tables present the fair value of the Company’s financial liabilities as at August 31, 2021 and February 28, 2021:

 

 

 

Fair Value Measurements as at August 31, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$

4,238,028

 

 

$

4,253,605

 

 

Level 2

 

 

 

 

Fair Value Measurements at February 28, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$2,454,123

 

 

$2,464,540

 

 

Level 2

 

 

9. Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Trade accounts payable

 

$3,577,365

 

 

$5,082,736

 

Accrued engineering fees

 

 

96,865

 

 

 

535,359

 

Accrued employee compensation

 

 

765,103

 

 

 

970,154

 

Accrued professional fees

 

 

448,567

 

 

 

1,270,628

 

Other accrued liabilities

 

 

346,467

 

 

 

265,988

 

 

 

$5,234,367

 

 

$8,124,865

 

 

 
F-11

Table of Contents

 

10. Joint Venture

 

On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture.

 

Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive worldwide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber.

 

ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to August 31, 2021 and, as at August 31, 2021, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the six-month period ended August 31, 2021, we made no contributions to ILT (2020 – $650,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.

 

In conjunction with the SK strategic partnership described in Note 13, on June 18, 2021, the Company, Loop Innovations, LLC, a wholly-owned subsidiary of the Company (“Loop Innovations”), Indorama Ventures Holdings LP (“Indorama”) and Indorama Loop Technologies, LLC (the “Indorama Joint Venture Company”) amended (i) the Limited Liability Company Agreement between Loop Innovations, LLC and Indorama Ventures Holdings LP (the “LLC Agreement”), (ii) the Marketing Agreement between the Company and Indorama Loop Technologies, LLC (the “Marketing Agreement”) and (iii) the License Agreement between the Company and the Indorama Joint Venture Company (the “License Agreement”), each dated September 24, 2018 (collectively such amendments, the “Indorama Joint Venture Amendments”).

 

Under the Indorama Joint Venture Amendments, the Company, Indorama and the Indorama Joint Venture Company agreed to:

 

 

·

terminate Indorama’s right of first refusal under the LLC Agreement over any facility to produce products utilizing any waste-to-resin technology applying the PET depolymerization process of the Company;

 

·

amend the non-compete obligations under the LLC Agreement to solely apply to the Company;

 

·

limit the scope of the Company’s grant of intellectual property rights and the scope of the exclusivity rights of the Indorama Joint Venture Company for the retrofit of existing facilities under the License Agreement to North America and Europe; and

 

·

limit the scope of the Indorama Joint Venture Company’s permitted marketing rights under the Marketing Agreement to North America and Europe.

  

11. Long-Term Debt

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Investissement Québec financing facility :

 

 

 

 

 

 

Principal amount

 

$3,645,875

 

 

$1,741,612

 

Unamortized discount

 

 

(388,155)

 

 

(268,192)

Accrued interest

 

 

64,876

 

 

 

42,588

 

Total Investissement Québec financing facility

 

 

3,322,596

 

 

 

1,516,008

 

Term loan

 

 

 

 

 

 

 

 

Principal amount

 

 

915,432

 

 

 

938,116

 

Less: current portion

 

 

(915,432)

 

 

(938,116)

Total term loan, net of current portion

 

 

-

 

 

 

-

 

Long-term debt, net of current portion

 

$3,322,596

 

 

$1,516,008

 

 

 
F-12

Table of Contents

 

Investissement Québec financing facility

 

On February 21, 2020, the Company received $1,750,998 (CDN$2,209,234) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $36,459 (CDN$46,000) to Investissment Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss.

 

On August 26, 2021, the Company received $1,894,877 (CDN$2,390,766) from Investissement Québec as the second disbursement of our financing facility, the balance of the total amount available under the financing facility of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The second disbursement bears the same interest rate and repayment terms as the first disbursement. The Company established the fair value of the loan for the first disbursement at $1,750,395 based on a discount rate of 3.95%, which reflected a debt discount of $139,390. The discount rate used was based on the external financing from a Canadian bank. There were no fees associated with the second disbursement. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss.

 

The Company recorded interest expense on the Investissement Québec loan for the three- and six-month periods ended August 31, 2021 in the amount of $11,512 and $22,394 respectively (2020 – $9,875 and $19,291) and an accretion expense of $11,046 and $21,573 respectively (2020 – $9,112 and $17,658).

 

The Company also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $364,587 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection with the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at August 31, 2021. In connection with the second disbursement of the Financing Facility, the Company issued a warrant (“Second Disbursement Warrant”) to acquire 17,180 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $69,323 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The Second Disbursement Warrant remains outstanding as at August 31, 2021.

 

Term loan

 

On January 24, 2018, the Company obtained a $1,109,614 (CDN$1,400,000) 20-year term installment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,623 (CDN$5,833) plus interest, until January 2022, at which time the monthly repayment amount and interest rate are subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. During the three- and six-month periods ended August 31, 2021, we repaid $13,870 and $27,740 respectively (2020 – $14,143 and $26,836) on the principal balance of the Loan and interest paid amounted to $10,543 and $19,496 and (2020 – $9,130 and $19,441). The terms of the credit facility require the Company to comply with certain financial covenants. As at August 31, 2021 and 2020, the Company was in compliance with its financial covenants.

 

 
F-13

Table of Contents

 

Principal repayments due on the Company’s long-term debt over the next five years are as follows:

 

Years ending

 

Amount

 

February 28, 2022

 

$

915,432

 

February 28, 2023

 

 

-

 

February 29, 2024

 

 

520,831

 

February 28, 2025

 

 

520,831

 

February 28, 2026

 

 

520,831

 

Thereafter

 

 

2,083,382

 

Total

 

$

4,561,307

 

 

12. Related Party Transactions

 

Employment Agreement

 

On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term.

 

On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan. Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.

 

On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement. The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic that is far simpler to purify.

 

During the quarters ended August 31, 2021 and 2020, no outstanding milestones were probable of being met based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.

 

13. Stockholders’ Equity

 

Common Stock

 

For the period ended August 31, 2021

 

Number of

shares

 

 

Amount

 

Balance, February 28, 2021

 

 

42,413,691

 

 

$4,242

 

Issuance of shares upon settlement of restricted stock units

 

 

31,660

 

 

 

4

 

Issuance of shares for cash

 

 

4,714,813

 

 

 

471

 

Balance, August 31, 2021

 

 

47,160,164

 

 

$4,717

 

 

For the period ended August 31, 2020

 

Number of

shares

 

 

Amount

 

Balance, February 29, 2020

 

 

39,910,774

 

 

$3,992

 

Issuance of shares upon settlement of restricted stock units

 

 

24,436

 

 

 

2

 

Balance, August 31, 2020

 

 

39,935,210

 

 

$3,994

 

 

During the six months ended August 31, 2021, the Company recorded the following common stock transactions:

 

(i)

The Company issued 31,660 shares of the common stock to settle restricted stock units that vested in the period.

(ii)

The Company issued 4,714,813 shares of its common stock, with warrants, at an aggregate offering price of $12.00 per share for total gross proceeds of $56,577,756 and net proceeds of $56,084,304.

 

 
F-14

Table of Contents

 

During the six months ended August 31, 2020, the Company recorded the following common stock transaction:

 

(i)

The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.

 

On June 22, 2021, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) by and between the Company and SK global chemical Co., Ltd, an accredited investor (the “Purchaser”). Pursuant to the Purchase Agreement, the Company sold to the Purchaser the following securities on July 29, 2021 for an aggregate purchase price of $56.5 million (collectively, the “SKGC Investment”):

 

 

·

an aggregate of 4,714,813 shares (the “Shares”) of the Company’s common stock (the “Common Stock”);

 

·

warrants to purchase 4,714,813 shares of Common Stock for an exercise price of $15.00 (the “First Tranche Warrants”), with an expiration date of the third anniversary of the issue date;

 

·

warrants to purchase 2,357,407 shares of Common Stock for an exercise price of $20.00 (the “Second Tranche Warrants”), with an expiration date of the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date; and

 

·

warrants to purchase 461,298 shares of Common Stock for an exercise price of $11.00, with an expiration date of June 14, 2022 (the “Third Tranche Warrants,” and together with First Tranche Warrants and the Second Tranche Warrants, the “Warrants”).

  

The Purchaser may exercise the First Tranche Warrant at any time beginning on January 29, 2022 and the Second Tranche Warrant at any time on or after the later to occur of (i) January 29, 2022 and (ii) the first business day following the First Plant Milestone (as defined in the Second Tranche Warrant) prior to its expiration date. The Purchaser may exercise the Third Tranche Warrant at any time prior to June 14, 2022.

 

The table below summarizes the allocation of the aggregate purchase price, net of issuance costs, based on the relative fair-value of the components at the grant date:

 

Common stock

 

$34,622,854

 

First Tranche Warrants

 

 

13,158,981

 

Second Tranche Warrants

 

 

7,167,195

 

Third Tranche Warrants

 

 

1,135,274

 

 

 

$56,084,304

 

 

The fair value of the warrants was determined using the Black-Scholes model.

 

After the closing of the SKGC Investment, the Purchaser owns approximately 10.0% of the issued and outstanding Common Stock as of that date.

 

14. Research and Development Expenses

 

Research and development expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$2,485,232

 

 

$-

 

Employee compensation

 

 

1,492,688

 

 

 

1,060,669

 

External engineering

 

 

551,381

 

 

 

942,117

 

Plant and laboratory operating expenses

 

 

707,043

 

 

 

584,394

 

Other

 

 

48,453

 

 

 

162,042

 

 

 

$5,284,797

 

 

$2,749,222

 

 

 
F-15

Table of Contents

 

Research and development expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$5,108,125

 

 

$-

 

Employee compensation

 

 

3,578,816

 

 

 

1,879,717

 

External engineering

 

 

3,454,829

 

 

 

1,017,049

 

Plant and laboratory operating expenses

 

 

1,398,510

 

 

 

870,497

 

Other

 

 

382,352

 

 

 

462,547

 

 

 

$13,922,632

 

 

$4,229,810

 

 

During the six-month period ended August 31, 2021, we recorded research and development tax credits of $152,391 as a reduction of research and development expenses and an expense of $267,743 in the six-month period ended August 31, 2020. The expense in the six-month period ended August 31, 2020 was due to a revision of research and development tax credits by Canadian tax authorities. During the six-month period ended August 31, 2021, we recorded no government grants as a reduction of research and development expenses (2020 – $191,439).

 

 

15. General and Administrative Expenses

 

General and administrative expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$856,997

 

 

$420,434

 

Employee compensation

 

 

868,122

 

 

 

1,002,473

 

Directors and officers insurance

 

 

1,059,153

 

 

 

502,368

 

Other

 

 

331,954

 

 

 

123,966

 

 

 

$3,116,226

 

 

$2,049,241

 

 

General and administrative expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$2,488,447

 

 

$642,131

 

Employee compensation(1)

 

 

1,329,527

 

 

 

2,145,325

 

Directors and officers insurance

 

 

1,927,799

 

 

 

975,941

 

Other

 

 

531,024

 

 

 

238,926

 

 

 

$6,276,797

 

 

$4,002,323

 

______________ 

(1)

Includes stock-based compensation expense. In the six-month period ended August 31, 2021, the Company recorded RSU forfeitures for an amount of $935,837 (2020 – $4,005) as a net reversal of stock-based compensation.

 

16. Share-based Payments

 

Stock Options

 

During the three-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).

 

During the six-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).

 

The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. There were no new issuances of stock options for the three- and six-month periods ended August 31, 2021 and 2020.

 

The total number of stock options outstanding as at August 31, 2021 was 1,587,081 (2020 – 1,587,081) with a weighted average exercise price of $6.81 (2020 - $6.81), of which 1,278,748 were exercisable (2020 – 1,083,748) with a weighted average exercise price of $7.30 (2020 – $7.05).

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $343,653 and $553,540, respectively, and is included in operating expenses.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $892,971 and $1,110,435, respectively, and is included in operating expenses.

 

 
F-16

Table of Contents

 

Restricted Stock Units

 

During the three-month period ended August 31, 2021, the Company granted 33,184 restricted stock units (“RSUs”) (2020 – 38,648) with a weighted average fair value of $13.05 (2020 – $9.20), settled 12,031 RSUs (2020 – 18,305) with a weighted average fair value of $8.48 (2020 – $9.85) and no RSUs were forfeited (2020 – nil).

 

During the six-month period ended August 31, 2021, the Company granted 286,942 restricted stock units (“RSUs”) (2020 – 122,373) with a weighted average fair value of $9.41 (2020 – $8.86), settled 31,660 RSUs (2020 – 24,436) with a weighted average fair value of $8.82 (2020 – $9.78) and 295,524 RSUs were forfeited (2020 – 2,989) with a weighted average fair value of $7.93 (2020 – $8.78).

 

The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.

 

The total number of RSUs outstanding as at August 31, 2021 was 4,170,278 (2020 – 4,313,750), of which 725,313 were vested (2020 – 891,327).

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to $379,165 and $312,390, respectively, and is included in expenses.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to ($173,238) and $682,877, respectively, and is included in operating expenses. The net reversal in expenses attributable to RSUs in the three-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).

 

Stock-Based Compensation Expenses

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $394,527 and $352,282, respectively, and in general and administrative expenses amounted to $313,282 and $513,649, respectively.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $790,072 and $704,289, respectively, and in general and administrative expenses amounted to ($70,338) and $1,173,466, respectively. The net reversal in stock-based compensation included in general and administrative expenses in the six-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).

 

17. Equity Incentive Plan

 

On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2021 and 2020, the Board of Directors opted to waive the annual share reserve increase. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.

 

 
F-17

Table of Contents

 

The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the six-month periods ended August 31, 2021 and 2020:

 

 

 

2021

 

 

2020

 

 

 

Number of units

 

 

Number of units

 

Outstanding, beginning of period

 

 

1,083,412

 

 

 

1,300,518

 

Share reserve increase

 

 

-

 

 

 

-

 

Units granted

 

 

(286,942)

 

 

(125,762)

Units forfeited

 

 

295,524

 

 

 

2,989

 

Units expired

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

1,091,994

 

 

 

1,177,745

 

 

18. Warrants

 

During the six-month period ended August 31, 2021, the Company issued warrants to purchase 7,550,698 shares of our common stock. No warrants were exercised, were forfeited, nor expired in the six-month period ended August 31, 2021. The table below summarizes the warrants granted during the six-month period ended August 31, 2021:

 

Number of warrants

 

Exercise Price

 

Expiration date

4,714,813

 

$

15.00

 

July 29, 2024

2,357,407

 

 

20.00

 

(1)

461,298

 

 

11.00

 

June 14, 2022

17,180

 

$

11.00

 

August 26, 2024

_______________ 

 

(1)

Expiration date is the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date.

 

During the six-month period ended August 31, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. No warrants were exercised or forfeited in the six-month period ended August 31, 2021.

 

19. Interest and Other Finance Costs

 

Interest and other finance costs for the three-month periods ended August 31, 2021 and 2020 are as follows:

 

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$22,056

 

 

$19,005

 

Accretion expense

 

 

11,046

 

 

 

9,112

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

(87,022)

 

 

$33,102

 

 

$(58,905)

 

Interest and other finance costs for the six-month periods ended August 31, 2021 and 2020 are as follows:

 

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$41,890

 

 

$38,732

 

Accretion expense

 

 

21,573

 

 

 

17,658

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

11,481

 

Other

 

 

226

 

 

 

-

 

 

 

$63,689

 

 

$67,871

 

 

 
F-18

Table of Contents

 

20. Commitments and Contingencies

 

Commercial Commitments

 

On September 2, 2020, the Company entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total amount of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. As at August 31, 2021, the cumulative amount paid was $900,000 and during the six-month period ended August 31, 2021, no additional amount was paid by the Company related to this agreement and included in research and development expenses.

 

Contingencies

 

On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.

 

On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.

 

On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class-action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.

 

Plaintiffs served a consolidated amended complaint on February 18, 2021 which alleges defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relies on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021.

 

On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.

 

Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.

 

 
F-19

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following information and any forward-looking statements should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q, including those risks identified in the “Risk Factors” section of our most recent Annual Report on Form 10-K.

 

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q of Loop Industries, Inc., a Nevada corporation (the “Company,” “Loop Industries,” “we,” or “our”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, ability to improve and expand our capabilities, competition, expected activities and expenditures as we pursue our business plan, the adequacy of our available cash resources, regulatory compliance, plans for future growth and future operations, the size of our addressable market, market trends, and the effectiveness of the Company’s internal control over financial reporting. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. These risks and other factors include, but are not limited to, those listed under “Risk Factors.” Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (i) commercialization of our technology and products, (ii) our status of relationship with partners, (iii) development and protection of our intellectual property and products, (iv) industry competition, (v) our need for and ability to obtain additional funding, (vi) building our manufacturing facility, (vii) our ability to scale, manufacture and sell our products in order to generate revenues, (viii) our proposed business model and our ability to execute thereon, (ix) adverse effects on the Company’s business and operations as a result of increased regulatory, media or financial reporting scrutiny, practices, rumors, or otherwise, (x) disease epidemics and health-related concerns, such as the current outbreak of a novel strain of coronavirus (COVID-19), which could result in (and, in the case of the COVID-19 outbreak, has resulted in some of the following) reduced access to capital markets, supply chain disruptions and scrutiny or embargoing of goods produced in affected areas, government-imposed mandatory business closures and resulting furloughs of our employees, government employment subsidy programs, travel restrictions or the like to prevent the spread of disease, and market or other changes that could result in noncash impairments of our intangible assets, and property, plant and equipment, (xi) the outcome of the current SEC investigation or recent class action litigation filed against us, (xii) our ability to hire and/or retain qualified employees and consultants and (xiii) other factors discussed in our subsequent filings with the SEC.

 

Management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available.

 

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as at the date of this Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

 

We caution readers not to place undue reliance on any such forward-looking statements, which speak only as at the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

 

 
3

Table of Contents

 

Introduction

 

Loop Industries is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from our dependence on fossil fuels. Loop owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpets and textiles of any color, transparency or condition and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin and polyester fiber suitable for use in food-grade packaging, thus enabling our customers to meet their sustainability objectives. Loop Industries is contributing to the global movement towards a circular economy by preventing plastic waste and recovering waste plastic for a more sustainable future for all.

 

Industry Background and Market Opportunity

 

The global annual market demand for PET plastic and polyester fiber will exceed $160 billion by 2022 as projected in the 2018 IHS Polymer Market Report.

 

We believe, plastic pollution continues to be one of the most persistently covered environmental issues by media and local and global environmental non-governmental organizations. Some of the main concerns associated with PET are the emissions associated with its production from non-renewable hydrocarbons and the length of time it persists in landfills and the natural environment. There is an increasing demand for action to address the global plastic crisis, which has been characterized by facts provided by leading academic and not-for-profit organizations. In the last few years, governments in North America and Europe have been enacting and proposing laws and regulations mandating the use of minimum recycled content in packaging underlying the strength of this issue in the marketplace. Consumer brands are seeking a solution to their plastic challenge, and they are taking action. In recent years we have seen major brands make significant commitments to close the loop on their plastic packaging by transitioning their packaging to recyclable materials and by incorporating more recycled content into their packaging.

 

Global consumer goods companies, apparel manufacturers, and retail brands have announced significant public commitments and targets to make the transition to a circular plastic economy, namely:

 

 

·

In January 2018, Danone’s evian® brand bottled spring water committed to a 100% recycled content package by 2025;

 

·

In 2018, Coca-Cola committed to an average recycled content of 50% across its packaging by 2030;

 

·

In 2021, PepsiCo committed to 11 European markets moving key Pepsi-branded products to 100% rPET bottles by 2022, and in the U.S., all Pepsi-branded products will be converted to 100% rPET bottles by 2030;

 

·

In 2020, L’OCCITANE en Provence committed to 100% recycled content plastic in their bottles by 2025;

 

·

In 2020, L’Oréal Group committed to using 100% recycled or biobased plastic in their packaging by 2030;

 

·

By 2025, Unilever targets increasing the use of post-consumer recycled plastic material in their packaging to at least 25%;

 

·

Colgate-Palmolive states a 2025 goal of using at least 25% post-consumer recycled plastic in packaging;

 

·

Nestlé aims to increase the amount of recycled PET used across their brands globally to 50% by 2025;

 

·

Adidas Group aims to replace all virgin polyester with recycled polyester in all adidas and Reebok products where a solution exists by 2024;

 

·

H&M is aiming to ensure that at least 25% of the plastic they use is from post-consumer recycled materials.

 

·

Walmart has an objective to use at least 17% post-consumer recycled content globally in their private brand plastic packaging and is taking action to eliminate problematic or unnecessary plastic packaging and move from single-use toward reuse models where relevant by 2025; and

 

·

Ikea’s ambition is, that by 2030, all plastic used in their products will be based on renewable or recycled material.

 

There is a growing regulatory and policy environment to encourage a reduction in the production of virgin fossil fuel-based plastic and for minimum recycled content in packaging imposed by various governments. For example, on July 21 2020, the European Union announced a new tax on plastic waste starting January 1, 2021. This tax will have a rate of €800/ton on non-recycled plastic packaging. In the UK, a new £200/ton tax will apply to plastic packaging produced or imported into the UK that does not contain at least 30% recycled plastic, effective 2022. A California law enacted on September 24, 2020 requires that plastic bottles contain at least 15% post-consumer resin by 2022, 25% by 2025 and 50% by 2030. The growing regulatory environment is expected to increase the demand for recycled PET plastic further.

 

 
4

Table of Contents

 

As explained by the International Bottled Water Association, currently, mechanical recycled PET (rPET) plastic is produced principally through the conversion of bales of PET bottles. The materials have been collected and transported to a materials recovery facility (“MRF”), where they are sorted from other materials, baled, and sent to specific PET recycling facilities. The bales are broken and sorted to remove any non-PET materials. The PET is then ground and put through a separation process which separates the PET from the bottle cap and label materials. Clean PET flake is then further processed depending on its intended end market. It may become more highly refined PET pellet for new bottles or extruded into PET sheet for clamshells, trays, and cups. Recycled PET is also spun into fiber for carpet, clothing, fiber fill, or other materials.

 

We believe mechanically recycled PET has a number of challenges in meeting the quality specifications and growing volume requirements implied by commitments from major brands, mainly due to the cost and variety of acceptable PET feedstock. Some mechanical recycling processes involve remelting the PET flake which reduces the quality of the rPET output each time it is recycled relative to the specifications of virgin PET produced from fossil fuels. Each time the PET plastic is mechanically recycled, its quality and clarity are reduced. Therefore, mechanically recycled PET may need to be mixed with virgin PET from fossil fuels to maintain quality. Lower quality mechanically recycled PET is often downcycled to alternate uses such as polyester fibers which may be dyed and used in carpets or clothing. Additionally, mechanically recycled PET manufactured for use in clear bottles or food containers requires predominantly clear and clean PET flakes separated from waste bales, and cannot accommodate darkly colored PET flakes, lower quality fiber feedstock, or materially contaminated feedstock, which may be cheaper.

 

We believe the commercialization plans of Loop™ PET resin and polyester fiber may provide the ideal solution for global brands because Loop™ PET resin and polyester fiber contains 100% recycled PET and polyester fiber content. The Loop™ PET resin and polyester fiber is virgin-quality suitable for use in food-grade packaging. That means consumer packaged goods companies will be able to choose to market packaging made from a 100% Loop™ branded PET resin and polyester fiber.

 

Proprietary Technology and Intellectual Property

 

We believe, the power of our technology lies in its ability to use post-industrial and post-consumer waste PET plastic and polyester fiber feedstocks, which could end up in landfills, rivers, oceans and natural areas, to create Loop™ PET resin. We believe our technology can deliver high-purity profitable virgin-quality PET resin suitable for use in food-grade packaging and polyester fiber.

 

Our Generation I technology (“GEN I”) is a hydrolysis-based depolymerization technology which yielded purified terephthalic acid (“PTA”) and monoethylene glycol (“MEG”), two common monomers of PET. As the Company evaluated the transition from the GEN I technology from pilot scale to commercial scale, several challenges involving PTA and MEG purification were identified. To overcome the GEN I technology challenges, we embarked on the development of a second generation of our technology. Our Generation II technology (“GEN II”) is a methanolysis-based depolymerization technology that uses temperatures below 90 °C to depolymerize waste PET and polyester fiber. The low temperature offers several key advantages which the company believes will improve its ability to commercialize the GEN II technology, including;

 

 

·

Lower energy usage during depolymerization and therefore reduced processing cost relative to higher temperature processes;

 

·

Avoidance of side reactions with non-PET waste, which are inherent in waste PET feedstock streams, during depolymerization which may occur during higher temperature and higher pressure depolymerization processes. This allows for a simplified distillation purification process resulting in less, and more effective, steps to isolate the desired high purity DMT and MEG monomers suitable to produce virgin-quality PET required to meet food contact regulations as well as the quality and clarity requirements of global consumer product companies;

 

·

Allowing the depolymerization of less costly and low-quality feedstocks, which cannot be effectively recycled today, such as carpet fiber, clothing and mixed plastics, and upcycling them into high-quality PET that can be used in food contact use; and

 

·

The GEN II technology uses only trace amounts of water, eliminates the need for a halogenated solvent and uses a catalyst at low concentration.

 

 
5

Table of Contents

 

This shift, from producing the monomer PTA to the monomer DMT, was a pivotal moment for Loop Industries. We believe that GEN II requires less energy and fewer resource inputs than conventional PET production processes. We also believe it is an environmentally sustainable method for producing virgin-quality food-grade PET plastic by decoupling PET manufacturing from the fossil fuel industry.

 

To independently validate that our GEN II technology can produce DMT and MEG monomers at mini-pilot and pilot scale, we commissioned Kemitek, a College Centre for Technology Transfer specialized in the fields of green chemistry and chemical process scale-up. Kemitek’s findings allowed them to confirm that our technology produces monomers that meet our purity specifications for the production of PET resin and polyester fiber. The complete Kemitek report was filed with the SEC by the Company on December 14, 2020.

 

To protect our technology, we rely on a combination of patents, trademarks, trade secrets, confidentiality agreements and provisions as well as other contractual provisions to protect our proprietary rights, which are primarily our patents, brand names, product designs and marks, we have two technology areas, referred to as GEN I technology and the GEN II technology, with patent claims relating to our technology for depolymerizing PET.

 

 

·

The GEN I technology portfolio has three issued U.S. patents, all expected to expire on or around July 2035. Internationally, we also have issued patents in China, the Eurasian Patent Organization, Europe, Japan, the Gulf Cooperation Council, and various other countries, an allowed patent application in the Philippines, and pending patent applications in Canada, India, Japan, South Korea, and various other countries all expected to expire, if granted, on or around July 2036, not including any patent term extension.

 

·

The GEN II technology portfolio currently consists of four patent families:

 

 

o

The first has two issued U.S. patent and a pending U.S. application, all expected to expire on or around September 2037. Internationally, we also have an issued patent in Bangladesh, and pending applications in Canada, China, the Eurasian Patent Organization, Europe, the Gulf Cooperation Council, India, Japan, Mexico, South Korea, and various other countries, all expected to expire on or around September 2038, if granted and not including any patent term extension.

 

o

An additional aspect of the GEN II technology is claimed in an issued U.S. patent and a pending U.S. application, all expected to expire on or around June 2039. Internationally, we also have an allowed patent application in Bangladesh and pending applications in Canada, China, the Eurasian Patent Organization, Europe, the Gulf Cooperation Council, India, Japan, Mexico, South Korea, and various other countries, all expected to expire on or around June 2039, if granted and not including any patent term extension.

 

o

A further additional aspect of the GEN II technology is the subject of a pending U.S. application. Any patents that would ultimately grant from this application would be expected to expire on or around March 2040, not including any patent term extension.

 

o

Another further additional aspect of the GEN II technology is the subject of a pending U.S. application, a pending International application, and pending applications in Canada, the Eurasian Patent Organization, Europe, the Gulf Cooperation Council, India, Japan, Mexico, and various other countries. Any patents that would ultimately grant from these applications would be expected to expire on or around March 2040, if granted and not including any patent term extension.

 

Loop owns registrations for its trademarks in Canada, the European Union, the United Kingdom, and the U.S. Loop also has pending applications in Cambodia, Canada, Indonesia, Taiwan, the U.S., and Vietnam.

 

 
6

Table of Contents

 

Government Regulation and Approvals

 

As we seek to further develop and commercialize our technology, we will be subject to extensive and frequently developing federal, state, provincial and local laws and regulations. Compliance with current and future regulations, including food packaging regulations, could increase our operational costs.

 

Our operations require various governmental permits and approvals. We are in the process of obtaining all necessary permits and approvals for the operation of our business; however, any of these permits or approvals may be subject to denial, revocation or modification under various circumstances. Additionally, due to the impact of the COVID-19 pandemic, we may experience delays in obtaining such permits or approvals. Failure to obtain or comply with the conditions of permits and approvals or to have the necessary approvals in place may adversely affect our operations and may subject us to penalties. See “Risk Factors” below for additional information.

 

We believe that if we are successful in addressing food packaging regulations in various countries and economic regions, that the regulatory environment may provide Loop™ PET resin a competitive advantage relative to mechanically recycled alternative resins and virgin PET.

 

Loop’s PET resin was subjected to independent testing by an external and certified laboratory, which confirmed the PET complies with FDA Regulation 21 CFR § 177.1630 on August 26, 2021, as well as EU Commission Regulation No 10/2011 on July 27, 2021. These results attest that Loop’s PET is safe for use in food-contact applications, including but not limited to bottled water, carbonated drinks and food trays. Demonstration of compliance with food-contact requirements follows the No Objection Letter (“NOL”) from the FDA previously granted to Loop in March 2021. The NOL confirms Loop’s monomers can produce rPET of a purity suitable for food-contact use, provided it meets the applicable requirements of Title 21 of the Code of Federal Regulations. The monomers used in the PET resin submitted for testing were produced at Loop’s small-scale production facility in Terrebonne, Quebec.

 

We have received from the European Chemicals Agency a confirmation of registration for our MEG on November 17, 2020, and for our DMT on December 7, 2020. The registration under the Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”) Regulation (EC 1907/2006) confirms that our monomers are of a purity equal to what is currently recognized within Europe and entitles us to manufacture/import the monomers into Europe. It should be noted that MEG and DMT are on the positive list for plastic materials, which means that the two monomers can be used as food contact materials.

 

On August 31, 2021, Loop also received a NOL from Health Canada, which states that the PET produced by Loop’s recycling process is suitable for use in the manufacture of water bottles and articles for contact with all food types under all conditions of use. In this letter, Health Canada confirms it sees no reason to object to the use of Loop’s recycling process, provided it is technically suitable for the intended end-uses.

 

Supply Agreements with Global Consumer Brands

 

Consumer brands are seeking a solution to their plastic challenge and they are taking bold action. In the past years, we have seen major brands make significant commitments to close the loop on their plastic use in two ways; by transitioning their packaging to recyclable materials and by incorporating more recycled content into their packaging. We believe Loop™ PET resin provides the ideal solution for these brands because it is recyclable and is made from 100% recycled PET waste and polyester fiber, while being virgin-quality and suitable for use in food-grade packaging and polyester fiber.

 

Due to the commitments by large global consumer brands to incorporate more recycled content into their product packaging, the regulatory requirements for minimum recycled content in packaging imposed by governments, the virgin-quality of Loop™ branded PET resin and its marketability to extoll the sustainability credentials of consumer brands that incorporate it, we believe we will be able to sell Loop™ branded PET resin at a premium price relative to virgin and mechanically recycled PET resin.

 

 
7

Table of Contents

 

We are pursuing supply agreements with customers that are located in North America, Europe, and Asia. We currently have agreements with some of the world’s leading brands to be supplied from our planned commercial facility from our joint venture with Indorama Ventures Holdings LP (“Indorama”) in Spartanburg, South Carolina, including:

 

 

·

Multi-year supply agreement with Danone SA, one of the world’s leading global food and beverage companies. Danone will purchase 100% sustainable and upcycled Loop™ branded PET for use in brands across its portfolio including evian®, Danone’s iconic natural spring water;

 

 

 

 

·

Multi-year supply agreement with PepsiCo, one of the largest purchasers of recycled PET plastic, enabling PepsiCo to purchase production capacity and incorporate Loop™ PET resin into its product packaging;

 

 

 

 

·

Multi-year supply agreement with L’OCCITANE en Provence to supply 100% recycled and sustainable Loop™ PET resin and incorporate Loop™ PET resin into its product packaging; and

 

 

 

 

·

Multi-year supply agreement with L’Oréal Group, the global leader in the beauty industry, enabling L’Oréal Group to purchase production capacity and incorporate Loop™ PET resin into its product packaging.

 

Turning PET Waste into Feedstock

 

We use waste PET plastic and polyester fiber as feedstock. Our technology can use PET plastic bottles and packaging of any color, transparency or condition, carpet, clothing and other polyester textiles that may contain colors, dyes or additives, and even PET plastics that have been recovered from the ocean and degraded by exposure to sun and salt. We believe that our ability to use many materials that mechanical recyclers cannot use is an important advantage of Loop™ PET resin over mechanically recycled PET resin. This also means we are creating a new market for materials that have persistently been leaking out of the waste management system and into our shared rivers, oceans and natural areas.

 

Commercialization Plan and Progress

 

During the six-month period ended August 31, 2021, we continued executing our corporate strategy with a focus on the commercialization of our technology. We are progressing on the engineering of our full-scale commercial facilities with our engineering partner Worley, a leading global engineering, procurement and construction company. The engineering philosophy we have adopted is “design one, build many.” This approach allows for the process design package, which has been completed, to be used as the base engineering platform for all future geographical expansion. We believe this approach allows for a quick execution, speed to market and lends itself well to modular construction.

 

The Infinite Loop™ manufacturing technology is the key pillar of our commercialization blueprint. We believe our technology is at the forefront of the global transition away from fossil fuels and petrochemicals and into the circular economy, where PET plastic and polyester fiber are produced from recycled content. The Infinite Loop™ technology is being engineered to support the commitment of global consumer brands to achieve a high level of recycled content in packaging. Infinite Loop™ facilities could be located near large urban centers where more plastic is being consumed and therefore more waste plastic feedstock is likely available.

 

Our objective is to achieve global expansion of the technology through a mix of fully owned facilities, strategic partnerships, and licensing agreements. We believe that industrial companies, some of which today may not be in the business of manufacturing PET resin or polyester fiber, will view involvement in Infinite Loop™ projects as a growth opportunity, which may offer attractive economic returns either as Loop manufacturing partners or as licensees of the technology. We are currently pursuing projects for future commercial production facilities in four regions: Canada, Europe, Asia and the U.S.

 

On September 2, 2020, we entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET resin and polyester fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The INVISTA know how will be used for the polymerization of DMT and MEG monomer output from Loop’s depolymerization technology, the result of which is LoopTM PET resin or polyester fiber made from 100% recycled content. The INVISTA polymerization process and the associated designs are historically proven in the commercial production of PET resin and polyester fiber.

 

 
8

Table of Contents

 

We continue to focus on the completion of the Infinite Loop™ engineering design with an initial target capacity of up to 70,000 metric tons/year. Permitting, site and regulatory considerations may impact plant capacity for the various projects. The design includes the integration of our depolymerization technology with INVISTA’s polymerization technology in partnership with Worley. We intend to use this design when evaluating Infinite Loop™ facilities in various regions. Worley has completed the pre-feasibility engineering as part of the planning phase for an Infinite Loop™ manufacturing facility in the province of Québec. We expect that Worley may also play a role in the feasibility phase of engineering and the future design of larger capacity facilities.

 

Our market strategy is to assist global consumer goods brands in meeting their public sustainability commitments by offering packaging or polyester fibers that are made with Loop co-branded, 100% recycled, virgin-quality PET or polyester fibers. We believe that Infinite Loop™ recycled PET resin and polyester fiber could command premium pricing over virgin, petroleum-based PET resin and provide attractive economic returns. We are targeting multi-year take or pay offtake agreements for planned Infinite Loop™ production. Factors under consideration in determining project economics include pre-feasibility design engineering and cost estimate work, timing and permitting of a facility, customer offtake demand, commitment terms, and feedstock sources, quality, availability, logistics, and ramp up, among others.

 

Strategic Partnership with SK geo centric

 

Loop and SK geo centric Co., Ltd. (formerly known as SK global chemical Co. Ltd.) (“SKGC”) intend to form a joint venture with exclusivity to build sustainable PET plastic and polyester fiber manufacturing facilities throughout Asia, which accounts for approximately 60 percent of the world’s population and an estimated 70% of global PET consumption making it the largest market in terms of plastic manufacturing, consumption and waste. Under the terms of the Memorandum of Understanding (“MOU”) for the proposed joint venture, SKGC will own 51 percent of the joint venture and Loop will own 49 percent. Loop will also receive a recurring annual royalty fee as a percentage of revenue from each facility for the use of its technology.

 

In addition, Loop and SKGC have concluded a definitive agreement for SKGC to become a strategic investor in Loop. SKGC purchased 4,714,813 new treasury common shares of Loop at a price of $12 per share, for total consideration of $56.5 million. The equity investment transaction closed on July 29, 2021. SKGC was also granted warrants to acquire an additional 461,298 common shares at $11 per share within the next 12 months, 4,714,813 common shares at a price of $15 per share, within the next 3 years, and a further 2,357,407 shares at $20 per share, conditional upon the timing of construction of the first Asian manufacturing facility. SKGC was granted one seat on Loop’s Board of Directors and as such is expected to provide valued input into the continuing development of Loop’s global commercialization strategy.

 

SKGC now owns approximately 10% of Loop’s common shares. In conjunction with the equity investment, Mr. Jonghyuk Lee, Vice President of SKGC’s Green Business Division, has been appointed to Loop’s Board of Directors. This appointment reflects SKGC’s strategic view of the importance of its investment in Loop, as part of its “Green for Better Life” global strategic vision.

 

As reported on July 8, 2021 SKGC signed a memorandum of understanding (“MOU”) with the city of Ulsan, South Korea to develop an industrial complex which would be planned to include the first Infinite Loop™ manufacturing facility in Asia.

 

SK global chemical unveiled on August 31, 2021 its rebrand as SK geo centric, aligning with the company’s goal of transforming into a green company and focusing on eco-friendly products such as recyclable plastics. These announcements further reinforce Loop’s alignment as an important strategic partner for SK geocentric, as we move to commercialize our technology in Asia.

 

Unveiling of New evian Loop Bottle

 

On September 20, 2021, Loop, in partnership with iconic global beverage brand evian, unveiled a new “evian Loop” prototype virgin-quality water bottle made from 100 percent recycled content. The monomers used to produce the evian Loop bottles were made at Loop’s small-scale production facility in Terrebonne, Quebec. Evian plans to begin selling water bottles made from Loop™ PET initially in South Korea next year, and subsequently in other global markets. The waste plastic used to produce these bottles include polyester fibers from carpets and clothing which are considered unrecyclable and destined for landfill and other natural environments. This initiative reflects evian’s commitment to its stated 2025 goals for circularity and recycled content.

  

Loop continues to work toward new brand and market introductions with additional consumer goods brand companies.

 

 
9

Table of Contents

 

Infinite Loop™ Bécancour, Québec

 

We are in the planning phase for an Infinite Loop™ manufacturing facility in the province of Québec (the “Québec Project”). On May 27, 2021, we acquired a 19 million square foot parcel of land in Bécancour, Québec for $4.8 million (CDN $5.9 million). The site offers attractive logistics being located on the St-Lawrence river and access to rail. The site size exceeds our project needs and we plan to sell a portion of the land to offset part of our project commitment.

 

The Québec Project is currently contemplated as wholly-owned and operated by Loop Industries which allows us to commercialize near our innovation and engineering teams located in Terrebonne, Québec. To fund the project and enhance our target returns, we are exploring financing options. Alternatives under exploration include incentive and financing programs supported by, or in partnership with, various levels of government.

 

The Québec Project would allow the Company to proceed with Infinite Loop™ commercialization in a more expeditious manner without being impacted by COVID-19 restrictions on international travel.

 

Infinite Loop™ Europe

 

We announced on September 10, 2020 a strategic partnership with SUEZ GROUP (“Suez”), with the objective to build the first Infinite Loop™ manufacturing facility in Europe. With the combination of the Infinite Loop™ technology and the resource management expertise of Suez, this partnership seeks to respond to growth in demand in Europe from global beverage and consumer goods brand companies for virgin quality PET resin made from 100 percent recycled content. Together with Suez, we have initiated the work to enable us to make a final investment decision for the project with the current priorities being site selection, feedstock sourcing and customer contracts. We continue to work with our partner on finalizing the details of the site selection.

  

Joint Venture with Indorama

 

In September 2018 we announced a joint venture with Indorama to retrofit certain PET manufacturing facilities. We entered into a Limited Liability Company Agreement between (the “LLC Agreement”), a Marketing Agreement (the “Marketing Agreement”) and a License Agreement (the “License Agreement”), each dated September 24, 2018, with Indorama through our wholly-owned subsidiary Loop Innovations, LLC (“Loop Innovations”), a Delaware limited liability company. Each company has 50/50 equity interest in the joint venture. We are contributing to the 50/50 joint venture an exclusive worldwide royalty-free license to use our proprietary technology to produce 100% sustainably produced PET resin in addition to our equity cash contribution. In 2019, the joint venture decided to increase the capacity of the planned Spartanburg, South Carolina plant due to customer demand to 40,000 metric tons per year from the initially planned 20,700 metric tons per year.

 

We have currently contracted for the sale of approximately 40% of the planned capacity, of the expected output of the Spartanburg facility and we will resume discussions for the remaining volume once we have more visibility on the commissioning date of the facility, although we have had and may continue to experience delays due to the COVID-19 pandemic (see “The global COVID-19 pandemic” as noted under “Risk Factors”). As part of the Joint Venture Agreement, we are committed to contribute our equity share for the costs under the joint venture agreement to construct the facility. During the year ended February 28, 2021, we made a contribution of $650,000 and as at August 31, 2021, we have contributed a total of $1,500,000 to the joint venture.

 

The joint venture made a decision over the summer of 2020 that due to the COVID-19 pandemic it would temporarily delay work on the project. Since then, no expenditures have been incurred by the joint venture. While both joint venture partners currently remain committed to the project, we continue to monitor the COVID-19 implications on the project timetable.

 

 
10

Table of Contents

 

In conjunction with the SK strategic partnership mentioned above, on June 18, 2021, the Company, Loop Innovations, Indorama and Indorama Loop Technologies, LLC (the “Indorama Joint Venture Company”) amended (i) the LLC Agreement, (ii) the Marketing Agreement and (iii) the License Agreement (collectively such amendments, the “Indorama Joint Venture Amendments”).

 

Under the Indorama Joint Venture Amendments, the Company, Indorama and the Indorama Joint Venture Company agreed to:

 

 

·

terminate Indorama’s right of first refusal under the LLC Agreement over any facility to produce products utilizing any waste-to-resin technology applying the PET depolymerization process of the Company;

 

·

amend the non-compete obligations under the LLC Agreement to solely apply to the Company;

 

·

limit the scope of the Company’s grant of intellectual property rights and the scope of the exclusivity rights of the Indorama Joint Venture Company for the retrofit of existing facilities under the License Agreement to North America and Europe; and

 

·

limit the scope of the Indorama Joint Venture Company’s permitted marketing rights under the Marketing Agreement to North America and Europe.

 

The foregoing description of the Indorama Joint Venture Amendments does not purport to be complete and is qualified in its entirety by reference to the Indorama Joint Venture Amendments, a copy of which was filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended May 31, 2021 and incorporated therein by reference.

 

Small-scale Production Facility and Innovation Center in Terrebonne, Québec

 

As part of our plan for the commercialization of future Infinite Loop™ manufacturing facilities, we decided to convert our Terrebonne, Québec pilot plant to an Infinite Loop™ small-scale production facility. This facility will be used to showcase the Infinite Loop™ end to end technology and deliver initial production volumes to support co-branded market launch campaigns with partners and customers, and train operational teams in advance of the commissioning of the Infinite Loop™ full-scale commercial plants.

 

We made significant investments in the small-scale production facility during the six-month period ended August 31, 2021. In particular, we installed and began operation of new distillation columns in this period. We also advanced testing and production on the two installed depolymerization reactors which substantially increase our small-scale production facility’s depolymerization capacity and confirm the design and scale-up factor for the feasibility engineering of the planned commercial-scale facilities. We anticipate the Infinite Loop™ small-scale production facility depolymerization upgrades to be largely completed by late in calendar 2021. We have also previously entered into an agreement to acquire PET polymerization equipment from Chemtex to manufacture of Loop™ branded PET resin at our small-scale production facility and deliver Loop™ branded PET resin to customers in calendar 2022.

 

In addition to the capital requirements for our commercialization, we continue to invest in strengthening our intellectual property portfolio, building a core competency in managing strategic relationships and continue enhancing our brand value with activities such as the September 20, 2021 co-branded marketing launch of an evian Loop bottle for the South Korean market in 2022. Our research and development innovation center in Terrebonne, Québec will continue to push forward the development of our technology.

 

Human Capital

 

Our employees are essential to our success and we are committed to providing a safe, productive, discrimination-free and harassment-free work environment. All employees are responsible for compliance with our Code of Ethics as well as our health and safety, and anti-harassment policies. These policies and practices help us foster a workplace environment that promotes inclusion and diversity.

 

To attract and retain highly capable and innovative employees, we have developed competitive compensation packages and benefits programs. Our compensation packages include market-competitive pay, healthcare benefits, paid time off and family leave and flexible work schedules. We also offer equity awards with multi-year vesting provisions to incentivize and reward our employees for long-term corporate performance and promote retention throughout the vesting period.

  

To support our employees this fiscal year and to promote their health and safety, we encouraged administrative and engineering employees to work remotely. We provided emergency leave for employees to take care of a child or parent due to COVID-19 disruptions.

 

As of August 31, 2021, we had 79 employees of which 32 work in research and development and 34 in engineering and operations.

 

 
11

Table of Contents

 

Results of Operations

 

The following table summarizes our operating results for the three-month periods ended August 31, 2021 and 2020, in U.S. Dollars.

 

 

 

Three months ended August 31,

 

 

 

2021

 

 

2020

 

 

Change

 

Revenues

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

394,527

 

 

 

352,282

 

 

 

42,245

 

External engineering

 

 

551,381

 

 

 

942,117

 

 

 

(390,736)

Employee compensation

 

 

1,098,161

 

 

 

708,387

 

 

 

389,774

 

Machinery and equipment expenditures

 

 

2,485,232

 

 

 

-

 

 

 

2,485,232

 

Plant and laboratory operating expenses

 

 

707,043

 

 

 

584,394

 

 

 

122,649

 

Other

 

 

48,453

 

 

 

162,042

 

 

 

(113,589)

Total research and development

 

 

5,284,797

 

 

 

2,749,222

 

 

 

2,535,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

313,292

 

 

 

513,649

 

 

 

(200,357)

Professional fees

 

 

856,997

 

 

 

420,434

 

 

 

436,563

 

Employee compensation

 

 

554,830

 

 

 

488,824

 

 

 

66,006

 

Directors and officers insurance

 

 

1,059,153

 

 

 

502,368

 

 

 

556,785

 

Other

 

 

331,954

 

 

 

123,966

 

 

 

207,988

 

Total general and administrative

 

 

3,116,226

 

 

 

2,049,241

 

 

 

1,066,985

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

140,770

 

 

 

302,587

 

 

 

(161,817)

Interest and other financial expenses

 

 

33,102

 

 

 

(58,905)

 

 

92,007

 

Interest income

 

 

(8,413)

 

 

(18,039)

 

 

9,626

 

Foreign exchange loss (gain)

 

 

(174,066)

 

 

103,618

 

 

 

(277,684)

Total expenses

 

 

8,392,416

 

 

 

5,127,724

 

 

 

3,264,692

 

Net loss

 

$(8,392,416)

 

$(5,127,724)

 

$(3,264,692)

 

Second Quarter Ended August 31, 2021

 

The net loss for the three-month period ended August 31, 2021 increased $3.26 million to $8.39 million, as compared to the net loss for the three-month period ended August 31, 2020 which was $5.13 million. The increase is primarily due to increased research and development expenses of $2.54 million and increased general and administrative expenses of $1.07 million, offset by a lower foreign exchange loss of $0.28 million and a decrease in depreciation and amortization expenses of $0.16 million.


The $2.54 million increase in research and development for the three-month period ended August 31, 2021 was primarily attributable to the following:

 

 

·

$2.49 million increase in purchases of research and development machinery and equipment. Starting in Q3 of fiscal 2021, the Company expensed machinery and equipment in accordance with ASC 730, Research and Development Costs, and no longer capitalized these costs. The timing of this accounting treatment is related to management’s decision to convert our pilot plant to a small-scale production facility for brand activation, initial customer volumes and Infinite Loop™ demonstration, research and development activities;

 

·

$0.39 million increase in employee compensation expenses; and

 

·

$0.12 million increase in plant and laboratory operating expenses.

  

These increases are offset by a $0.39 million decrease in external engineering expenses as a larger proportion of ongoing design work for our Infinite Loop™ manufacturing process was performed by our in-house engineering team during the three months ended August 31, 2021.

 

 
12

Table of Contents

 

The $1.07 million increase in general and administrative expenses for the three-month period ended August 31, 2021 was primarily attributable to the following:

 

 

·

$0.56 million increase in insurance expenses mainly due to directors and officers (“D&O”) insurance renewal costs; and

 

·

$0.44 million increase in expenses for legal and professional fees due to costs principally associated with the SEC investigation and class action suits described in “Part II, Item 1. Legal Proceedings”.

 

The $0.16 million decrease in depreciation and amortization expenses for the three-month period ended August 31, 2021 is mainly attributable to the write-down of machinery and equipment assets related to the decision in the third quarter of fiscal 2021 to dedicate the small-scale production facility to brand activation, initial customer volumes and Infinite Loop™ demonstration, research and development activities. Although the machinery and equipment will continue to be utilized at our small-scale production facility as it is an integral part of supporting the commercialization of our technology, application of ASC 730, Research and Development Costs requires machinery and equipment assets to be written off and all future costs associated with the small-scale production facility to be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss.

 

Six Months Ended August 31, 2021

 

The following table summarizes our operating results for the six-month periods ended August 31, 2021 and 2020, in U.S. Dollars.

 

 

 

Six months ended August 31,

 

 

 

2021

 

 

2020

 

 

Change

 

Revenues

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

790,072

 

 

 

704,289

 

 

 

85,783

 

External engineering

 

 

3,454,829

 

 

 

1,017,049

 

 

 

2,437,780

 

Employee compensation

 

 

2,788,744

 

 

 

1,175,428

 

 

 

1,613,316

 

Machinery and equipment expenditures

 

 

5,108,125

 

 

 

-

 

 

 

5,108,125

 

Plant and laboratory operating expenses

 

 

1,398,510

 

 

 

870,497

 

 

 

528,013

 

Other

 

 

382,352

 

 

 

462,547

 

 

 

(80,195)

Total research and development

 

 

13,922,632

 

 

 

4,229,810

 

 

 

9,692,822

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(70,338)

 

 

1,173,466

 

 

 

(1,243,804)

Professional fees

 

 

2,488,447

 

 

 

642,131

 

 

 

1,846,316

 

Employee compensation

 

 

1,399,865

 

 

 

971,859

 

 

 

428,006

 

Directors and officers insurance

 

 

1,927,799

 

 

 

975,941

 

 

 

951,858

 

Other

 

 

531,024

 

 

 

238,926

 

 

 

292,098

 

Total general and administrative

 

 

6,276,797

 

 

 

4,002,323

 

 

 

2,274,474

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

272,770

 

 

 

558,561

 

 

 

(285,791)

Interest and other financial expenses

 

 

63,689

 

 

 

67,871

 

 

 

(4,182)

Interest income

 

 

(18,174)

 

 

(58,386)

 

 

40,212

 

Foreign exchange loss

 

 

32,066

 

 

 

180,259

 

 

 

(148,193)

Total expenses

 

 

20,549,780

 

 

 

8,980,438

 

 

 

11,569,342

 

Net loss

 

$(20,549,780)

 

$(8,980,438)

 

$(11,569,342)

 

The net loss for the six-month period ended August 31, 2021 increased $11.57 million to $20.55 million, as compared to the net loss for the six-month period ended August 31, 2020 which was $8.98 million. The increase is primarily due to increased research and development expenses of $9.69 million and increased general and administrative expenses of $2.27 million, offset by lower depreciation and amortization expenses of $0.29 million and a decrease in foreign exchange loss of $0.15 million.

 

 
13

Table of Contents

 
The $9.69 million increase in research and development for the six-month period ended August 31, 2021 was primarily attributable to the following:

 

 

·

$5.11 million increase in purchases of research and development machinery and equipment. Starting in Q3 of fiscal 2021, the Company expensed research and development machinery and equipment in accordance with ASC 730, Research and Development Costs, and no longer capitalized these costs. The timing of this accounting treatment is related to management’s decision to convert our pilot plant to a small-scale production facility for brand activation, initial customer volumes and Infinite Loop™ demonstration, research and development activities;

 

·

$2.44 million increase in external engineering expenses for ongoing design work for our Infinite Loop™ manufacturing process;

 

·

$1.61 million increase in employee compensation expenses; and

 

·

$0.53 million increase in plant and laboratory operating expenses.

 

The $2.27 million increase in general and administrative expenses for the six-month period ended August 31, 2021 was primarily attributable to the following:

 

 

·

$1.85 million increase in expenses for legal and professional fees due to costs principally associated with the SEC investigation and class action suits described in “Part II, Item 1. Legal Proceedings”;

 

·

$0.95 million increase in insurance expenses mainly due to directors and officers (“D&O”) insurance renewal costs; and

 

·

$0.43 million increase in employee compensation expenses.

 

The listed increases in general and administrative expenses were partially offset by lower stock-based compensation expenses of $1.04 million which are mainly due to forfeitures of RSUs recorded in the six-month period ended August 31, 2021 for a total of $0.94 million.

 

The $0.29 million decrease in depreciation and amortization expenses for the six-month period ended August 31, 2021 is mainly attributable to the write-down of machinery and equipment assets related to the decision in the third quarter of fiscal 2021 to dedicate the small-scale production facility to brand activation, initial customer volumes and Infinite Loop™ demonstration, research and development activities. Although the machinery and equipment will continue to be utilized at our small-scale production facility as it is an integral part of supporting the commercialization of our technology, application of ASC 730, Research and Development Costs requires machinery and equipment assets to be written off and all future costs associated with the small-scale production facility to be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Liquidity

 

We are a development stage company with no revenues, and our ongoing operations and commercialization plans have been financed primarily by raising new equity capital. To date, we have been successful in raising capital to finance our ongoing operations. As at August 31, 2021, we had cash and cash equivalents on hand of $65.56 million. Management actively monitors the Company’s cash balance and short term cash commitments to ensure current operations are funded.

    

As part of our strategic partnership with SKGC, SKGC purchased 4,714,813 new treasury common shares of Loop at a price of $12 per share, for total consideration of $56.5 million. The strategic equity investment closed on July 29, 2021. SKGC was also granted options to acquire an additional 461,298 common shares at $11 per share within the next 12 months, 4,714,813 common shares at a price of $15 per share, within the next 3 years, and a further 2,357,407 shares at $20 per share, conditional upon the timing of construction of the first Asian manufacturing facility.

 

Management continues to pursue our growth strategy and is evaluating our financing plans to continue to raise capital to finance the start-up of commercial operations and continue to fund our ongoing operations. Although our liquidity position consists of cash and cash equivalents on hand of $65.56 million, our liquidity position may change and is subject to risks and uncertainties, including those discussed under “Cautionary Statements Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q and the Risk Factors section included in Part I, Item 1A of our 2021 Annual Report on Form 10-K.

    

 
14

Table of Contents

 

As reflected in the accompanying consolidated financial statements, we are a development stage company, we have not yet begun commercial operations and we do not have any sources of revenue. Management believes that the Company has sufficient financial resources to fund committed operating and capital expenditures and other working capital needs for at least, but not limited to, the 12-month period from the date of issuance of the August 31, 2021 consolidated financial statements. There can be no assurance that any future financing will be available or, if available, that it will be on terms that are satisfactory to us.

 

We have a short-term debt obligation to a Canadian bank in connection with the purchase, in the year ended February 28, 2018, of the land and building where our small-scale production facility, research and development center and corporate offices are located at 480 Fernand-Poitras, Terrebonne, Québec, Canada J6Y 1Y4. On January 24, 2018, the Company obtained a $1,109,614 (CDN$1,400,000) 20-year term installment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,623 (CDN$5,833) plus interest, until January 2022, at which time it will be subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty.

 

We also have a long-term debt obligation to Investissement Québec in connection with a financing facility equal to 63.45% of all eligible expenses incurred for the expansion of its small-scale production facility up to a maximum of $3,645,875 (CDN$4,600,000). We received the first disbursement in the amount of $1,750,998 (CDN$2,209,234) on February 21, 2020 and the second disbursement in the amount of $1,894,877 (CDN$2,390,766) on August 26, 2021. There is a 36-month moratorium on both capital and interest repayments as of the first disbursement date. At the end of the 36-month moratorium, capital and interest will be repayable in 84 monthly installments. The loan bears interest at 2.36%. We have also agreed to issue to Investissement Québec warrants to purchase shares of our common stock in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $364,587 (CDN$460,000). The warrants were issued at a price per share equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and have a term of three years from the date of issuance. The loan can be repaid at any time by us without penalty. On February 21, 2020, upon the receipt of the first disbursement under this facility, we issued a warrant to purchase 15,153 shares of common stock at a price of $11.00 to Investissement Québec. On August 26, 2021, upon the receipt of the second disbursement under this facility, we issued a warrant to purchase 17,180 shares of common stock at a price of $11.00 to Investissement Québec. There is no remaining amount available under the financing facility after the second disbursement.

 

Flow of Funds

 

Summary of Cash Flows

 

A summary of cash flows for the six months ended August 31, 2021 and 2020 was as follows:

 

 

 

Six Months Ended August 31,

 

 

 

2021

 

 

2020

 

Net cash used in operating activities

 

$(22,400,420)

 

$(7,455,787)

Net cash used in investing activities

 

 

(5,101,573)

 

 

(2,232,238)

Net cash from (used by) financing activities

 

 

57,954,883

 

 

 

(26,836)

Effect of exchange rate changes on cash

 

 

(113,479)

 

 

125,433

 

Net (decrease) increase in cash

 

$30,339,411

 

 

$(10,589,428)

 

Net Cash Used in Operating Activities

 

During the six-month period ended August 31, 2021, we used $22.4 million in operations compared to $7.46 million during the six-month period ended August 31, 2020. The increase over each year is mainly due to increased spending on upgrades to the small-scale production facility, engineering and operating expenses as we advance on commercialization activities of Loop’s technology and D&O insurance payments in the amount of $1.9 million. As discussed above in the Results of Operations, the main increases in expenses were engineering fees, research and development machinery and equipment, employee compensation and professional fees.

 

 
15

Table of Contents

 

Net Cash Used in Investing Activities

   

During the six months ended August 31, 2021, the Company made investments of $5.10 million in property, plant and equipment as compared to $2.32 million for the six months ended August 31, 2020, primarily in connection with the purchase for $4.82 million of a parcel of Land in Bécancour, Québec for the construction of our first Infinite Loop™ manufacturing facility. The size of this parcel of land exceeds that needed for the construction of the Infinite Loop™ manufacturing facility and a portion of the land is therefore available for sale. For additional information on the land held for sale, please refer to Note 5 of the attached condensed consolidated financial statements. During the six months ended August 31, 2021, the Company made investments in intangible assets of $0.1 million, particularly in its patent technology in the United States and around the world.

   

During the six months ended August 31, 2020, the Company made investments of $1.12 million in property, plant and equipment as compared to $1.20 million for the six months ended August 31, 2019, primarily in connection with the upgrade of its small-scale production facility. Additionally, the Company made deposits on equipment of $1.31 million as at August 31, 2020. During the six months ended August 31, 2020, the Company made investments in intangible assets of $0.16 million as compared to $0.08 million for the six months ended August 31, 2019, particularly in its GEN II patent technology in the United States and around the world. During the six months ended August 31, 2020, the Company also made an additional contribution of $0.65 million to Indorama Loop Technologies, LLC, the joint venture with Indorama Ventures Holdings LP, USA.

 

Net Cash (Used) Provided by Financing Activities

 

During the quarter ended August 31, 2021, we raised $56.5 million through a private offering of common stock, together with warrants, in the net amount of $56.1 million. We also made payments totaling $0.03 million against our long-term debt, representing the loan agreement we entered into during the year ended February 28, 2018 to purchase the land and building of our small-scale production facility, research and development center and executive offices.

 

On August 26, 2021, we received $1,894,877 (CDN$2,390,766) in connection with the credit facility from Investissement Québec to finance capital expenses incurred for the expansion of our pilot plant. There is a moratorium on both capital and interest repayments until February 2023.

 

During the six months ended August 31, 2020, we repaid $0.03 million of long-term debt.

 

 
16

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are subject to risks associated with currency fluctuations and changes in foreign currency exchange rates as well as fluctuations in the supply and price of raw materials and commodity prices.

 

Foreign Currency Exchange Risk

 

We operate mainly through two entities, Loop Industries, Inc., which is a Nevada corporation and has a U.S. dollar functional currency, and our wholly-owned subsidiary, Loop Canada Inc. (“Loop Canada”), which is based in Terrebonne, Québec, Canada and has a Canadian dollar functional currency. Our reporting currency is the U.S. dollar.

 

We mainly finance our operations through the sale and issuance of shares of common stock and debt of Loop Industries, Inc. in U.S. dollars while our operations are concentrated in our wholly-owned subsidiary, Loop Canada. Accordingly, we are exposed to foreign exchange risk as we maintain bank accounts in U.S. dollars and a significant portion of our operational costs (including payroll, site costs, costs of locally sourced supplies and income taxes) are denominated in Canadian dollars.

 

Significant fluctuations in the U.S. dollar to the Canadian dollar exchange rates could materially affect our result of operations, cash position and funding requirements. To the extent that fluctuations in currency exchange rates cause our results of operations to differ materially from our expectations or the expectations of our investors, the trading price of our common stock could be adversely affected.

 

From time to time, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. As part of our risk management program, we may enter into foreign exchange forward contracts to lock in the exchange rates for future foreign currency transactions, which is intended to reduce the variability of our operating costs and future cash flows denominated in currencies that differs from our functional currencies. We do not enter into these contracts for trading purposes or speculation, and our management believes all such contracts are entered into as hedges of underlying transactions. Nonetheless, these instruments involve costs and have risks of their own in the form of transaction costs, credit requirements and counterparty risk. If our hedging program is not successful, or if we change our hedging activities in the future, we may experience significant unexpected expenses from fluctuations in exchange rates. Any hedging technique we implement may fail to be effective. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on the trading price of our common stock.

 

Commodity Price Risk

 

The plastics manufacturing industry is extremely price competitive because of the commodity like nature of PET resin and its correlation to the price of crude oil. The demand for recycled PET has fluctuated with the price of crude oil. If crude oil prices decline, the cost to manufacture recycled PET may become comparatively higher than the cost to manufacture virgin PET. Our ability to penetrate the market will depend in part on the cost of manufacturing virgin PET and if we do not successfully distinguish our product from those of virgin PET manufacturers, our entry into the market and our ability to secure customer contracts can be adversely affected.

 

Raw Material Price Risk

 

We purchase raw materials and packaging supplies from several sources. While all such materials are available from independent suppliers, raw materials are subject to fluctuations in price and availability attributable to a number of factors, including general economic conditions, commodity price fluctuations, the demand by other industries for the same raw materials and the availability of complementary and substitute materials. The profitability of our business also depends on the availability and proximity of these raw materials to our factories. The choice of raw materials to be used at our facility is determined primarily by the price and availability, the yield loss of lower quality raw materials, and the capabilities of the producer’s production facility. Additionally, the high cost of transportation could favor suppliers located in close proximity to our factories. If the quality of these raw materials is lower, the quality of our product may suffer. Economic and financial factors could impact our suppliers, thereby causing supply shortages. Increases in raw material costs could have a material adverse effect on our business, financial condition or results of operations. Our hedging procedures may be insufficient, and our results could be materially impacted if costs of materials increase. In light of the uncertain and evolving situation relating to the global COVID-19 pandemic, our access to raw materials, the quality and proximity of such materials may be disrupted. We currently cannot predict the impact that the global COVID-19 pandemic will have on our access to raw materials.

 

 
17

Table of Contents

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Evaluation of our Disclosure Controls and Procedures

 

A. Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

As of the end of the period covered by this Quarterly Report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), pursuant to Rule 13a-15(b) of the Exchange Act. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of August 31, 2021.

 

B. Changes in Internal Control over Financial Reporting

 

There were no other changes in our internal control over financial reporting during the three-month period ended August 31, 2021 that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

  

 
18

Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

SEC Investigation

 

As previously disclosed in our Current Report on Form 8-K filed with the SEC on October 16, 2020, on October 15, 2020, we received a subpoena from the SEC requesting certain information from us, including information regarding testing, testing results and details of results from our GEN I and GEN II technologies and certain of our partnerships and agreements. Prior to its receipt, there had been no previous communication between us and the SEC on this issue. The SEC informed us that its investigation does not mean that the SEC has concluded that anyone has violated the law and that the investigation does not mean that the SEC has a negative opinion of us. We cannot predict when this matter will be resolved or what, if any, action the SEC may take following the conclusion of the investigation.

 

Litigation

 

On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.

 

On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.

 

On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class-action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.

 

Plaintiffs served a consolidated amended complaint on February 18, 2021 which alleges defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relies on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021.

 

On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (the “Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.

 

 
19

Table of Contents

 

From time to time, we may become involved in various lawsuits and legal proceedings or investigations which arise in the ordinary course of business. Except as noted above, we are not presently a party to any legal proceedings, government actions, administrative actions, investigations or claims that are pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business, financial condition or operating results. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

It is possible that we may expend financial and managerial resources in the defense of our intellectual property rights in the future if we believe that our rights have been violated. It is also possible that we may expend financial and managerial resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

 

ITEM 1A. RISK FACTORS

 

We are subject to various risks and uncertainties in the course of our business. Risk factors relating to us are set forth under “Risk Factors” in our Annual Report on Form 10-K, filed on June 1, 2021. No material changes to such risk factors have occurred during the six months ended August 31, 2021.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

As discussed further in Note 13 to the financial statements included in this Quarterly Report, in connection with the strategic partnership with SKGC, on July 29, 2021, we issued 4,714,813 shares of our common stock and warrants to purchase 7,533,518 shares of our common stock SK geo centric Co., Ltd. (formerly known as SK global chemical Co. Ltd.).

 

As discussed further in Note 11 to the financial statements included in this Quarterly Report, in connection with the Investissement Québec financing facility, on August 26, 2021, we issued a warrant to purchase 17,180 shares of our common stock to Investissement Québec.

 

On May 12, 2020, we issued to a service provider a warrant to acquire 25,000 shares of common stock at a strike price of $9.43 per share.

 

Each issuance listed above was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506 of Regulation D promulgated thereunder.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 
20

Table of Contents

  

ITEM 6. EXHIBITS

 

The following Exhibits, as required by Item 601 of Regulation SK, are attached or incorporated by reference, as stated below.

 

Exhibit Index

 

Incorporated by Reference

Number

Description

Form

File No.

Filing Date

Exhibit No.

3.1

Articles of Incorporation, as amended to date

10-K

000-54768

May 30, 2017

3.1

3.2

By-laws, as amended to date

8-K

000-54768

April 10, 2018

3.1

10.1

 

Amendment to Joint Venture Agreements dated June 18, 2021 by and between the Company, Indorama Ventures Holdings LP and other parties thereto

 

10-Q

 

000-54768

 

July 15, 2021

 

10.1

10.2

 

Securities Purchase Agreement dated June 22, 2021 by and between SK Global Chemical Co. LTD.

 

10-Q

 

000-54768

 

July 15, 2021

 

10.2

24.1

Power of Attorney (contained on signature page to the previously filed Annual Report on Form 10-K)

 

10-K

 

000-54768

 

May 8, 2019

 

24.1

31.1

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Filed herewith

31.2

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

Filed herewith

 

 

 

 

32.1

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Furnished herewith

32.2

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

Furnished herewith

 

 

 

 

101.INS

XBRL Instance Document

Filed herewith

101.SCH

XBRL Taxonomy Extension Schema Document

 

 

 

Filed herewith

 

 

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

Filed herewith

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

Filed herewith

 

 

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

Filed herewith

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

Filed herewith

 

 

 

 

   

 
21

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 

Date: October 14, 2021

By:

/s/ Daniel Solomita

 

 

Name:

Daniel Solomita

 

 

Title:

President and Chief Executive Officer, and Director (Principal Executive Officer)

 

 

 

 

 

Date: October 14, 2021

By:

/s/ Drew Hickey

Name:

Drew Hickey

Title:

Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer)

 

 
22

 

EX-31.1 2 loop_ex311.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 loop_ex311.htm

EXHIBIT 31.1

 

SECTION 302 CERTIFICATION

 

I, Daniel Solomita, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 14, 2021

 

/s/ Daniel Solomita

 

 

Daniel Solomita

 

 

President and Chief Executive Officer (principal executive officer)

 

EX-31.2 3 loop_ex312.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 loop_ex312.htm

EXHIBIT 31.2

 

SECTION 302 CERTIFICATION

 

I, Drew Hickey, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 14, 2021

 

/s/Drew Hickey

 

 

Drew Hickey

 

 

Chief Financial Officer (principal financial officer and principal accounting officer)

 

EX-32.1 4 loop_ex321.htm CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 loop_ex321.htm

EXHIBIT 32.1

 

SECTION 906 CERTIFICATION

 

In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended August 31, 2021, the undersigned, Daniel Solomita, President and Chief Executive Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

such Quarterly Report on Form 10-Q for the quarter ended August 31, 2021, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2)

the information contained in such Quarterly Report on Form 10-Q for the quarter ended August 31, 2021, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.

 

Date: October 14, 2021

 

/s/ Daniel Solomita

 

 

 

Daniel Solomita

 

 

 

President and Chief Executive Officer (principal executive officer)

 

 

EX-32.2 5 loop_ex322.htm CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 loop_ex322.htm

 

EXHIBIT 32.2

 

SECTION 906 CERTIFICATION

 

In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended August 31, 2021, the undersigned, Drew Hickey, Chief Financial Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

such Quarterly Report on Form 10-K for the quarter ended August 31, 2021, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2)

the information contained in such Quarterly Report on Form 10-Q for the quarter ended August 31, 2021, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.

 

Date: October 14, 2021

 

/s/ Drew Hickey

 

 

Drew Hickey

 

 

Chief Financial Officer (principal financial officer and principal accounting officer)

 

 

GRAPHIC 6 loop_10qimg1.jpg IMAGE begin 644 loop_10qimg1.jpg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end EX-101.SCH 7 loop-20210831.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - The Company, Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Sales Tax, Tax Credits and Other Receivables link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Prepaid Expenses and Deposits link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Assets held for sale link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Joint Venture link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - Research and Development Expenses link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - General and Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - Share-Based Payments link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - Equity Incentive Plan link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - Interest and Other Finance Costs link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - Prepaid Expenses and Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - Assets held for sale (Tables) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - Research and Development Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - General and Administrative Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - Equity Incentive Plan (Tables) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - Interest and Other Financial Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - The Company Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - Sales Tax Tax Credits and Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - Prepaid Expenses and Deposits (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - Assets held for sale (Details) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - Assets held for sale (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - Property Plant and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - Joint Venture (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - LongTerm Debt (Details) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - LongTerm Debt (Details 1) link:presentationLink link:calculationLink link:definitionLink 000056 - Disclosure - LongTerm Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000057 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000058 - Disclosure - Stockholders Equity (Details) link:presentationLink link:calculationLink link:definitionLink 000059 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 000060 - Disclosure - Stockholders Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000061 - Disclosure - Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 000062 - Disclosure - Research and Development Expenses (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000063 - Disclosure - General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 000064 - Disclosure - General and Administrative Expenses (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000065 - Disclosure - Share-based Payments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000066 - Disclosure - Equity Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 000067 - Disclosure - Equity Incentive Plan (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000068 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 000069 - Disclosure - Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000070 - Disclosure - Interest and Other Financial Costs (Details) link:presentationLink link:calculationLink link:definitionLink 000071 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 loop-20210831_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 loop-20210831_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 loop-20210831_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Entity Interactive Data Current Entity Address Country Condensed Consolidated Balance Sheets Assets Current assets Cash and cash equivalents Sales tax, tax credits and other receivables (Note 3) Prepaid expenses and deposits (Note 4) Assets held for sale (Note 5) Total current assets [Assets, Current] Investment in joint venture (Note 10) Property, plant and equipment, net (Note 6) Intangible assets, net (Note 7) Total assets [Assets] Liabilities and Stockholders' Equity Current liabilities Accounts payable and accrued liabilities (Note 9) Current portion of long-term debt (Note 11) Total current liabilities [Liabilities, Current] Long-term debt (Note 11) Total liabilities [Liabilities] Stockholders' Equity Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding Common stock par value $0.0001: 250,000,000 shares authorized; 47,160,164 shares issued and outstanding (February 28, 2021 - 42,413,691) (Note 13) Additional paid-in capital Additional paid-in capital - Warrants (Note 18) Accumulated deficit Accumulated other comprehensive loss [Accumulated Other Comprehensive Income (Loss), Net of Tax] Total stockholders' equity [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Stockholders' Equity Series A preferred stock, par value Series A preferred stock, share authorized Series A preferred stock, share issued Series A preferred stock, share outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Revenue Expenses Research and development (Note 14) General and administrative (Note 15) Depreciation and amortization (Notes 6 and 7) Interest and other financial expenses (Note 19) Interest income [Interest and Dividend Income, Operating] Foreign exchange loss (gain) Total expenses [Operating Expenses] Net Loss Other comprehensive income (loss) Foreign currency translation adjustment Comprehensive income (loss) Loss per share Basic and Diluted Weighted average common shares outstanding Basic and Diluted [Weighted Average Number of Shares Outstanding, Basic and Diluted] Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Statement [Table] Statement [Line Items] Statement Equity Components Axis Common Stock Series A, Preferred Stock Additional Paid-In Capital Additional Paid-in Capital -Warrants [Member] Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Balance, shares [Shares, Issued] Balance, amount Warrant issued for services (Note 18) Issuance of shares upon the vesting of restricted stock units (Note 16), shares Issuance of shares upon the vesting of restricted stock units (Note 16), amount Stock options issued for services (Note 16) Restricted stock units issued for services (Note 16) Foreign currency translation Net loss Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), shares Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), amount Issuance of warrants for financing facility (Notes 11 and 18) Balance, shares Balance, amount Condensed Consolidated Statements of Cash Flows (Unaudited) Cash Flows from Operating Activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Notes 6 and 7) Stock-based compensation expense (Note 16) Accretion and accrued interest expenses (Note 19) Loss on revaluation of foreign exchange contracts (Note 19) Changes in operating assets and liabilities: Sales tax and tax credits receivable (Note 3) Prepaid expenses (Note 4) Accounts payable and accrued liabilities (Note 9) [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows from Investing Activities Investment in joint venture (Note 10) [Payments to Acquire Interest in Joint Venture] Deposits on machinery and equipment (Note 4) Additions to property, plant and equipment (Notes 5 and 6) [Payments to Acquire Property, Plant, and Equipment] Additions to intangible assets (Note 7) [Payments to Acquire Intangible Assets] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash Flows from Financing Activities Proceeds from sale of common shares and warrants, net of share issuance costs (Note 13) Proceeds from issuance of long-term debt (Note 11) Repayment of long-term debt (Note 11) [Repayments of Long-term Debt] Net cash (used) provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Effect of exchange rate changes Net increase (decrease) in cash Cash, beginning of period Cash, end of period Supplemental Disclosure of Cash Flow Information: Income tax paid Interest paid Interest received The Company, Basis of Presentation 1. The Company, Basis of Presentation Summary of Significant Accounting Policies 2. Summary of Significant Accounting Policies Sales Tax, Tax Credits and Other Receivables 3. Sales Tax, Tax Credits and Other Receivables Prepaid Expenses and Deposits 4. Prepaid Expenses and Deposits Assets held for sale 5. Assets held for sale Property, Plant and Equipment 6. Property, Plant and Equipment Intangible Assets 7. Intangible Assets Fair Value of Financial Instruments 8. Fair Value of Financial Instruments Accounts Payable and Accrued Liabilities 9. Accounts Payable and Accrued Liabilities Joint Venture 10. Joint Venture Long-Term Debt 11. Long-Term Debt Related Party Transactions 12. Related Party Transactions 13. Stockholders' Equity Research and Development Expenses 14. Research and development expenses General and Administrative Expenses 15. General and Administrative Expenses Share-Based Payments 16. Share-Based Payments Equity Incentive Plan 17. Equity Incentive Plan Warrants 18. Warrants Interest and Other Finance Costs 19. Interest and Other Finance Costs Commitments and Contingencies 20. Commitments and Contingencies Use of estimates Stock-based compensation Research and development expenses Assets held for sale Discontinued Operations, Policy [Policy Text Block] Foreign currency translations and transactions Net earnings (loss) per share Sales tax, tax credits and other receivables Prepaid expenses Summarizes cost of assets held for sale Property, plant and equipment Fair value of financial instruments Accounts payable and accrued liabilities Long-term debt Principal repayments Common stock Summarizes the allocation of the aggregate purchase price Research and development expenses [Research and development expenses] General and Administrative expenses Equity incentive plan Summarizes the warrants of granted Interest and other financial costs Related Party Transaction [Axis] Indorama Loop Technologies, LLC [Member] Ownership, percentage Financial Instrument [Axis] Award Type Axis Stock Options [Member] Restricted Stock Units Warrants [Warrants] Research and development expenses [Research and development expenses 1] Antidilutive securities Sales tax Research and development tax credits Other receivables Sales tax, research and development tax credits and other receivables Deposits on machinery and equipment Other Prepaid expenses Non refundable deposits on machinery and equipment Assets held for sale (Details) Long Lived Assets Held-for-sale by Asset Type [Axis] Property, plant and equipment, net [Member] Assets held for sale [Member] Total Assets held for sale Assets Held-for-sale, Description Land acquired descriprtion Land acquired for cash, amount Property Plant And Equipment By Type Axis Product and Service [Axis] Building [Member] Land [Member] Building and Land Improvements [Member] Machinery and Equipment [Member] Office Equipment and Furniture [Member] Property, plant and equipment, gross Less: accumulated depreciation, write-down and impairment [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Property, plant and equipment, net Depreciation expense Intangible assets Additions to intangible assets Amortization expense Fair Value By Fair Value Hierarchy Level Axis Long-term Debt [Member] Level 2 [Member] Total liabilities Fair value Trade accounts payable Accrued engineering fees Accrued employee compensation Accrued professional fees Other accrued liabilities Accounts payable and accrued liabilities [Accounts Payable and Accrued Liabilities] Investment in joint venture Equity method investment, carrying value Debt Instrument Axis Investissement Qu?bec Financing Facility [Member] Term Loan [Member] Long-term debt, net of current portion Principal amount Unamortized discount [Debt Instrument, Unamortized Discount] Accrued interest Less: current portion February 28, 2022 February 28, 2023 February 29, 2024 February 28, 2025 February 28, 2026 Thereafter Total First Disbursement Warrant [Member] Second Disbursement Warrant [Member] Ramaining financing facility Interest expense Mximum financing facility Disbursement from financing facility Interest rate on loan Number of monthly installments Fair value of the loan for the disbursement Discount rate Loan fees Debt discount Accretion expense Warrant exercise price Warrants issued to purchase common stock, amount Warrant term Warrants issued to purchase common stock, shares Fair value of warrant Repayment of long-term debt Loan amount Loan, term Loan, interest rate description Monthly repayment of loan Interest paid [Interest Paid, Including Capitalized Interest, Operating and Investing Activities] Related Party [Axis] President and Chief Executive Officer Restricted Stock Units Shares granted Closing price per share Business Acquisition [Axis] Common Stock [Member] Issuance of shares upon settlement of restricted stock units, shares Issuance of shares upon settlement of restricted stock units, amount Issuance of shares for cash, shares Issuance of shares for cash, amount Class of Warrant or Right [Axis] First Tranche Warrants [Member] Second Tranche Warrants [Member] Third Tranche Warrants [Member] Aggregate purchase price, net of issuance costs SKGC Investment [Member] First Tranche Warrants [Member] Second Tranche Warrants [Member] Third Tranche Warrants [Member] Offering price per share Issuance of shares upon the vesting of restricted stock units Issuance of shares for cash, shares Gross proceeds from issuance of shares with warrants Net proceeds from issuance of shares with warrant Aggregate purchase price Shares of common stock sold Issued and outstanding common stock, contribution Warrant exercise price [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price] Research And Development Arrangement Contract To Perform For Others By Type Axis Machinery and Equipment [Member] Employee Compensation [Member] External Engineering [Member] Plant and Laboratory Operating Expenses [Member] Other [Member] Research and development expenses [Research and Development Expense] Research and development, tax credits Research and development, government grants Nature Of Expense Axis Professional fees [Member] Employee Compensation [Member] Directors and officers insurance [Member] Other [Member] [Other [Member]] General and administrative expenses Net reversal of stock-based compensation Income Statement Location Axis Research and Development Expenses Research and Development Expense [Member] General and Administrative Expenses General and Administrative Expense [Member] Stock options granted Stock options forfeited Stock options expired Issuances of stock options Stock options outstanding Stock options outstanding, weighted average exercise price Stock options exercisable Stock options exercisable, weighted average exercise price Stock-based compensation expense Restricted stock units granted Restricted stock units granted, weighted average exercise price Restricted stock units settled Restricted stock units settled, weighted average exercise price Restricted stock units forfeited Restricted stock units forfeited, weighted average exercise price Restricted stock units outstanding Restricted stock units vested Restricted stock unit expense Net reversal in expenses attributable to RSUs Net reversal in stock-based compensation Equity Incentive Plan [Equity Incentive Plan] Outstanding, beginning of period Share reserve increase Units granted Units forfeited Units expired Outstanding, end of period Plan Name [Axis] 2017 Equity Incentive Plan Common stock shares reserved for future issuance Common stock shares reserved for future issuance annual increase Expected life Voting power percentage Life of option Common stock outstanding shares percentage Warrants 1 Warrants 2 Warrants 3 Warrants 4 Number of warrants Exercise Price Expiration date Warrants to issue shares of common stock Warrants to issue shares of common stock exercise price Warrant to purchase common stock shares for for consulting services Warrant to purchase common stock shares for for consulting services, per share price Warrants issued Interest on long-term debt Accretion expense [Accretion Expense] Loss (gain) on revaluation of foreign exchange contracts Other Interest and finance costs Interest and other finance costs Cumulative amount paid Total amount of Chemtex Agreement Milestones payments facility Net reversal in expenses attributable to RSUs Net reversal in stock-based compensation. Milestones payments facility. The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group. The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a EX-101.PRE 11 loop-20210831_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 loop_10q_htm.xml IDEA: XBRL DOCUMENT 0001504678 2021-03-01 2021-08-31 0001504678 2020-09-02 0001504678 loop:WarrantsMember 2021-08-31 0001504678 loop:WarrantsFourMember 2021-03-01 2021-08-31 0001504678 loop:WarrantsFourMember 2021-08-31 0001504678 loop:WarrantsThreeMember 2021-03-01 2021-08-31 0001504678 loop:WarrantsThreeMember 2021-08-31 0001504678 loop:WarrantsTwoMember 2021-08-31 0001504678 loop:WarrantsOneMember 2021-03-01 2021-08-31 0001504678 loop:WarrantsOneMember 2021-08-31 0001504678 loop:TwoThousandSeventeenEquityIncentivePlanMember 2017-07-01 2017-07-06 0001504678 loop:TwoThousandSeventeenEquityIncentivePlanMember 2021-03-01 2021-08-31 0001504678 loop:TwoThousandSeventeenEquityIncentivePlanMember 2017-07-06 0001504678 loop:EquityIncentiveplanMember 2020-08-31 0001504678 loop:EquityIncentiveplanMember 2021-08-31 0001504678 loop:EquityIncentiveplanMember 2020-03-01 2020-08-31 0001504678 loop:EquityIncentiveplanMember 2021-03-01 2021-08-31 0001504678 loop:EquityIncentiveplanMember 2020-02-29 0001504678 loop:EquityIncentiveplanMember 2021-02-28 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2020-06-01 2020-08-31 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2020-03-01 2020-08-31 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2021-03-01 2021-08-31 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2021-06-01 2021-08-31 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2020-06-01 2020-08-31 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2020-03-01 2020-08-31 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2021-03-01 2021-08-31 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2021-06-01 2021-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2021-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-06-01 2020-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2021-06-01 2021-08-31 0001504678 loop:OtherMember 2020-06-01 2020-08-31 0001504678 loop:DirectorsAndOfficersInsuranceMember 2020-06-01 2020-08-31 0001504678 loop:ProfessionalFeesMember 2020-06-01 2020-08-31 0001504678 loop:OtherMember 2020-03-01 2020-08-31 0001504678 loop:OtherMember 2021-03-01 2021-08-31 0001504678 loop:OtherMember 2021-06-01 2021-08-31 0001504678 loop:DirectorsAndOfficersInsuranceMember 2020-03-01 2020-08-31 0001504678 loop:DirectorsAndOfficersInsuranceMember 2021-03-01 2021-08-31 0001504678 loop:DirectorsAndOfficersInsuranceMember 2021-06-01 2021-08-31 0001504678 loop:ProfessionalFeesMember 2020-03-01 2020-08-31 0001504678 loop:ProfessionalFeesMember 2021-06-01 2021-08-31 0001504678 loop:ProfessionalFeesMember 2021-03-01 2021-08-31 0001504678 loop:OtherResearchAndDevelopmentExpenseMember 2021-03-01 2021-08-31 0001504678 loop:OtherResearchAndDevelopmentExpenseMember 2020-06-01 2020-08-31 0001504678 loop:OtherResearchAndDevelopmentExpenseMember 2021-06-01 2021-08-31 0001504678 loop:PlantAndLaboratoryOperatingExpensesMember 2020-03-01 2020-08-31 0001504678 loop:OtherResearchAndDevelopmentExpenseMember 2020-03-01 2020-08-31 0001504678 loop:PlantAndLaboratoryOperatingExpensesMember 2021-06-01 2021-08-31 0001504678 loop:PlantAndLaboratoryOperatingExpensesMember 2020-06-01 2020-08-31 0001504678 loop:PlantAndLaboratoryOperatingExpensesMember 2021-03-01 2021-08-31 0001504678 loop:ExternalEngineeringMember 2020-03-01 2020-08-31 0001504678 loop:ExternalEngineeringMember 2020-06-01 2020-08-31 0001504678 loop:ExternalEngineeringMember 2021-06-01 2021-08-31 0001504678 loop:ExternalEngineeringMember 2021-03-01 2021-08-31 0001504678 loop:EmployeeCompensationMember 2021-03-01 2021-08-31 0001504678 loop:EmployeeCompensationMember 2020-06-01 2020-08-31 0001504678 loop:EmployeeCompensationMember 2021-06-01 2021-08-31 0001504678 loop:EmployeeCompensationMember 2020-03-01 2020-08-31 0001504678 us-gaap:MachineryAndEquipmentMember 2020-03-01 2020-08-31 0001504678 us-gaap:MachineryAndEquipmentMember 2020-06-01 2020-08-31 0001504678 us-gaap:MachineryAndEquipmentMember 2021-06-01 2021-08-31 0001504678 us-gaap:MachineryAndEquipmentMember 2021-03-01 2021-08-31 0001504678 loop:SkgcInvestmentMember 2021-08-31 0001504678 loop:ThirdTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-29 0001504678 loop:ThirdTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-01 2021-07-29 0001504678 loop:SecondTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-29 0001504678 loop:SecondTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-01 2021-07-29 0001504678 loop:FirstTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-01 2021-07-29 0001504678 loop:FirstTrancheWarrantsMember loop:SkgcInvestmentMember 2021-07-29 0001504678 loop:SkgcInvestmentMember 2021-07-01 2021-07-29 0001504678 loop:SkgcInvestmentMember 2021-07-29 0001504678 loop:ThirdTrancheWarrantsMember 2021-08-31 0001504678 loop:SecondTrancheWarrantsMember 2021-08-31 0001504678 loop:FirstTrancheWarrantsMember 2021-08-31 0001504678 loop:CommonStock1Member 2020-08-31 0001504678 loop:CommonStock1Member 2021-08-31 0001504678 loop:CommonStock1Member 2021-06-01 2021-08-31 0001504678 loop:CommonStock1Member 2020-06-01 2020-08-31 0001504678 loop:CommonStock1Member 2020-05-31 0001504678 loop:CommonStock1Member 2021-05-31 0001504678 loop:PresidentAndChiefExecutiveOfficerMember 2020-04-30 0001504678 loop:PresidentAndChiefExecutiveOfficerMember 2018-07-01 2018-07-13 0001504678 us-gaap:RestrictedStockUnitsRSUMember loop:PresidentAndChiefExecutiveOfficerMember 2018-07-01 2018-07-13 0001504678 loop:TermLoanMember 2021-03-01 2021-08-31 0001504678 loop:TermLoanMember 2018-01-09 2018-01-24 0001504678 loop:TermLoanMember 2018-01-24 0001504678 loop:TermLoanMember 2020-03-01 2020-08-31 0001504678 loop:TermLoanMember 2020-06-01 2020-08-31 0001504678 loop:TermLoanMember 2021-06-01 2021-08-31 0001504678 loop:SecondDisbursementWarrantMember loop:InvestissementQuebecFinancingFacilityMember 2021-08-31 0001504678 loop:SecondDisbursementWarrantMember loop:InvestissementQuebecFinancingFacilityMember 2021-06-01 2021-08-31 0001504678 loop:FirstDisbursementWarrantMember loop:InvestissementQuebecFinancingFacilityMember 2021-08-31 0001504678 loop:FirstDisbursementWarrantMember loop:InvestissementQuebecFinancingFacilityMember 2021-06-01 2021-08-31 0001504678 loop:WarrantsMember loop:InvestissementQuebecFinancingFacilityMember 2021-06-01 2021-08-31 0001504678 loop:WarrantsMember loop:InvestissementQuebecFinancingFacilityMember 2021-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2021-03-01 2021-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2020-03-01 2020-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2021-06-01 2021-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2020-02-21 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2020-06-01 2020-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2021-08-26 0001504678 loop:TermLoanMember 2021-02-28 0001504678 loop:TermLoanMember 2021-08-31 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2021-02-28 0001504678 loop:InvestissementQuebecFinancingFacilityMember 2021-08-31 0001504678 us-gaap:FairValueInputsLevel2Member us-gaap:LongTermDebtMember 2021-08-31 0001504678 us-gaap:FairValueInputsLevel2Member us-gaap:LongTermDebtMember 2021-02-28 0001504678 loop:OfficeEquipmentAndFurnitureMember 2021-08-31 0001504678 us-gaap:MachineryAndEquipmentMember 2021-08-31 0001504678 us-gaap:BuildingImprovementsMember 2021-08-31 0001504678 us-gaap:LandMember 2021-08-31 0001504678 us-gaap:BuildingMember 2021-08-31 0001504678 loop:OfficeEquipmentAndFurnitureMember 2021-02-28 0001504678 us-gaap:MachineryAndEquipmentMember 2021-02-28 0001504678 us-gaap:BuildingImprovementsMember 2021-02-28 0001504678 us-gaap:LandMember 2021-02-28 0001504678 us-gaap:BuildingMember 2021-02-28 0001504678 loop:AssetsHeldForSaleMember 2021-08-31 0001504678 loop:AssetsHeldForSaleMember 2021-03-01 2021-08-31 0001504678 loop:PropertyPlantAndEquipmentNetMember 2021-08-31 0001504678 loop:PropertyPlantAndEquipmentNetMember 2021-03-01 2021-08-31 0001504678 loop:WarrantsMember 2020-03-01 2020-08-31 0001504678 loop:WarrantsMember 2021-03-01 2021-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-03-01 2020-08-31 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2021-03-01 2021-08-31 0001504678 us-gaap:StockOptionMember 2020-03-01 2020-08-31 0001504678 us-gaap:StockOptionMember 2021-03-01 2021-08-31 0001504678 loop:IndoramaLoopTechnologiesLlcMember 2021-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-01 2021-08-31 0001504678 us-gaap:RetainedEarningsMember 2021-06-01 2021-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2021-06-01 2021-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2021-06-01 2021-08-31 0001504678 loop:SeriesAPreferredStocksMember 2021-06-01 2021-08-31 0001504678 us-gaap:CommonStockMember 2021-06-01 2021-08-31 0001504678 2021-05-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-31 0001504678 us-gaap:RetainedEarningsMember 2021-05-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2021-05-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001504678 loop:SeriesAPreferredStocksMember 2021-05-31 0001504678 us-gaap:CommonStockMember 2021-05-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-31 0001504678 us-gaap:RetainedEarningsMember 2021-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2021-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2021-08-31 0001504678 loop:SeriesAPreferredStocksMember 2021-08-31 0001504678 us-gaap:CommonStockMember 2021-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-01 2021-08-31 0001504678 us-gaap:RetainedEarningsMember 2021-03-01 2021-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2021-03-01 2021-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-08-31 0001504678 loop:SeriesAPreferredStocksMember 2021-03-01 2021-08-31 0001504678 us-gaap:CommonStockMember 2021-03-01 2021-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-28 0001504678 us-gaap:RetainedEarningsMember 2021-02-28 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2021-02-28 0001504678 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001504678 loop:SeriesAPreferredStocksMember 2021-02-28 0001504678 us-gaap:CommonStockMember 2021-02-28 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-01 2020-08-31 0001504678 us-gaap:RetainedEarningsMember 2020-06-01 2020-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2020-06-01 2020-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-06-01 2020-08-31 0001504678 loop:SeriesAPreferredStocksMember 2020-06-01 2020-08-31 0001504678 us-gaap:CommonStockMember 2020-06-01 2020-08-31 0001504678 2020-05-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-31 0001504678 us-gaap:RetainedEarningsMember 2020-05-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2020-05-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0001504678 loop:SeriesAPreferredStocksMember 2020-05-31 0001504678 us-gaap:CommonStockMember 2020-05-31 0001504678 2020-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-31 0001504678 us-gaap:RetainedEarningsMember 2020-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2020-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001504678 loop:SeriesAPreferredStocksMember 2020-08-31 0001504678 us-gaap:CommonStockMember 2020-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-01 2020-08-31 0001504678 us-gaap:RetainedEarningsMember 2020-03-01 2020-08-31 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2020-03-01 2020-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2020-08-31 0001504678 loop:SeriesAPreferredStocksMember 2020-03-01 2020-08-31 0001504678 us-gaap:CommonStockMember 2020-03-01 2020-08-31 0001504678 2020-02-29 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-29 0001504678 us-gaap:RetainedEarningsMember 2020-02-29 0001504678 loop:AdditionalPaidInCapitalWarrantsMember 2020-02-29 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0001504678 loop:SeriesAPreferredStocksMember 2020-02-29 0001504678 us-gaap:CommonStockMember 2020-02-29 0001504678 2020-03-01 2020-08-31 0001504678 2020-06-01 2020-08-31 0001504678 2021-06-01 2021-08-31 0001504678 2021-02-28 0001504678 2021-08-31 0001504678 2021-10-13 iso4217:USD shares iso4217:USD shares pure loop:integer 0001504678 false --12-31 false Q2 2022 00000 0.0001 25000000 1 1 1 1 0.0001 250000000 42413691 47160164 267743 On May 27, 2021, we acquired&nbsp;land in Bécancour, Québec for cash of $ million (CDN $5.9 million). The site is part of our planning for an Infinite LoopTM manufacturing facility. We plan on using a portion of the land in connection with the construction of our Infinite LoopTM manufacturing facility and selling the excess land 4238028 4253605 0 0 0 P3Y 267743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10-Q true 2021-08-31 false 000-54768 Loop Industries, Inc NV 27-2094706 480 Fernand-Poitras Terrebonne CA 450 951-8555 Common Stock LOOP NASDAQ Yes Yes Non-accelerated Filer true false 47160164 65561362 35221951 1343417 1763835 972149 609782 3411037 0 71287965 37595568 1500000 1500000 4818028 3513051 871050 794894 78477043 43403513 5234367 8124865 915432 938116 6149799 9062981 3322596 1516008 9472395 10578989 0.0001 25000000 0 0 0.0001 250000000 47160164 42413691 4717 4242 149008231 113662677 30356938 8826165 -110211750 -89661970 -153488 -6590 69004648 32824524 78477043 43403513 0 0 0 0 5284797 2749222 13922632 4229810 3116226 2049241 6276797 4002323 140770 302587 272770 558561 33102 -58905 63689 67871 8413 18039 18174 58386 -174066 103618 32066 180259 8392416 5127724 20549780 8980438 -8392416 -5127724 -20549780 -8980438 -353713 402812 -146898 232400 -8746129 -4724912 -20696678 -8748038 -0.19 -0.13 -0.47 -0.22 44132872 39928047 43282989 39922443 39916905 3993 1 0 83306794 9870241 -57169761 -558861 35452406 18305 1 0 -1 0 0 0 0 0 0 553540 0 0 0 553540 0 0 312390 0 0 0 312390 0 0 0 0 0 402812 402812 0 0 0 0 -5127724 0 -5127724 39935210 3994 1 0 84172723 9870241 -62297485 -156049 31593424 42433320 4244 1 0 113663032 8826165 -101819334 200225 20874332 4714813 471 0 34622383 21461450 0 0 56084304 0 0 0 69323 0 0 69323 12031 2 0 -2 0 0 0 0 0 0 343653 0 0 0 343653 0 0 379165 0 0 0 379165 0 0 0 0 0 -353713 -353713 0 0 0 0 -8392416 0 -8392416 47160164 4717 1 0 149008231 30356938 -110211750 -153488 69004648 39910774 3992 1 0 82379413 9785799 -53317047 -388449 38463708 0 0 0 84442 0 0 84442 24436 2 0 -2 0 0 0 0 0 0 1110435 0 0 0 1110435 0 0 682877 0 0 0 682877 0 0 0 0 0 232400 232400 0 0 0 0 -8980438 0 -8980438 39935210 3994 1 0 84172723 9870241 -62297485 -156049 31593424 42413691 4242 1 0 113662677 8826165 -89661970 -6590 32824524 4714813 471 0 34625825 21461450 0 0 56087746 0 0 0 69323 0 0 69323 31660 4 0 -4 0 0 0 0 0 0 892971 0 0 0 892971 0 0 -173238 0 0 0 -173238 0 0 0 0 0 -146898 -146898 0 0 0 0 -20549780 0 -20549780 47160164 4717 1 0 149008231 30356938 -110211750 -153488 69004648 -20549780 -8980438 272770 558561 719733 1877754 43967 36949 0 11482 436236 169018 -365769 -824675 -2957577 -304438 -22400420 -7455787 0 650000 0 -1305010 5010982 1116744 90591 160484 -5101573 -3232238 56087746 0 1894877 0 27740 26836 57954883 -26836 -113479 125433 30339411 -10589428 35221951 33717671 65561362 23128243 0 0 19720 19441 18174 30497 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. The Company, Basis of Presentation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>The Company</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loop Industries, Inc. (the “Company,” “Loop Industries,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Basis of Presentation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2021, filed with the SEC on June 1, 2021. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 28, 2021, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and six-month periods ended August 31, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, for the fiscal year ending February 28, 2022, or for any other period.</p> 0.50 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2. Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Use of estimates</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards and the judgment in the assessment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Stock-based compensation</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Research and development expenses</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development expenses relate primarily to process development and design, testing of preproduction samples, purchases of machinery and equipment for the small-scale production facility, compensation, and consulting fees, and are expensed as incurred. Total research and development expenses recorded during the six-month periods ended August 31, 2021 and 2020 amounted to $13,922,632 and $4,229,810, respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Assets held for sale</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Assets are classified as held for sale when they met the criteria set out in <em>ASC 360-10-45-9</em><em> </em><em>Long-lived assets classified as held for sale</em>:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Management, having the authority to approve the action, commits to a plan to sell the asset;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Foreign currency translations and transactions</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Net earnings (loss) per share</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company computes net loss per share in accordance with FASB ASC 260, <em>Earnings Per Share</em>. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the six-month periods ended August 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at August 31, 2021, the potentially dilutive securities consisted of 1,587,081 outstanding stock options (2020 – 1,587,081), 4,170,278 outstanding restricted stock units (2020 – 4,313,750), and 11,684,418 outstanding warrants (2020 – 4,884,331).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards and the judgment in the assessment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development expenses relate primarily to process development and design, testing of preproduction samples, purchases of machinery and equipment for the small-scale production facility, compensation, and consulting fees, and are expensed as incurred. Total research and development expenses recorded during the six-month periods ended August 31, 2021 and 2020 amounted to $13,922,632 and $4,229,810, respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.</p> 13922632 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Assets are classified as held for sale when they met the criteria set out in <em>ASC 360-10-45-9</em><em> </em><em>Long-lived assets classified as held for sale</em>:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Management, having the authority to approve the action, commits to a plan to sell the asset;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company computes net loss per share in accordance with FASB ASC 260, <em>Earnings Per Share</em>. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the six-month periods ended August 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at August 31, 2021, the potentially dilutive securities consisted of 1,587,081 outstanding stock options (2020 – 1,587,081), 4,170,278 outstanding restricted stock units (2020 – 4,313,750), and 11,684,418 outstanding warrants (2020 – 4,884,331).</p> 1587081 1587081 4170278 4313750 11684418 4884331 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>3. </strong><strong>Sales Tax, Tax Credits and Other Receivables</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales tax, research and development tax credits and other receivables as at August 31, 2021 and February 28, 2021 were as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>599,706</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,155,504</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development tax credits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>588,843</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">435,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>154,868</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">172,864</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,343,417</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,763,835</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>599,706</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,155,504</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development tax credits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>588,843</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">435,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>154,868</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">172,864</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,343,417</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,763,835</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 599706 1155504 588843 435467 154868 172864 1343417 1763835 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. </strong><strong>Prepaid Expenses and Deposits</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expenses as at August 31, 2021 and February 28, 2021 were as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deposits on machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>733,586</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">379,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>238,563</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">230,387</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>972,149</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">609,782</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2020, the Company made non-refundable cash deposits on machinery and equipment of $1,305,010 which were classified as a cashflow from investing activities in the statement of cash flows as costs of machinery and equipment were previously capitalized. Starting in the third quarter of fiscal 2021, the Company treats costs of machinery and equipment as research and development expenses in the period they are incurred.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deposits on machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>733,586</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">379,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>238,563</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">230,387</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>972,149</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">609,782</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 733586 379395 238563 230387 972149 609782 1305010 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>5. </strong><strong>Assets held for sale</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 27, 2021, we acquired land in Bécancour, Québec for cash of $4.8 million (CDN $5.9 million). The site is part of our planning for an Infinite Loop™ manufacturing facility. We plan on using a portion of the land in connection with the construction of our Infinite Loop <sup>TM</sup> manufacturing facility and selling the excess land. The portion of the land we are committed to selling meets all criteria under <em>ASC 360 Property, plant and equipment</em> to be classified as an asset held for sale.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total purchase cost of the land has been allocated between the portion of land held for sale and the land to be used for the planned Infinite Loop™ manufacturing facility based on surface area.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Description</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance sheet line item</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Land held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Assets held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,411,037</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Infinite Loop™ manufacturing facility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property, plant and equipment, net</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1,410,858</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">4,821,895</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p> 4800000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Description</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance sheet line item</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Land held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Assets held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,411,037</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Infinite Loop™ manufacturing facility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property, plant and equipment, net</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1,410,858</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">4,821,895</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> Assets held for sale 3411037 Property, plant and equipment, net 1410858 4821895 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>6. Property, Plant and Equipment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property, plant and equipment as at August 31, 2021 and February 28, 2021 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As at August 31, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated depreciation, write-down and impairment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net book value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,964,878</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(235,410</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,729,468</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building and Land Improvements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,921,952</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(666,509</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,255,443</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,514,252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,514,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment and furniture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">295,474</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(116,094</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">179,380</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">12,350,293</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7,532,265</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,818,028</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As at February 28, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated depreciation, write-down and impairment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net book value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,954,345</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(201,589</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,752,756</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">241,578</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">241,578</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building and Land Improvements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,804,872</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(474,114</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,330,758</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,514,252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,514,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment and furniture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">292,946</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(104,987</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">187,959</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10,807,993</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7,294,942</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,513,051</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2021, the Company acquired a parcel of land in Bécancour, Québec for $4.8 million (CDN $5.9 million). The Company intends to use a portion of the property for the construction of a commercial facility to manufacture Loop™ branded PET resin using its Infinite Loop™ technology. The excess land is classified as held for sale, as described in Note 5.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense for the three- and six-month periods ended August 31, 2021 amounted to $121,733 and $236,790, respectively (2020– $291,498 and $539,697, respectively), and is recorded as an operating expense in the consolidated statements of operations and comprehensive loss.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As at August 31, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated depreciation, write-down and impairment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net book value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,964,878</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(235,410</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,729,468</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building and Land Improvements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,921,952</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(666,509</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,255,443</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,514,252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,514,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment and furniture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">295,474</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(116,094</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">179,380</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">12,350,293</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7,532,265</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,818,028</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As at February 28, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cost</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated depreciation, write-down and impairment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net book value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,954,345</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(201,589</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,752,756</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">241,578</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">241,578</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Building and Land Improvements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,804,872</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(474,114</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,330,758</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,514,252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,514,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment and furniture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">292,946</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(104,987</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">187,959</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10,807,993</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7,294,942</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,513,051</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1964878 235410 1729468 1653737 0 1653737 1921952 666509 1255443 6514252 6514252 0 295474 116094 179380 12350293 7532265 4818028 1954345 201589 1752756 241578 0 241578 1804872 474114 1330758 6514252 6514252 0 292946 104987 187959 10807993 7294942 3513051 121733 236790 291498 539697 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>7. Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets as at August 31, 2021 and February 28, 2021 were $871,050 and $794,894, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-months periods ended August 31, 2021 and 2020, we made additions to intangible assets of $90,591 and $160,484, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Amortization expense for the three- and six-month periods ended August 31, 2021 amounted to $19,036 and $35,980, respectively (2020 - $11,088 and $18,864, respectively), and is recorded as an operating expense in the unaudited condensed consolidated statements of operations and comprehensive loss.</p> 871050 794894 90591 160484 19036 35980 11088 18864 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>8. </strong><strong>Fair value of financial instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables present the fair value of the Company’s financial liabilities as at August 31, 2021 and February 28, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="9" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements as at August 31, 2021</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Carrying </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amount</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Fair </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Value</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Level in the hierarchy</p></td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Instruments measured at amortized cost:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.8pt; text-align:justify;">Long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,238,028</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,253,605</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Level 2</p></td><td style="width:1%;"> </td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="9" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements at February 28, 2021</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Carrying </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amount</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Fair </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Value</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Level in the hierarchy</p></td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Instruments measured at amortized cost:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.8pt; text-align:justify;">Long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,454,123</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,464,540</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Level 2</p></td><td style="width:1%;"> </td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="9" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements as at August 31, 2021</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Carrying </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amount</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Fair </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Value</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Level in the hierarchy</p></td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Instruments measured at amortized cost:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.8pt; text-align:justify;">Long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,238,028</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,253,605</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Level 2</p></td><td style="width:1%;"> </td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="9" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements at February 28, 2021</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Carrying </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amount</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Fair </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Value</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Level in the hierarchy</p></td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Instruments measured at amortized cost:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.8pt; text-align:justify;">Long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,454,123</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,464,540</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Level 2</p></td><td style="width:1%;"> </td></tr></tbody></table> 2454123 2464540 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>9.</strong> <strong>Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities as at August 31, 2021 and February 28, 2021 were as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade accounts payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,577,365</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,082,736</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued engineering fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>96,865</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535,359</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>765,103</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">970,154</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>448,567</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,270,628</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>346,467</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">265,988</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,234,367</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">8,124,865</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade accounts payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,577,365</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,082,736</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued engineering fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>96,865</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535,359</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>765,103</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">970,154</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>448,567</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,270,628</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>346,467</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">265,988</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,234,367</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">8,124,865</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3577365 5082736 96865 535359 765103 970154 448567 1270628 346467 265988 5234367 8124865 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>10. Joint Venture</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive worldwide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to August 31, 2021 and, as at August 31, 2021, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the six-month period ended August 31, 2021, we made no contributions to ILT (2020 – $650,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In conjunction with the SK strategic partnership described in Note 13, on June 18, 2021, the Company, Loop Innovations, LLC, a wholly-owned subsidiary of the Company (“Loop Innovations”), Indorama Ventures Holdings LP (“Indorama”) and Indorama Loop Technologies, LLC (the “Indorama Joint Venture Company”) amended (i) the Limited Liability Company Agreement between Loop Innovations, LLC and Indorama Ventures Holdings LP (the “LLC Agreement”), (ii) the Marketing Agreement between the Company and Indorama Loop Technologies, LLC (the “Marketing Agreement”) and (iii) the License Agreement between the Company and the Indorama Joint Venture Company (the “License Agreement”), each dated September 24, 2018 (collectively such amendments, the “Indorama Joint Venture Amendments”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under the Indorama Joint Venture Amendments, the Company, Indorama and the Indorama Joint Venture Company agreed to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:justify;margin-left:auto;line-height:normal;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">terminate Indorama’s right of first refusal under the LLC Agreement over any facility to produce products utilizing any waste-to-resin technology applying the PET depolymerization process of the Company;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">amend the non-compete obligations under the LLC Agreement to solely apply to the Company;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">limit the scope of the Company’s grant of intellectual property rights and the scope of the exclusivity rights of the Indorama Joint Venture Company for the retrofit of existing facilities under the License Agreement to North America and Europe; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">limit the scope of the Indorama Joint Venture Company’s permitted marketing rights under the Marketing Agreement to North America and Europe.</td></tr></tbody></table> 1500000 650000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>11. Long-Term Debt</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Investissement Québec financing facility :</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Principal amount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,645,875</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,741,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Unamortized discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(388,155</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(268,192</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Accrued interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>64,876</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">42,588</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 22.8pt; text-align:justify;">Total Investissement Québec financing facility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,322,596</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,516,008</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Term loan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Principal amount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>915,432</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">938,116</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Less: current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(915,432</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(938,116</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.8pt">Total term loan, net of current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term debt, net of current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,322,596</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,516,008</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Investissement Québec financing facility</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 21, 2020, the Company received $1,750,998 (CDN$2,209,234) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $36,459 (CDN$46,000) to Investissment Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 26, 2021, the Company received $1,894,877 (CDN$2,390,766) from Investissement Québec as the second disbursement of our financing facility, the balance of the total amount available under the financing facility of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The second disbursement bears the same interest rate and repayment terms as the first disbursement. The Company established the fair value of the loan for the first disbursement at $1,750,395 based on a discount rate of 3.95%, which reflected a debt discount of $139,390. The discount rate used was based on the external financing from a Canadian bank. There were no fees associated with the second disbursement. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company recorded interest expense on the Investissement Québec loan for the three- and six-month periods ended August 31, 2021 in the amount of $11,512 and $22,394 respectively (2020 – $9,875 and $19,291) and an accretion expense of $11,046 and $21,573 respectively (2020 – $9,112 and $17,658).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $364,587 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection with the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at August 31, 2021. In connection with the second disbursement of the Financing Facility, the Company issued a warrant (“Second Disbursement Warrant”) to acquire 17,180 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $69,323 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The Second Disbursement Warrant remains outstanding as at August 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Term loan</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 24, 2018, the Company obtained a $1,109,614 (CDN$1,400,000) 20-year term installment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,623 (CDN$5,833) plus interest, until January 2022, at which time the monthly repayment amount and interest rate are subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. During the three- and six-month periods ended August 31, 2021, we repaid $13,870 and $27,740 respectively (2020 – $14,143 and $26,836) on the principal balance of the Loan and interest paid amounted to $10,543 and $19,496 and (2020 – $9,130 and $19,441). The terms of the credit facility require the Company to comply with certain financial covenants. As at August 31, 2021 and 2020, the Company was in compliance with its financial covenants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Principal repayments due on the Company’s long-term debt over the next five years are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Years ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">915,432</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 29, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,083,382</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,561,307</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Investissement Québec financing facility :</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Principal amount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,645,875</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,741,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Unamortized discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(388,155</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(268,192</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Accrued interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>64,876</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">42,588</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 22.8pt; text-align:justify;">Total Investissement Québec financing facility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,322,596</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,516,008</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Term loan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Principal amount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>915,432</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">938,116</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.65pt; text-align:justify;">Less: current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(915,432</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(938,116</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.8pt">Total term loan, net of current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term debt, net of current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,322,596</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,516,008</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3645875 1741612 388155 268192 64876 42588 3322596 1516008 915432 938116 915432 938116 3322596 1516008 1750998 3645875 0.0236 84 1354408 0.0545 290714 36459 1894877 3645875 1750395 0.0395 139390 11512 22394 9875 19291 11046 21573 9112 17658 364587 11.00 15153 11.00 77954 17180 11.00 69323 1109614 P20Y prime rate plus 1.5% 4623 13870 27740 14143 26836 10543 19496 9130 19441 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Years ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">915,432</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 29, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">February 28, 2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">520,831</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,083,382</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,561,307</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 915432 0 520831 520831 520831 2083382 4561307 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>12. Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Employment Agreement</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan. Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement. The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic that is far simpler to purify.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the quarters ended August 31, 2021 and 2020, no outstanding milestones were probable of being met based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.</p> 4000000 4000000 7.74 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>13. Stockholders’ Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the period ended August 31, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance, February 28, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,413,691</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,242</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares upon settlement of restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">31,660</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares for cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,714,813</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">471</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, August 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">47,160,164</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,717</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the period ended August 31, 2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance, February 29, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">39,910,774</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,992</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares upon settlement of restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">24,436</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, August 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">39,935,210</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,994</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six months ended August 31, 2021, the Company recorded the following common stock transactions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(i)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 31,660 shares of the common stock to settle restricted stock units that vested in the period.</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(ii)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 4,714,813 shares of its common stock, with warrants, at an aggregate offering price of $12.00 per share for total gross proceeds of $56,577,756 and net proceeds of $56,084,304.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six months ended August 31, 2020, the Company recorded the following common stock transaction:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(i)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 22, 2021, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) by and between the Company and SK global chemical Co., Ltd, an accredited investor (the “Purchaser”). Pursuant to the Purchase Agreement, the Company sold to the Purchaser the following securities on July 29, 2021 for an aggregate purchase price of $56.5 million (collectively, the “SKGC Investment”):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an aggregate of 4,714,813 shares (the “Shares”) of the Company’s common stock (the “Common Stock”);</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">warrants to purchase 4,714,813 shares of Common Stock for an exercise price of $15.00 (the “First Tranche Warrants”), with an expiration date of the third anniversary of the issue date;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">warrants to purchase 2,357,407 shares of Common Stock for an exercise price of $20.00 (the “Second Tranche Warrants”), with an expiration date of the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">warrants to purchase 461,298 shares of Common Stock for an exercise price of $11.00, with an expiration date of June 14, 2022 (the “Third Tranche Warrants,” and together with First Tranche Warrants and the Second Tranche Warrants, the “Warrants”).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Purchaser may exercise the First Tranche Warrant at any time beginning on January 29, 2022 and the Second Tranche Warrant at any time on or after the later to occur of (i) January 29, 2022 and (ii) the first business day following the First Plant Milestone (as defined in the Second Tranche Warrant) prior to its expiration date. The Purchaser may exercise the Third Tranche Warrant at any time prior to June 14, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the allocation of the aggregate purchase price, net of issuance costs, based on the relative fair-value of the components at the grant date:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">34,622,854</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">First Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,158,981</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Second Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,167,195</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Third Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,135,274</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,084,304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the warrants was determined using the Black-Scholes model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After the closing of the SKGC Investment, the Purchaser owns approximately 10.0% of the issued and outstanding Common Stock as of that date.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the period ended August 31, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance, February 28, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,413,691</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,242</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares upon settlement of restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">31,660</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares for cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,714,813</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">471</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, August 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">47,160,164</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,717</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the period ended August 31, 2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance, February 29, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">39,910,774</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,992</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Issuance of shares upon settlement of restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">24,436</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, August 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">39,935,210</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,994</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 42413691 4242 31660 4 4714813 471 47160164 4717 39910774 3992 24436 2 39935210 3994 31660 4714813 12.00 56577756 56084304 24436 56500000 4714813 4714813 15.00 2357407 20.00 461298 11.00 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">34,622,854</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">First Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,158,981</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Second Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,167,195</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Third Tranche Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,135,274</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,084,304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 34622854 13158981 7167195 1135274 56084304 0.100 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>14. Research and Development Expenses</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment expenditures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,485,232</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,492,688</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,060,669</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">External engineering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>551,381</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">942,117</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Plant and laboratory operating expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>707,043</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">584,394</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>48,453</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">162,042</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,284,797</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,749,222</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment expenditures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,108,125</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,578,816</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,879,717</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">External engineering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,454,829</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,017,049</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Plant and laboratory operating expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,398,510</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">870,497</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>382,352</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">462,547</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>13,922,632</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,229,810</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2021, we recorded research and development tax credits of $152,391 as a reduction of research and development expenses and an expense of $267,743 in the six-month period ended August 31, 2020. The expense in the six-month period ended August 31, 2020 was due to a revision of research and development tax credits by Canadian tax authorities. During the six-month period ended August 31, 2021, we recorded no government grants as a reduction of research and development expenses (2020 – $191,439).</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment expenditures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,485,232</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,492,688</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,060,669</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">External engineering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>551,381</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">942,117</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Plant and laboratory operating expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>707,043</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">584,394</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>48,453</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">162,042</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,284,797</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,749,222</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment expenditures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,108,125</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,578,816</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,879,717</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">External engineering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,454,829</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,017,049</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Plant and laboratory operating expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,398,510</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">870,497</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>382,352</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">462,547</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>13,922,632</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,229,810</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 2485232 0 1492688 1060669 551381 942117 707043 584394 48453 162042 5284797 2749222 5108125 0 3578816 1879717 3454829 1017049 1398510 870497 382352 462547 13922632 152391 267743 191439 <p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>15. General and Administrative Expenses</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>856,997</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">420,434</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>868,122</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,002,473</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors and officers insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,059,153</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">502,368</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>331,954</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">123,966</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,116,226</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,049,241</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,488,447</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">642,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation<sup>(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,329,527</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,145,325</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors and officers insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,927,799</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">975,941</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>531,024</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">238,926</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>6,276,797</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,002,323</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">______________ </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="MARGIN: 0px;width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Includes stock-based compensation expense. In the six-month period ended August 31, 2021, the Company recorded RSU forfeitures for an amount of $935,837 (2020 – $4,005) as a net reversal of stock-based compensation.</p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>856,997</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">420,434</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>868,122</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,002,473</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors and officers insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,059,153</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">502,368</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>331,954</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">123,966</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,116,226</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,049,241</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">August 31, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 14.2pt; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,488,447</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">642,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Employee compensation<sup>(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,329,527</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,145,325</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors and officers insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,927,799</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">975,941</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>531,024</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">238,926</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>6,276,797</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,002,323</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 856997 420434 868122 1002473 1059153 502368 331954 123966 3116226 2049241 2488447 642131 1329527 2145325 1927799 975941 531024 238926 6276797 4002323 935837 4005 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>16. Share-based Payments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. There were no new issuances of stock options for the three- and six-month periods ended August 31, 2021 and 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of stock options outstanding as at August 31, 2021 was 1,587,081 (2020 – 1,587,081) with a weighted average exercise price of $6.81 (2020 - $6.81), of which 1,278,748 were exercisable (2020 – 1,083,748) with a weighted average exercise price of $7.30 (2020 – $7.05).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $343,653 and $553,540, respectively, and is included in operating expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $892,971 and $1,110,435, respectively, and is included in operating expenses. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Restricted Stock Units</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended August 31, 2021, the Company granted 33,184 restricted stock units (“RSUs”) (2020 – 38,648) with a weighted average fair value of $13.05 (2020 – $9.20), settled 12,031 RSUs (2020 – 18,305) with a weighted average fair value of $8.48 (2020 – $9.85) and no RSUs were forfeited (2020 – nil).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2021, the Company granted 286,942 restricted stock units (“RSUs”) (2020 – 122,373) with a weighted average fair value of $9.41 (2020 – $8.86), settled 31,660 RSUs (2020 – 24,436) with a weighted average fair value of $8.82 (2020 – $9.78) and 295,524 RSUs were forfeited (2020 – 2,989) with a weighted average fair value of $7.93 (2020 – $8.78).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of RSUs outstanding as at August 31, 2021 was 4,170,278 (2020 – 4,313,750), of which 725,313 were vested (2020 – 891,327).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to $379,165 and $312,390, respectively, and is included in expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to ($173,238) and $682,877, respectively, and is included in operating expenses. The net reversal in expenses attributable to RSUs in the three-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expenses</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $394,527 and $352,282, respectively, and in general and administrative expenses amounted to $313,282 and $513,649, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $790,072 and $704,289, respectively, and in general and administrative expenses amounted to ($70,338) and $1,173,466, respectively. The net reversal in stock-based compensation included in general and administrative expenses in the six-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).</p> 1587081 1587081 6.81 6.81 1278748 1083748 7.30 7.05 343653 553540 892971 1110435 33184 38648 13.05 9.20 12031 18305 8.48 9.85 286942 122373 9.41 8.86 31660 24436 8.82 9.78 295524 2989 7.93 8.78 4170278 4313750 725313 891327 379165 312390 173238 682877 935837 4005 394527 352282 313282 513649 790072 704289 70338 1173466 935837 4005 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>17. Equity Incentive Plan</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2021 and 2020, the Board of Directors opted to waive the annual share reserve increase. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the six-month periods ended August 31, 2021 and 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of units</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Number of units</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, beginning of period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,083,412</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,300,518</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share reserve increase</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(286,942</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(125,762</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>295,524</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,989</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, end of period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,091,994</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,177,745</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3000000 1500000 5 P10Y 10 P5Y <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of units</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Number of units</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, beginning of period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,083,412</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,300,518</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share reserve increase</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(286,942</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(125,762</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>295,524</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,989</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Units expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, end of period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,091,994</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,177,745</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1083412 1300518 286942 125762 295524 2989 1091994 1177745 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>18. Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2021, the Company issued warrants to purchase 7,550,698 shares of our common stock. No warrants were exercised, were forfeited, nor expired in the six-month period ended August 31, 2021. The table below summarizes the warrants granted during the six-month period ended August 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of warrants</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiration date</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4,714,813</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:1%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">$</p></td><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">15.00</p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:36%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">July 29, 2024</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2,357,407</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">20.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">461,298</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June 14, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">17,180</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">$</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">August 26, 2024</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">_______________ </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expiration date is the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six-month period ended August 31, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. No warrants were exercised or forfeited in the six-month period ended August 31, 2021.</p> 7550698 <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of warrants</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiration date</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4,714,813</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:1%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">$</p></td><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">15.00</p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:36%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">July 29, 2024</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2,357,407</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">20.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">461,298</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June 14, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">17,180</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">$</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11.00</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">August 26, 2024</p></td></tr></tbody></table> 4714813 15.00 2024-07-29 2357407 20.00 461298 11.00 2022-06-14 17180 11.00 2024-08-26 25000 9.43 200000 11.00 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>19. Interest and Other Finance Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest and other finance costs for the three-month periods ended August 31, 2021 and 2020 are as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest on long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>22,056</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,005</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accretion expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>11,046</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,112</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss (gain) on revaluation of foreign exchange contracts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(87,022</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>33,102</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(58,905</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest and other finance costs for the six-month periods ended August 31, 2021 and 2020 are as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest on long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>41,890</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,732</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accretion expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>21,573</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,658</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss (gain) on revaluation of foreign exchange contracts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,481</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>226</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>63,689</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">67,871</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest on long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>22,056</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,005</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accretion expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>11,046</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,112</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss (gain) on revaluation of foreign exchange contracts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(87,022</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>33,102</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(58,905</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest and other finance costs for the six-month periods ended August 31, 2021 and 2020 are as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest on long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>41,890</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,732</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accretion expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>21,573</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,658</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss (gain) on revaluation of foreign exchange contracts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,481</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>226</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>63,689</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">67,871</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 22056 19005 11046 9112 0 -87022 33102 -58905 41890 38732 21573 17658 0 11481 226 0 63689 67871 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>20. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Commercial Commitments</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 2, 2020, the Company entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total amount of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. As at August 31, 2021, the cumulative amount paid was $900,000 and during the six-month period ended August 31, 2021, no additional amount was paid by the Company related to this agreement and included in research and development expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Contingencies</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned <em>Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti</em>, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned <em>Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti</em>, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class-action lawsuits filed in New York as <em>In re Loop Industries, Inc. Securities Litigation</em>, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay &amp; Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Plaintiffs served a consolidated amended complaint on February 18, 2021 which alleges defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relies on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The <em>Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act</em> (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.<strong> </strong></p> 4300000 2150000 900000 XML 13 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
6 Months Ended
Aug. 31, 2021
Oct. 13, 2021
Cover [Abstract]    
Entity Registrant Name Loop Industries, Inc  
Entity Central Index Key 0001504678  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Document Period End Date Aug. 31, 2021  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Entity Common Stock Shares Outstanding   47,160,164
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-54768  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 27-2094706  
Entity Address Address Line 1 480 Fernand-Poitras  
Entity Address City Or Town Terrebonne  
Entity Address Postal Zip Code 00000  
City Area Code 450  
Local Phone Number 951-8555  
Security 12b Title Common Stock  
Trading Symbol LOOP  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Entity Address Country CA  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Current assets    
Cash and cash equivalents $ 65,561,362 $ 35,221,951
Sales tax, tax credits and other receivables (Note 3) 1,343,417 1,763,835
Prepaid expenses and deposits (Note 4) 972,149 609,782
Assets held for sale (Note 5) 3,411,037 0
Total current assets 71,287,965 37,595,568
Investment in joint venture (Note 10) 1,500,000 1,500,000
Property, plant and equipment, net (Note 6) 4,818,028 3,513,051
Intangible assets, net (Note 7) 871,050 794,894
Total assets 78,477,043 43,403,513
Current liabilities    
Accounts payable and accrued liabilities (Note 9) 5,234,367 8,124,865
Current portion of long-term debt (Note 11) 915,432 938,116
Total current liabilities 6,149,799 9,062,981
Long-term debt (Note 11) 3,322,596 1,516,008
Total liabilities 9,472,395 10,578,989
Stockholders' Equity    
Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding 0 0
Common stock par value $0.0001: 250,000,000 shares authorized; 47,160,164 shares issued and outstanding (February 28, 2021 - 42,413,691) (Note 13) 4,717 4,242
Additional paid-in capital 149,008,231 113,662,677
Additional paid-in capital - Warrants (Note 18) 30,356,938 8,826,165
Accumulated deficit (110,211,750) (89,661,970)
Accumulated other comprehensive loss (153,488) (6,590)
Total stockholders' equity 69,004,648 32,824,524
Total liabilities and stockholders' equity $ 78,477,043 $ 43,403,513
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Aug. 31, 2021
Feb. 28, 2021
Stockholders' Equity    
Series A preferred stock, par value $ 0.0001 $ 0.0001
Series A preferred stock, share authorized 25,000,000 25,000,000
Series A preferred stock, share issued 1 1
Series A preferred stock, share outstanding 1 1
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 47,160,164 42,413,691
Common stock, shares outstanding 47,160,164 42,413,691
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)        
Revenue $ 0 $ 0 $ 0 $ 0
Expenses        
Research and development (Note 14) 5,284,797 2,749,222 13,922,632 4,229,810
General and administrative (Note 15) 3,116,226 2,049,241 6,276,797 4,002,323
Depreciation and amortization (Notes 6 and 7) 140,770 302,587 272,770 558,561
Interest and other financial expenses (Note 19) 33,102 (58,905) 63,689 67,871
Interest income (8,413) (18,039) (18,174) (58,386)
Foreign exchange loss (gain) (174,066) 103,618 32,066 180,259
Total expenses 8,392,416 5,127,724 20,549,780 8,980,438
Net Loss (8,392,416) (5,127,724) (20,549,780) (8,980,438)
Other comprehensive income (loss)        
Foreign currency translation adjustment (353,713) 402,812 (146,898) 232,400
Comprehensive income (loss) $ (8,746,129) $ (4,724,912) $ (20,696,678) $ (8,748,038)
Loss per share        
Basic and Diluted $ (0.19) $ (0.13) $ (0.47) $ (0.22)
Weighted average common shares outstanding        
Basic and Diluted 44,132,872 39,928,047 43,282,989 39,922,443
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) - USD ($)
Total
Common Stock
Series A, Preferred Stock
Additional Paid-In Capital
Additional Paid-in Capital -Warrants [Member]
Retained Earnings (Accumulated Deficit)
Accumulated other comprehensive loss
Balance, shares at Feb. 29, 2020   39,910,774 1        
Balance, amount at Feb. 29, 2020 $ 38,463,708 $ 3,992 $ 0 $ 82,379,413 $ 9,785,799 $ (53,317,047) $ (388,449)
Warrant issued for services (Note 18) 84,442 $ 0 0 0 84,442 0 0
Issuance of shares upon the vesting of restricted stock units (Note 16), shares   24,436          
Issuance of shares upon the vesting of restricted stock units (Note 16), amount 0 $ 2 0 (2) 0 0 0
Stock options issued for services (Note 16) 1,110,435 0 0 1,110,435 0 0 0
Restricted stock units issued for services (Note 16) 682,877 0 0 682,877 0 0 0
Foreign currency translation 232,400 0 0 0 0 0 232,400
Net loss (8,980,438) $ 0 $ 0 0 0 (8,980,438) 0
Balance, shares at Aug. 31, 2020   39,935,210 1        
Balance, amount at Aug. 31, 2020 31,593,424 $ 3,994 $ 0 84,172,723 9,870,241 (62,297,485) (156,049)
Balance, shares at May. 31, 2020   39,916,905 1        
Balance, amount at May. 31, 2020 35,452,406 $ 3,993 $ 0 83,306,794 9,870,241 (57,169,761) (558,861)
Issuance of shares upon the vesting of restricted stock units (Note 16), shares   18,305          
Issuance of shares upon the vesting of restricted stock units (Note 16), amount 0 $ 1 0 (1) 0 0 0
Stock options issued for services (Note 16) 553,540 0 0 553,540 0 0 0
Restricted stock units issued for services (Note 16) 312,390 0 0 312,390 0 0 0
Foreign currency translation 402,812 0 0 0 0 0 402,812
Net loss (5,127,724) $ 0 $ 0 0 0 (5,127,724) 0
Balance, shares at Aug. 31, 2020   39,935,210 1        
Balance, amount at Aug. 31, 2020 31,593,424 $ 3,994 $ 0 84,172,723 9,870,241 (62,297,485) (156,049)
Balance, shares at Feb. 28, 2021   42,413,691 1        
Balance, amount at Feb. 28, 2021 32,824,524 $ 4,242 $ 0 113,662,677 8,826,165 (89,661,970) (6,590)
Issuance of shares upon the vesting of restricted stock units (Note 16), shares   31,660          
Issuance of shares upon the vesting of restricted stock units (Note 16), amount 0 $ 4 0 (4) 0 0 0
Stock options issued for services (Note 16) 892,971 0 0 892,971 0 0 0
Restricted stock units issued for services (Note 16) (173,238) 0 0 (173,238) 0 0 0
Foreign currency translation (146,898) 0 0 0 0 0 (146,898)
Net loss (20,549,780) $ 0 0 0 0 (20,549,780) 0
Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), shares   4,714,813          
Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), amount 56,087,746 $ 471 0 34,625,825 21,461,450 0 0
Issuance of warrants for financing facility (Notes 11 and 18) 69,323 $ 0 $ 0 0 69,323 0 0
Balance, shares at Aug. 31, 2021   47,160,164 1        
Balance, amount at Aug. 31, 2021 69,004,648 $ 4,717 $ 0 149,008,231 30,356,938 (110,211,750) (153,488)
Balance, shares at May. 31, 2021   42,433,320 1        
Balance, amount at May. 31, 2021 20,874,332 $ 4,244 $ 0 113,663,032 8,826,165 (101,819,334) 200,225
Issuance of shares upon the vesting of restricted stock units (Note 16), shares   12,031          
Issuance of shares upon the vesting of restricted stock units (Note 16), amount 0 $ 2 0 (2) 0 0 0
Stock options issued for services (Note 16) 343,653 0 0 343,653 0 0 0
Restricted stock units issued for services (Note 16) 379,165 0 0 379,165 0 0 0
Foreign currency translation (353,713) 0 0 0 0 0 (353,713)
Net loss (8,392,416) $ 0 0 0 0 (8,392,416) 0
Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), shares   4,714,813          
Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), amount 56,084,304 $ 471 0 34,622,383 21,461,450 0 0
Issuance of warrants for financing facility (Notes 11 and 18) 69,323 $ 0 $ 0 0 69,323 0 0
Balance, shares at Aug. 31, 2021   47,160,164 1        
Balance, amount at Aug. 31, 2021 $ 69,004,648 $ 4,717 $ 0 $ 149,008,231 $ 30,356,938 $ (110,211,750) $ (153,488)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Cash Flows from Operating Activities    
Net loss $ (20,549,780) $ (8,980,438)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization (Notes 6 and 7) 272,770 558,561
Stock-based compensation expense (Note 16) 719,733 1,877,754
Accretion and accrued interest expenses (Note 19) 43,967 36,949
Loss on revaluation of foreign exchange contracts (Note 19) 0 11,482
Changes in operating assets and liabilities:    
Sales tax and tax credits receivable (Note 3) 436,236 169,018
Prepaid expenses (Note 4) (365,769) (824,675)
Accounts payable and accrued liabilities (Note 9) (2,957,577) (304,438)
Net cash used in operating activities (22,400,420) (7,455,787)
Cash Flows from Investing Activities    
Investment in joint venture (Note 10) 0 (650,000)
Deposits on machinery and equipment (Note 4) 0 (1,305,010)
Additions to property, plant and equipment (Notes 5 and 6) (5,010,982) (1,116,744)
Additions to intangible assets (Note 7) (90,591) (160,484)
Net cash used in investing activities (5,101,573) (3,232,238)
Cash Flows from Financing Activities    
Proceeds from sale of common shares and warrants, net of share issuance costs (Note 13) 56,087,746 0
Proceeds from issuance of long-term debt (Note 11) 1,894,877 0
Repayment of long-term debt (Note 11) (27,740) (26,836)
Net cash (used) provided by financing activities 57,954,883 (26,836)
Effect of exchange rate changes (113,479) 125,433
Net increase (decrease) in cash 30,339,411 (10,589,428)
Cash, beginning of period 35,221,951 33,717,671
Cash, end of period 65,561,362 23,128,243
Supplemental Disclosure of Cash Flow Information:    
Income tax paid 0 0
Interest paid 19,720 19,441
Interest received $ 18,174 $ 30,497
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
The Company, Basis of Presentation
6 Months Ended
Aug. 31, 2021
The Company, Basis of Presentation  
1. The Company, Basis of Presentation

1. The Company, Basis of Presentation

 

The Company

 

Loop Industries, Inc. (the “Company,” “Loop Industries,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber.

 

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2021, filed with the SEC on June 1, 2021. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.

 

Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 28, 2021, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and six-month periods ended August 31, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, for the fiscal year ending February 28, 2022, or for any other period.

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
6 Months Ended
Aug. 31, 2021
Summary of Significant Accounting Policies  
2. Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Use of estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards and the judgment in the assessment.

 

The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.

Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.

 

Stock-based compensation

 

The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.

 

The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.

 

The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.

 

The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.

 

Research and development expenses

 

Research and development expenses relate primarily to process development and design, testing of preproduction samples, purchases of machinery and equipment for the small-scale production facility, compensation, and consulting fees, and are expensed as incurred. Total research and development expenses recorded during the six-month periods ended August 31, 2021 and 2020 amounted to $13,922,632 and $4,229,810, respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.

 

Assets held for sale

 

Assets are classified as held for sale when they met the criteria set out in ASC 360-10-45-9 Long-lived assets classified as held for sale:

 

 

·

Management, having the authority to approve the action, commits to a plan to sell the asset;

 

·

The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;

 

·

An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;

 

·

The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;

 

·

The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and

 

·

Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

   

When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.

Foreign currency translations and transactions

 

The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.

 

For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.

 

Net earnings (loss) per share

 

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the six-month periods ended August 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at August 31, 2021, the potentially dilutive securities consisted of 1,587,081 outstanding stock options (2020 – 1,587,081), 4,170,278 outstanding restricted stock units (2020 – 4,313,750), and 11,684,418 outstanding warrants (2020 – 4,884,331).

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Sales Tax, Tax Credits and Other Receivables
6 Months Ended
Aug. 31, 2021
Sales Tax, Tax Credits and Other Receivables  
3. Sales Tax, Tax Credits and Other Receivables

3. Sales Tax, Tax Credits and Other Receivables

 

Sales tax, research and development tax credits and other receivables as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Sales tax

 

$599,706

 

 

$1,155,504

 

Research and development tax credits

 

 

588,843

 

 

 

435,467

 

Other receivables

 

 

154,868

 

 

 

172,864

 

 

 

$1,343,417

 

 

$1,763,835

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Deposits
6 Months Ended
Aug. 31, 2021
Prepaid Expenses and Deposits  
4. Prepaid Expenses and Deposits

4. Prepaid Expenses and Deposits

 

Prepaid expenses as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Deposits on machinery and equipment

 

$733,586

 

 

$379,395

 

Other

 

 

238,563

 

 

 

230,387

 

 

 

$972,149

 

 

$609,782

 

Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received.

 

During the six-month period ended August 31, 2020, the Company made non-refundable cash deposits on machinery and equipment of $1,305,010 which were classified as a cashflow from investing activities in the statement of cash flows as costs of machinery and equipment were previously capitalized. Starting in the third quarter of fiscal 2021, the Company treats costs of machinery and equipment as research and development expenses in the period they are incurred.

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Assets held for sale
6 Months Ended
Aug. 31, 2021
Assets held for sale  
5. Assets held for sale

5. Assets held for sale

 

On May 27, 2021, we acquired land in Bécancour, Québec for cash of $4.8 million (CDN $5.9 million). The site is part of our planning for an Infinite Loop™ manufacturing facility. We plan on using a portion of the land in connection with the construction of our Infinite Loop TM manufacturing facility and selling the excess land. The portion of the land we are committed to selling meets all criteria under ASC 360 Property, plant and equipment to be classified as an asset held for sale.

 

The total purchase cost of the land has been allocated between the portion of land held for sale and the land to be used for the planned Infinite Loop™ manufacturing facility based on surface area.

 

Description

 

Balance sheet line item

 

Cost

 

Land held for sale

 

Assets held for sale

 

$3,411,037

 

Infinite Loop™ manufacturing facility

 

Property, plant and equipment, net

 

 

1,410,858

 

 

 

 

 

$4,821,895

 

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Property, Plant and Equipment
3 Months Ended
Aug. 31, 2021
Property, Plant and Equipment  
6. Property, Plant and Equipment

6. Property, Plant and Equipment

 

Property, plant and equipment as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

As at August 31, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,964,878

 

 

$(235,410)

 

$1,729,468

 

Land

 

 

1,653,737

 

 

 

-

 

 

 

1,653,737

 

Building and Land Improvements

 

 

1,921,952

 

 

 

(666,509)

 

 

1,255,443

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

295,474

 

 

 

(116,094)

 

 

179,380

 

 

 

$12,350,293

 

 

$(7,532,265)

 

$4,818,028

 

 

 

 

As at February 28, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,954,345

 

 

$(201,589)

 

$1,752,756

 

Land

 

 

241,578

 

 

 

-

 

 

 

241,578

 

Building and Land Improvements

 

 

1,804,872

 

 

 

(474,114)

 

 

1,330,758

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

292,946

 

 

 

(104,987)

 

 

187,959

 

 

 

$10,807,993

 

 

$(7,294,942)

 

$3,513,051

 

During the six-month period ended August 31, 2021, the Company acquired a parcel of land in Bécancour, Québec for $4.8 million (CDN $5.9 million). The Company intends to use a portion of the property for the construction of a commercial facility to manufacture Loop™ branded PET resin using its Infinite Loop™ technology. The excess land is classified as held for sale, as described in Note 5.

 

Depreciation expense for the three- and six-month periods ended August 31, 2021 amounted to $121,733 and $236,790, respectively (2020– $291,498 and $539,697, respectively), and is recorded as an operating expense in the consolidated statements of operations and comprehensive loss.

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets
6 Months Ended
Aug. 31, 2021
Intangible Assets  
7. Intangible Assets

7. Intangible Assets

 

Intangible assets as at August 31, 2021 and February 28, 2021 were $871,050 and $794,894, respectively.

 

During the six-months periods ended August 31, 2021 and 2020, we made additions to intangible assets of $90,591 and $160,484, respectively.

 

Amortization expense for the three- and six-month periods ended August 31, 2021 amounted to $19,036 and $35,980, respectively (2020 - $11,088 and $18,864, respectively), and is recorded as an operating expense in the unaudited condensed consolidated statements of operations and comprehensive loss.

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments
6 Months Ended
Aug. 31, 2021
Fair Value of Financial Instruments  
8. Fair Value of Financial Instruments

8. Fair value of financial instruments

 

The following tables present the fair value of the Company’s financial liabilities as at August 31, 2021 and February 28, 2021:

 

 

 

Fair Value Measurements as at August 31, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$

4,238,028

 

 

$

4,253,605

 

 

Level 2

 

 

 

 

Fair Value Measurements at February 28, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$2,454,123

 

 

$2,464,540

 

 

Level 2

 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Payable and Accrued Liabilities
6 Months Ended
Aug. 31, 2021
Accounts Payable and Accrued Liabilities  
9. Accounts Payable and Accrued Liabilities

9. Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities as at August 31, 2021 and February 28, 2021 were as follows:

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Trade accounts payable

 

$3,577,365

 

 

$5,082,736

 

Accrued engineering fees

 

 

96,865

 

 

 

535,359

 

Accrued employee compensation

 

 

765,103

 

 

 

970,154

 

Accrued professional fees

 

 

448,567

 

 

 

1,270,628

 

Other accrued liabilities

 

 

346,467

 

 

 

265,988

 

 

 

$5,234,367

 

 

$8,124,865

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Joint Venture
6 Months Ended
Aug. 31, 2021
Joint Venture  
10. Joint Venture

10. Joint Venture

 

On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture.

 

Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive worldwide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber.

 

ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to August 31, 2021 and, as at August 31, 2021, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the six-month period ended August 31, 2021, we made no contributions to ILT (2020 – $650,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.

 

In conjunction with the SK strategic partnership described in Note 13, on June 18, 2021, the Company, Loop Innovations, LLC, a wholly-owned subsidiary of the Company (“Loop Innovations”), Indorama Ventures Holdings LP (“Indorama”) and Indorama Loop Technologies, LLC (the “Indorama Joint Venture Company”) amended (i) the Limited Liability Company Agreement between Loop Innovations, LLC and Indorama Ventures Holdings LP (the “LLC Agreement”), (ii) the Marketing Agreement between the Company and Indorama Loop Technologies, LLC (the “Marketing Agreement”) and (iii) the License Agreement between the Company and the Indorama Joint Venture Company (the “License Agreement”), each dated September 24, 2018 (collectively such amendments, the “Indorama Joint Venture Amendments”).

 

Under the Indorama Joint Venture Amendments, the Company, Indorama and the Indorama Joint Venture Company agreed to:

 

 

·

terminate Indorama’s right of first refusal under the LLC Agreement over any facility to produce products utilizing any waste-to-resin technology applying the PET depolymerization process of the Company;

 

·

amend the non-compete obligations under the LLC Agreement to solely apply to the Company;

 

·

limit the scope of the Company’s grant of intellectual property rights and the scope of the exclusivity rights of the Indorama Joint Venture Company for the retrofit of existing facilities under the License Agreement to North America and Europe; and

 

·

limit the scope of the Indorama Joint Venture Company’s permitted marketing rights under the Marketing Agreement to North America and Europe.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt
6 Months Ended
Aug. 31, 2021
Long-Term Debt  
11. Long-Term Debt

11. Long-Term Debt

 

 

 

August 31,

2021

 

 

February 28,

2021

 

Investissement Québec financing facility :

 

 

 

 

 

 

Principal amount

 

$3,645,875

 

 

$1,741,612

 

Unamortized discount

 

 

(388,155)

 

 

(268,192)

Accrued interest

 

 

64,876

 

 

 

42,588

 

Total Investissement Québec financing facility

 

 

3,322,596

 

 

 

1,516,008

 

Term loan

 

 

 

 

 

 

 

 

Principal amount

 

 

915,432

 

 

 

938,116

 

Less: current portion

 

 

(915,432)

 

 

(938,116)

Total term loan, net of current portion

 

 

-

 

 

 

-

 

Long-term debt, net of current portion

 

$3,322,596

 

 

$1,516,008

 

Investissement Québec financing facility

 

On February 21, 2020, the Company received $1,750,998 (CDN$2,209,234) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $36,459 (CDN$46,000) to Investissment Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss.

 

On August 26, 2021, the Company received $1,894,877 (CDN$2,390,766) from Investissement Québec as the second disbursement of our financing facility, the balance of the total amount available under the financing facility of $3,645,875 (CDN$4,600,000) (the “Financing Facility”). The second disbursement bears the same interest rate and repayment terms as the first disbursement. The Company established the fair value of the loan for the first disbursement at $1,750,395 based on a discount rate of 3.95%, which reflected a debt discount of $139,390. The discount rate used was based on the external financing from a Canadian bank. There were no fees associated with the second disbursement. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss.

 

The Company recorded interest expense on the Investissement Québec loan for the three- and six-month periods ended August 31, 2021 in the amount of $11,512 and $22,394 respectively (2020 – $9,875 and $19,291) and an accretion expense of $11,046 and $21,573 respectively (2020 – $9,112 and $17,658).

 

The Company also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $364,587 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection with the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at August 31, 2021. In connection with the second disbursement of the Financing Facility, the Company issued a warrant (“Second Disbursement Warrant”) to acquire 17,180 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $69,323 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The Second Disbursement Warrant remains outstanding as at August 31, 2021.

 

Term loan

 

On January 24, 2018, the Company obtained a $1,109,614 (CDN$1,400,000) 20-year term installment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,623 (CDN$5,833) plus interest, until January 2022, at which time the monthly repayment amount and interest rate are subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. During the three- and six-month periods ended August 31, 2021, we repaid $13,870 and $27,740 respectively (2020 – $14,143 and $26,836) on the principal balance of the Loan and interest paid amounted to $10,543 and $19,496 and (2020 – $9,130 and $19,441). The terms of the credit facility require the Company to comply with certain financial covenants. As at August 31, 2021 and 2020, the Company was in compliance with its financial covenants.

Principal repayments due on the Company’s long-term debt over the next five years are as follows:

 

Years ending

 

Amount

 

February 28, 2022

 

$

915,432

 

February 28, 2023

 

 

-

 

February 29, 2024

 

 

520,831

 

February 28, 2025

 

 

520,831

 

February 28, 2026

 

 

520,831

 

Thereafter

 

 

2,083,382

 

Total

 

$

4,561,307

 

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
6 Months Ended
Aug. 31, 2021
Related Party Transactions  
12. Related Party Transactions

12. Related Party Transactions

 

Employment Agreement

 

On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term.

 

On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan. Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.

 

On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement. The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic that is far simpler to purify.

 

During the quarters ended August 31, 2021 and 2020, no outstanding milestones were probable of being met based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity
6 Months Ended
Aug. 31, 2021
Stockholders Equity Abstract  
13. Stockholders' Equity

13. Stockholders’ Equity

 

Common Stock

 

For the period ended August 31, 2021

 

Number of

shares

 

 

Amount

 

Balance, February 28, 2021

 

 

42,413,691

 

 

$4,242

 

Issuance of shares upon settlement of restricted stock units

 

 

31,660

 

 

 

4

 

Issuance of shares for cash

 

 

4,714,813

 

 

 

471

 

Balance, August 31, 2021

 

 

47,160,164

 

 

$4,717

 

 

For the period ended August 31, 2020

 

Number of

shares

 

 

Amount

 

Balance, February 29, 2020

 

 

39,910,774

 

 

$3,992

 

Issuance of shares upon settlement of restricted stock units

 

 

24,436

 

 

 

2

 

Balance, August 31, 2020

 

 

39,935,210

 

 

$3,994

 

 

During the six months ended August 31, 2021, the Company recorded the following common stock transactions:

 

(i)

The Company issued 31,660 shares of the common stock to settle restricted stock units that vested in the period.

(ii)

The Company issued 4,714,813 shares of its common stock, with warrants, at an aggregate offering price of $12.00 per share for total gross proceeds of $56,577,756 and net proceeds of $56,084,304.

During the six months ended August 31, 2020, the Company recorded the following common stock transaction:

 

(i)

The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.

 

On June 22, 2021, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) by and between the Company and SK global chemical Co., Ltd, an accredited investor (the “Purchaser”). Pursuant to the Purchase Agreement, the Company sold to the Purchaser the following securities on July 29, 2021 for an aggregate purchase price of $56.5 million (collectively, the “SKGC Investment”):

 

 

·

an aggregate of 4,714,813 shares (the “Shares”) of the Company’s common stock (the “Common Stock”);

 

·

warrants to purchase 4,714,813 shares of Common Stock for an exercise price of $15.00 (the “First Tranche Warrants”), with an expiration date of the third anniversary of the issue date;

 

·

warrants to purchase 2,357,407 shares of Common Stock for an exercise price of $20.00 (the “Second Tranche Warrants”), with an expiration date of the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date; and

 

·

warrants to purchase 461,298 shares of Common Stock for an exercise price of $11.00, with an expiration date of June 14, 2022 (the “Third Tranche Warrants,” and together with First Tranche Warrants and the Second Tranche Warrants, the “Warrants”).

  

The Purchaser may exercise the First Tranche Warrant at any time beginning on January 29, 2022 and the Second Tranche Warrant at any time on or after the later to occur of (i) January 29, 2022 and (ii) the first business day following the First Plant Milestone (as defined in the Second Tranche Warrant) prior to its expiration date. The Purchaser may exercise the Third Tranche Warrant at any time prior to June 14, 2022.

 

The table below summarizes the allocation of the aggregate purchase price, net of issuance costs, based on the relative fair-value of the components at the grant date:

 

Common stock

 

$34,622,854

 

First Tranche Warrants

 

 

13,158,981

 

Second Tranche Warrants

 

 

7,167,195

 

Third Tranche Warrants

 

 

1,135,274

 

 

 

$56,084,304

 

 

The fair value of the warrants was determined using the Black-Scholes model.

 

After the closing of the SKGC Investment, the Purchaser owns approximately 10.0% of the issued and outstanding Common Stock as of that date.

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Research and Development Expenses
6 Months Ended
Aug. 31, 2021
Research and Development Expenses  
14. Research and development expenses

14. Research and Development Expenses

 

Research and development expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$2,485,232

 

 

$-

 

Employee compensation

 

 

1,492,688

 

 

 

1,060,669

 

External engineering

 

 

551,381

 

 

 

942,117

 

Plant and laboratory operating expenses

 

 

707,043

 

 

 

584,394

 

Other

 

 

48,453

 

 

 

162,042

 

 

 

$5,284,797

 

 

$2,749,222

 

Research and development expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$5,108,125

 

 

$-

 

Employee compensation

 

 

3,578,816

 

 

 

1,879,717

 

External engineering

 

 

3,454,829

 

 

 

1,017,049

 

Plant and laboratory operating expenses

 

 

1,398,510

 

 

 

870,497

 

Other

 

 

382,352

 

 

 

462,547

 

 

 

$13,922,632

 

 

$4,229,810

 

 

During the six-month period ended August 31, 2021, we recorded research and development tax credits of $152,391 as a reduction of research and development expenses and an expense of $267,743 in the six-month period ended August 31, 2020. The expense in the six-month period ended August 31, 2020 was due to a revision of research and development tax credits by Canadian tax authorities. During the six-month period ended August 31, 2021, we recorded no government grants as a reduction of research and development expenses (2020 – $191,439).

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
General and Administrative Expenses
6 Months Ended
Aug. 31, 2021
General and Administrative Expenses  
15. General and Administrative Expenses

 

15. General and Administrative Expenses

 

General and administrative expenses for the three-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$856,997

 

 

$420,434

 

Employee compensation

 

 

868,122

 

 

 

1,002,473

 

Directors and officers insurance

 

 

1,059,153

 

 

 

502,368

 

Other

 

 

331,954

 

 

 

123,966

 

 

 

$3,116,226

 

 

$2,049,241

 

 

General and administrative expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$2,488,447

 

 

$642,131

 

Employee compensation(1)

 

 

1,329,527

 

 

 

2,145,325

 

Directors and officers insurance

 

 

1,927,799

 

 

 

975,941

 

Other

 

 

531,024

 

 

 

238,926

 

 

 

$6,276,797

 

 

$4,002,323

 

______________ 

(1)

Includes stock-based compensation expense. In the six-month period ended August 31, 2021, the Company recorded RSU forfeitures for an amount of $935,837 (2020 – $4,005) as a net reversal of stock-based compensation.

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Payments
6 Months Ended
Aug. 31, 2021
Share-Based Payments  
16. Share-Based Payments

16. Share-based Payments

 

Stock Options

 

During the three-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).

 

During the six-month period ended August 31, 2021, the Company granted no stock options (2020 – nil), no stock options were forfeited (2020 – nil) or exercised (2020 – nil) and no stock options expired (2020 – nil).

 

The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. There were no new issuances of stock options for the three- and six-month periods ended August 31, 2021 and 2020.

 

The total number of stock options outstanding as at August 31, 2021 was 1,587,081 (2020 – 1,587,081) with a weighted average exercise price of $6.81 (2020 - $6.81), of which 1,278,748 were exercisable (2020 – 1,083,748) with a weighted average exercise price of $7.30 (2020 – $7.05).

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $343,653 and $553,540, respectively, and is included in operating expenses.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation expense attributable to stock options amounted to $892,971 and $1,110,435, respectively, and is included in operating expenses.

Restricted Stock Units

 

During the three-month period ended August 31, 2021, the Company granted 33,184 restricted stock units (“RSUs”) (2020 – 38,648) with a weighted average fair value of $13.05 (2020 – $9.20), settled 12,031 RSUs (2020 – 18,305) with a weighted average fair value of $8.48 (2020 – $9.85) and no RSUs were forfeited (2020 – nil).

 

During the six-month period ended August 31, 2021, the Company granted 286,942 restricted stock units (“RSUs”) (2020 – 122,373) with a weighted average fair value of $9.41 (2020 – $8.86), settled 31,660 RSUs (2020 – 24,436) with a weighted average fair value of $8.82 (2020 – $9.78) and 295,524 RSUs were forfeited (2020 – 2,989) with a weighted average fair value of $7.93 (2020 – $8.78).

 

The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.

 

The total number of RSUs outstanding as at August 31, 2021 was 4,170,278 (2020 – 4,313,750), of which 725,313 were vested (2020 – 891,327).

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to $379,165 and $312,390, respectively, and is included in expenses.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation attributable to RSUs amounted to ($173,238) and $682,877, respectively, and is included in operating expenses. The net reversal in expenses attributable to RSUs in the three-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).

 

Stock-Based Compensation Expenses

 

During the three-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $394,527 and $352,282, respectively, and in general and administrative expenses amounted to $313,282 and $513,649, respectively.

 

During the six-month periods ended August 31, 2021 and 2020, stock-based compensation included in research and development expenses amounted to $790,072 and $704,289, respectively, and in general and administrative expenses amounted to ($70,338) and $1,173,466, respectively. The net reversal in stock-based compensation included in general and administrative expenses in the six-month period ended August 31, 2021 is due to forfeitures recorded in the period for a total of $935,837 (2020 – $4,005).

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plan
6 Months Ended
Aug. 31, 2021
Equity Incentive Plan  
17. Equity Incentive Plan

17. Equity Incentive Plan

 

On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2021 and 2020, the Board of Directors opted to waive the annual share reserve increase. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.

The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the six-month periods ended August 31, 2021 and 2020:

 

 

 

2021

 

 

2020

 

 

 

Number of units

 

 

Number of units

 

Outstanding, beginning of period

 

 

1,083,412

 

 

 

1,300,518

 

Share reserve increase

 

 

-

 

 

 

-

 

Units granted

 

 

(286,942)

 

 

(125,762)

Units forfeited

 

 

295,524

 

 

 

2,989

 

Units expired

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

1,091,994

 

 

 

1,177,745

 

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants
6 Months Ended
Aug. 31, 2021
Warrants  
18. Warrants

18. Warrants

 

During the six-month period ended August 31, 2021, the Company issued warrants to purchase 7,550,698 shares of our common stock. No warrants were exercised, were forfeited, nor expired in the six-month period ended August 31, 2021. The table below summarizes the warrants granted during the six-month period ended August 31, 2021:

 

Number of warrants

 

Exercise Price

 

Expiration date

4,714,813

 

$

15.00

 

July 29, 2024

2,357,407

 

 

20.00

 

(1)

461,298

 

 

11.00

 

June 14, 2022

17,180

 

$

11.00

 

August 26, 2024

_______________ 

 

(1)

Expiration date is the earlier of (A) the date that is the third anniversary of the First Plant Milestone (as defined in the Second Tranche Warrants), (B) the expiration of the JV Negotiation Period (as defined in the Second Tranche Warrants), provided that the Joint Venture Transaction Agreements (as defined in the Second Tranche Warrants) have not been executed by the expiration of the JV Negotiation Period and (C) the third anniversary of the BDP Date (as defined in the Second Tranche Warrants), provided that the First Plant Milestone has not occurred as of such date.

 

During the six-month period ended August 31, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. No warrants were exercised or forfeited in the six-month period ended August 31, 2021.

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Interest and Other Finance Costs
6 Months Ended
Aug. 31, 2021
Interest and Other Finance Costs  
19. Interest and Other Finance Costs

19. Interest and Other Finance Costs

 

Interest and other finance costs for the three-month periods ended August 31, 2021 and 2020 are as follows:

 

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$22,056

 

 

$19,005

 

Accretion expense

 

 

11,046

 

 

 

9,112

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

(87,022)

 

 

$33,102

 

 

$(58,905)

 

Interest and other finance costs for the six-month periods ended August 31, 2021 and 2020 are as follows:

 

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$41,890

 

 

$38,732

 

Accretion expense

 

 

21,573

 

 

 

17,658

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

11,481

 

Other

 

 

226

 

 

 

-

 

 

 

$63,689

 

 

$67,871

 

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
6 Months Ended
Aug. 31, 2021
Commitments and Contingencies  
20. Commitments and Contingencies

20. Commitments and Contingencies

 

Commercial Commitments

 

On September 2, 2020, the Company entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total amount of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. As at August 31, 2021, the cumulative amount paid was $900,000 and during the six-month period ended August 31, 2021, no additional amount was paid by the Company related to this agreement and included in research and development expenses.

 

Contingencies

 

On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.

 

On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.

 

On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class-action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.

 

Plaintiffs served a consolidated amended complaint on February 18, 2021 which alleges defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relies on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021.

 

On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.

 

Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Aug. 31, 2021
Summary of Significant Accounting Policies  
Use of estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards and the judgment in the assessment.

 

The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.

Stock-based compensation

The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.

 

The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.

 

The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.

 

The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.

Research and development expenses

Research and development expenses relate primarily to process development and design, testing of preproduction samples, purchases of machinery and equipment for the small-scale production facility, compensation, and consulting fees, and are expensed as incurred. Total research and development expenses recorded during the six-month periods ended August 31, 2021 and 2020 amounted to $13,922,632 and $4,229,810, respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.

Assets held for sale

Assets are classified as held for sale when they met the criteria set out in ASC 360-10-45-9 Long-lived assets classified as held for sale:

 

 

·

Management, having the authority to approve the action, commits to a plan to sell the asset;

 

·

The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;

 

·

An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;

 

·

The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;

 

·

The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and

 

·

Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

   

When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.

Foreign currency translations and transactions

The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.

 

For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.

Net earnings (loss) per share

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the six-month periods ended August 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at August 31, 2021, the potentially dilutive securities consisted of 1,587,081 outstanding stock options (2020 – 1,587,081), 4,170,278 outstanding restricted stock units (2020 – 4,313,750), and 11,684,418 outstanding warrants (2020 – 4,884,331).

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Sales Tax, Tax Credits and Other Receivables (Tables)
6 Months Ended
Aug. 31, 2021
Sales Tax, Tax Credits and Other Receivables  
Sales tax, tax credits and other receivables

 

 

August 31,

2021

 

 

February 28,

2021

 

Sales tax

 

$599,706

 

 

$1,155,504

 

Research and development tax credits

 

 

588,843

 

 

 

435,467

 

Other receivables

 

 

154,868

 

 

 

172,864

 

 

 

$1,343,417

 

 

$1,763,835

 

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Deposits (Tables)
6 Months Ended
Aug. 31, 2021
Prepaid Expenses and Deposits  
Prepaid expenses

 

 

August 31,

2021

 

 

February 28,

2021

 

Deposits on machinery and equipment

 

$733,586

 

 

$379,395

 

Other

 

 

238,563

 

 

 

230,387

 

 

 

$972,149

 

 

$609,782

 

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Assets held for sale (Tables)
6 Months Ended
Aug. 31, 2021
Assets held for sale  
Summarizes cost of assets held for sale

Description

 

Balance sheet line item

 

Cost

 

Land held for sale

 

Assets held for sale

 

$3,411,037

 

Infinite Loop™ manufacturing facility

 

Property, plant and equipment, net

 

 

1,410,858

 

 

 

 

 

$4,821,895

 

XML 43 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Property, Plant and Equipment (Tables)
6 Months Ended
Aug. 31, 2021
Property, Plant and Equipment  
Property, plant and equipment

 

 

As at August 31, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,964,878

 

 

$(235,410)

 

$1,729,468

 

Land

 

 

1,653,737

 

 

 

-

 

 

 

1,653,737

 

Building and Land Improvements

 

 

1,921,952

 

 

 

(666,509)

 

 

1,255,443

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

295,474

 

 

 

(116,094)

 

 

179,380

 

 

 

$12,350,293

 

 

$(7,532,265)

 

$4,818,028

 

 

 

 

As at February 28, 2021

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Building

 

$1,954,345

 

 

$(201,589)

 

$1,752,756

 

Land

 

 

241,578

 

 

 

-

 

 

 

241,578

 

Building and Land Improvements

 

 

1,804,872

 

 

 

(474,114)

 

 

1,330,758

 

Machinery and equipment

 

 

6,514,252

 

 

 

(6,514,252)

 

 

-

 

Office equipment and furniture

 

 

292,946

 

 

 

(104,987)

 

 

187,959

 

 

 

$10,807,993

 

 

$(7,294,942)

 

$3,513,051

 

XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Aug. 31, 2021
Fair Value of Financial Instruments  
Fair value of financial instruments

 

 

Fair Value Measurements as at August 31, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$

4,238,028

 

 

$

4,253,605

 

 

Level 2

 

 

 

 

Fair Value Measurements at February 28, 2021

 

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Level in the hierarchy

 

Instruments measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt

 

$2,454,123

 

 

$2,464,540

 

 

Level 2

 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Payable and Accrued Liabilities (Tables)
6 Months Ended
Aug. 31, 2021
Accounts Payable and Accrued Liabilities  
Accounts payable and accrued liabilities

 

 

August 31,

2021

 

 

February 28,

2021

 

Trade accounts payable

 

$3,577,365

 

 

$5,082,736

 

Accrued engineering fees

 

 

96,865

 

 

 

535,359

 

Accrued employee compensation

 

 

765,103

 

 

 

970,154

 

Accrued professional fees

 

 

448,567

 

 

 

1,270,628

 

Other accrued liabilities

 

 

346,467

 

 

 

265,988

 

 

 

$5,234,367

 

 

$8,124,865

 

XML 46 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Long-Term Debt (Tables)
6 Months Ended
Aug. 31, 2021
Long-Term Debt  
Long-term debt

 

 

August 31,

2021

 

 

February 28,

2021

 

Investissement Québec financing facility :

 

 

 

 

 

 

Principal amount

 

$3,645,875

 

 

$1,741,612

 

Unamortized discount

 

 

(388,155)

 

 

(268,192)

Accrued interest

 

 

64,876

 

 

 

42,588

 

Total Investissement Québec financing facility

 

 

3,322,596

 

 

 

1,516,008

 

Term loan

 

 

 

 

 

 

 

 

Principal amount

 

 

915,432

 

 

 

938,116

 

Less: current portion

 

 

(915,432)

 

 

(938,116)

Total term loan, net of current portion

 

 

-

 

 

 

-

 

Long-term debt, net of current portion

 

$3,322,596

 

 

$1,516,008

 

Principal repayments

Years ending

 

Amount

 

February 28, 2022

 

$

915,432

 

February 28, 2023

 

 

-

 

February 29, 2024

 

 

520,831

 

February 28, 2025

 

 

520,831

 

February 28, 2026

 

 

520,831

 

Thereafter

 

 

2,083,382

 

Total

 

$

4,561,307

 

XML 47 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Tables)
6 Months Ended
Aug. 31, 2021
Stockholders Equity Abstract  
Common stock

For the period ended August 31, 2021

 

Number of

shares

 

 

Amount

 

Balance, February 28, 2021

 

 

42,413,691

 

 

$4,242

 

Issuance of shares upon settlement of restricted stock units

 

 

31,660

 

 

 

4

 

Issuance of shares for cash

 

 

4,714,813

 

 

 

471

 

Balance, August 31, 2021

 

 

47,160,164

 

 

$4,717

 

 

For the period ended August 31, 2020

 

Number of

shares

 

 

Amount

 

Balance, February 29, 2020

 

 

39,910,774

 

 

$3,992

 

Issuance of shares upon settlement of restricted stock units

 

 

24,436

 

 

 

2

 

Balance, August 31, 2020

 

 

39,935,210

 

 

$3,994

 

Summarizes the allocation of the aggregate purchase price

Common stock

 

$34,622,854

 

First Tranche Warrants

 

 

13,158,981

 

Second Tranche Warrants

 

 

7,167,195

 

Third Tranche Warrants

 

 

1,135,274

 

 

 

$56,084,304

 

XML 48 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Research and Development Expenses (Tables)
6 Months Ended
Aug. 31, 2021
Research and Development Expenses  
Research and development expenses

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$2,485,232

 

 

$-

 

Employee compensation

 

 

1,492,688

 

 

 

1,060,669

 

External engineering

 

 

551,381

 

 

 

942,117

 

Plant and laboratory operating expenses

 

 

707,043

 

 

 

584,394

 

Other

 

 

48,453

 

 

 

162,042

 

 

 

$5,284,797

 

 

$2,749,222

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Machinery and equipment expenditures

 

$5,108,125

 

 

$-

 

Employee compensation

 

 

3,578,816

 

 

 

1,879,717

 

External engineering

 

 

3,454,829

 

 

 

1,017,049

 

Plant and laboratory operating expenses

 

 

1,398,510

 

 

 

870,497

 

Other

 

 

382,352

 

 

 

462,547

 

 

 

$13,922,632

 

 

$4,229,810

 

XML 49 R37.htm IDEA: XBRL DOCUMENT v3.21.2
General and Administrative Expenses (Tables)
6 Months Ended
Aug. 31, 2021
General and Administrative Expenses  
General and Administrative expenses

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$856,997

 

 

$420,434

 

Employee compensation

 

 

868,122

 

 

 

1,002,473

 

Directors and officers insurance

 

 

1,059,153

 

 

 

502,368

 

Other

 

 

331,954

 

 

 

123,966

 

 

 

$3,116,226

 

 

$2,049,241

 

 

General and administrative expenses for the six-month periods ended August 31, 2021 and 2020 were as follows:

 

 

 

August 31,

2021

 

 

August 31,

2020

 

Professional fees

 

$2,488,447

 

 

$642,131

 

Employee compensation(1)

 

 

1,329,527

 

 

 

2,145,325

 

Directors and officers insurance

 

 

1,927,799

 

 

 

975,941

 

Other

 

 

531,024

 

 

 

238,926

 

 

 

$6,276,797

 

 

$4,002,323

 

XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plan (Tables)
6 Months Ended
Aug. 31, 2021
Equity Incentive Plan  
Equity incentive plan

 

 

2021

 

 

2020

 

 

 

Number of units

 

 

Number of units

 

Outstanding, beginning of period

 

 

1,083,412

 

 

 

1,300,518

 

Share reserve increase

 

 

-

 

 

 

-

 

Units granted

 

 

(286,942)

 

 

(125,762)

Units forfeited

 

 

295,524

 

 

 

2,989

 

Units expired

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

1,091,994

 

 

 

1,177,745

 

XML 51 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants (Tables)
6 Months Ended
Aug. 31, 2021
Accounts Payable and Accrued Liabilities  
Summarizes the warrants of granted

Number of warrants

 

Exercise Price

 

Expiration date

4,714,813

 

$

15.00

 

July 29, 2024

2,357,407

 

 

20.00

 

(1)

461,298

 

 

11.00

 

June 14, 2022

17,180

 

$

11.00

 

August 26, 2024

XML 52 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Interest and Other Financial Costs (Tables)
3 Months Ended
Aug. 31, 2021
Sales Tax, Tax Credits and Other Receivables  
Interest and other financial costs

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$22,056

 

 

$19,005

 

Accretion expense

 

 

11,046

 

 

 

9,112

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

(87,022)

 

 

$33,102

 

 

$(58,905)

 

Interest and other finance costs for the six-month periods ended August 31, 2021 and 2020 are as follows:

 

 

 

2021

 

 

2020

 

Interest on long-term debt

 

$41,890

 

 

$38,732

 

Accretion expense

 

 

21,573

 

 

 

17,658

 

Loss (gain) on revaluation of foreign exchange contracts

 

 

-

 

 

 

11,481

 

Other

 

 

226

 

 

 

-

 

 

 

$63,689

 

 

$67,871

 

XML 53 R41.htm IDEA: XBRL DOCUMENT v3.21.2
The Company Basis of Presentation (Details Narrative)
Aug. 31, 2021
Indorama Loop Technologies, LLC [Member]  
Ownership, percentage 50.00%
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Research and development expenses $ 13,922,632 $ 267,743
Restricted Stock Units    
Antidilutive securities 4,170,278 4,313,750
Warrants    
Antidilutive securities 11,684,418 4,884,331
Stock Options [Member]    
Antidilutive securities 1,587,081 1,587,081
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Sales Tax Tax Credits and Other Receivables (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Sales Tax, Tax Credits and Other Receivables    
Sales tax $ 599,706 $ 1,155,504
Research and development tax credits 588,843 435,467
Other receivables 154,868 172,864
Sales tax, research and development tax credits and other receivables $ 1,343,417 $ 1,763,835
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Deposits (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Prepaid Expenses and Deposits    
Deposits on machinery and equipment $ 733,586 $ 379,395
Other 238,563 230,387
Prepaid expenses $ 972,149 $ 609,782
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Deposits (Details Narrative)
6 Months Ended
Aug. 31, 2020
USD ($)
Prepaid Expenses and Deposits  
Non refundable deposits on machinery and equipment $ 1,305,010
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Assets held for sale (Details)
6 Months Ended
Aug. 31, 2021
USD ($)
Total Assets held for sale $ 4,821,895
Property, plant and equipment, net [Member]  
Total Assets held for sale $ 1,410,858
Assets Held-for-sale, Description Assets held for sale
Assets held for sale [Member]  
Total Assets held for sale $ 3,411,037
Assets Held-for-sale, Description Property, plant and equipment, net
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Assets held for sale (Details Narrative)
$ in Millions
6 Months Ended
Aug. 31, 2021
USD ($)
Assets held for sale (Details)  
Land acquired descriprtion On May 27, 2021, we acquired land in Bécancour, Québec for cash of $ million (CDN $5.9 million). The site is part of our planning for an Infinite LoopTM manufacturing facility. We plan on using a portion of the land in connection with the construction of our Infinite LoopTM manufacturing facility and selling the excess land
Land acquired for cash, amount $ 4.8
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Property Plant and Equipment (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Property, plant and equipment, gross $ 12,350,293 $ 10,807,993
Less: accumulated depreciation, write-down and impairment (7,532,265) (7,294,942)
Property, plant and equipment, net 4,818,028 3,513,051
Land [Member]    
Property, plant and equipment, gross 1,653,737 241,578
Less: accumulated depreciation, write-down and impairment 0 0
Property, plant and equipment, net 1,653,737 241,578
Building [Member]    
Property, plant and equipment, gross 1,964,878 1,954,345
Less: accumulated depreciation, write-down and impairment (235,410) (201,589)
Property, plant and equipment, net 1,729,468 1,752,756
Building and Land Improvements [Member]    
Property, plant and equipment, gross 1,921,952 1,804,872
Less: accumulated depreciation, write-down and impairment (666,509) (474,114)
Property, plant and equipment, net 1,255,443 1,330,758
Machinery and Equipment [Member]    
Property, plant and equipment, gross 6,514,252 6,514,252
Less: accumulated depreciation, write-down and impairment (6,514,252) (6,514,252)
Property, plant and equipment, net 0 0
Office Equipment and Furniture [Member]    
Property, plant and equipment, gross 295,474 292,946
Less: accumulated depreciation, write-down and impairment (116,094) (104,987)
Property, plant and equipment, net $ 179,380 $ 187,959
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Property Plant and Equipment (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Property, Plant and Equipment        
Depreciation expense $ 121,733 $ 291,498 $ 236,790 $ 539,697
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Feb. 28, 2021
Intangible Assets          
Intangible assets $ 871,050   $ 871,050   $ 794,894
Additions to intangible assets     90,591 $ 160,484  
Amortization expense $ 19,036 $ 11,088 $ 35,980 $ 18,864  
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Total liabilities $ 9,472,395 $ 10,578,989
Long-term Debt [Member] | Level 2 [Member]    
Total liabilities 4,238,028 2,454,123
Fair value $ 4,253,605 $ 2,464,540
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Payable and Accrued Liabilities (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Accounts Payable and Accrued Liabilities    
Trade accounts payable $ 3,577,365 $ 5,082,736
Accrued engineering fees 96,865 535,359
Accrued employee compensation 765,103 970,154
Accrued professional fees 448,567 1,270,628
Other accrued liabilities 346,467 265,988
Accounts payable and accrued liabilities $ 5,234,367 $ 8,124,865
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Joint Venture (Details Narrative) - USD ($)
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Joint Venture    
Investment in joint venture $ 0 $ 650,000
Equity method investment, carrying value $ 1,500,000  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.21.2
LongTerm Debt (Details) - USD ($)
Aug. 31, 2021
Feb. 28, 2021
Long-term debt, net of current portion $ 3,322,596 $ 1,516,008
Principal amount 4,561,307  
Less: current portion (915,432) (938,116)
Investissement Qu?bec Financing Facility [Member]    
Long-term debt, net of current portion 3,322,596 1,516,008
Principal amount 3,645,875 1,741,612
Unamortized discount (388,155) (268,192)
Accrued interest 64,876 42,588
Term Loan [Member]    
Long-term debt, net of current portion 0 0
Principal amount 915,432 938,116
Less: current portion $ (915,432) $ (938,116)
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.21.2
LongTerm Debt (Details 1)
Aug. 31, 2021
USD ($)
Long-Term Debt  
February 28, 2022 $ 915,432
February 28, 2023 0
February 29, 2024 520,831
February 28, 2025 520,831
February 28, 2026 520,831
Thereafter 2,083,382
Total $ 4,561,307
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.21.2
LongTerm Debt (Details Narrative)
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 24, 2018
USD ($)
Aug. 31, 2021
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
Aug. 31, 2021
USD ($)
$ / shares
Aug. 31, 2020
USD ($)
Aug. 26, 2021
USD ($)
Feb. 21, 2020
USD ($)
integer
Repayment of long-term debt       $ 27,740 $ 26,836    
Investissement Qu?bec Financing Facility [Member]              
Ramaining financing facility           $ 3,645,875  
Interest expense   $ 11,512 $ 9,875 22,394 19,291    
Mximum financing facility             $ 3,645,875
Disbursement from financing facility           1,894,877 $ 1,750,998
Interest rate on loan             2.36%
Number of monthly installments | integer             84
Fair value of the loan for the disbursement           $ 1,750,395 $ 1,354,408
Discount rate           3.95% 5.45%
Loan fees             $ 36,459
Debt discount           $ 139,390 $ 290,714
Accretion expense   $ 11,046 9,112 $ 21,573 17,658    
Investissement Qu?bec Financing Facility [Member] | Warrants              
Warrant exercise price | $ / shares   $ 11.00   $ 11.00      
Warrants issued to purchase common stock, amount   $ 364,587          
Warrant term   3 years          
Investissement Qu?bec Financing Facility [Member] | First Disbursement Warrant [Member]              
Warrant exercise price | $ / shares   $ 11.00   $ 11.00      
Warrants issued to purchase common stock, shares | shares   15,153          
Fair value of warrant   $ 77,954   $ 77,954      
Investissement Qu?bec Financing Facility [Member] | Second Disbursement Warrant [Member]              
Warrant exercise price | $ / shares   $ 11.00   $ 11.00      
Warrants issued to purchase common stock, shares | shares   17,180          
Fair value of warrant   $ 69,323   $ 69,323      
Term Loan [Member]              
Repayment of long-term debt   13,870 14,143 27,740 26,836    
Loan amount $ 1,109,614            
Loan, term 20 years            
Loan, interest rate description prime rate plus 1.5%            
Monthly repayment of loan $ 4,623            
Interest paid   $ 10,543 $ 9,130 $ 19,496 $ 19,441    
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Details Narrative) - $ / shares
3 Months Ended 6 Months Ended
Jul. 13, 2018
Aug. 31, 2021
Aug. 31, 2021
Apr. 30, 2020
Shares granted   0 0  
President and Chief Executive Officer        
Shares granted 4,000,000      
Closing price per share       $ 7.74
President and Chief Executive Officer | Restricted Stock Units        
Shares granted 4,000,000      
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders Equity (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Balance, amount $ 20,874,332 $ 35,452,406 $ 32,824,524 $ 38,463,708
Issuance of shares upon settlement of restricted stock units, shares     31,660 24,436
Issuance of shares for cash, shares     4,714,813  
Balance, amount $ 69,004,648 $ 31,593,424 $ 69,004,648 $ 31,593,424
Common Stock [Member]        
Balance, shares 42,413,691 39,910,774    
Balance, amount $ 4,242 $ 3,992    
Issuance of shares upon settlement of restricted stock units, shares 31,660 24,436    
Issuance of shares upon settlement of restricted stock units, amount $ 4 $ 2    
Issuance of shares for cash, shares 4,714,813      
Issuance of shares for cash, amount $ 471      
Balance, shares 47,160,164 39,935,210 47,160,164 39,935,210
Balance, amount $ 4,717 $ 3,994 $ 4,717 $ 3,994
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Details 1)
Aug. 31, 2021
USD ($)
Aggregate purchase price, net of issuance costs $ 56,084,304
Common Stock [Member]  
Aggregate purchase price, net of issuance costs 34,622,854
First Tranche Warrants [Member]  
Aggregate purchase price, net of issuance costs 13,158,981
Second Tranche Warrants [Member]  
Aggregate purchase price, net of issuance costs 7,167,195
Third Tranche Warrants [Member]  
Aggregate purchase price, net of issuance costs $ 1,135,274
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders Equity (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jul. 29, 2021
Aug. 31, 2021
Aug. 31, 2020
Offering price per share   $ 12.00  
Issuance of shares upon the vesting of restricted stock units   31,660 24,436
Issuance of shares for cash, shares   4,714,813  
Gross proceeds from issuance of shares with warrants   $ 56,577,756  
Net proceeds from issuance of shares with warrant   $ 56,084,304  
Warrant exercise price   $ 7.30 $ 7.05
SKGC Investment [Member]      
Aggregate purchase price $ 56,500,000    
Shares of common stock sold 4,714,813    
Issued and outstanding common stock, contribution   10.00%  
SKGC Investment [Member] | First Tranche Warrants [Member]      
Issuance of shares for cash, shares 4,714,813    
Warrant exercise price $ 15.00    
SKGC Investment [Member] | Second Tranche Warrants [Member]      
Issuance of shares for cash, shares 2,357,407    
Warrant exercise price $ 20.00    
SKGC Investment [Member] | Third Tranche Warrants [Member]      
Issuance of shares for cash, shares 461,298    
Warrant exercise price $ 11.00    
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Research and Development Expenses (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Research and development expenses $ 5,284,797 $ 2,749,222 $ 13,922,632 $ 267,743
Employee Compensation [Member]        
Research and development expenses 1,492,688 1,060,669 3,578,816 1,879,717
External Engineering [Member]        
Research and development expenses 551,381 942,117 3,454,829 1,017,049
Plant and Laboratory Operating Expenses [Member]        
Research and development expenses 707,043 584,394 1,398,510 870,497
Other [Member]        
Research and development expenses 48,453 162,042 382,352 462,547
Machinery and Equipment [Member]        
Research and development expenses $ 2,485,232 $ 0 $ 5,108,125 $ 0
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Research and Development Expenses (Details Narrative) - USD ($)
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Summary of Significant Accounting Policies    
Research and development, tax credits $ 152,391 $ 267,743
Research and development, government grants   $ 191,439
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.21.2
General and Administrative Expenses (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
General and administrative expenses $ 3,116,226 $ 2,049,241 $ 6,276,797 $ 4,002,323
Employee Compensation [Member]        
General and administrative expenses 868,122 1,002,473 1,329,527 2,145,325
Professional fees [Member]        
General and administrative expenses 856,997 420,434 2,488,447 642,131
Directors and officers insurance [Member]        
General and administrative expenses 1,059,153 502,368 1,927,799 975,941
Other [Member]        
General and administrative expenses $ 331,954 $ 123,966 $ 531,024 $ 238,926
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.21.2
General and Administrative Expenses (Details Narrative) - USD ($)
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Net reversal of stock-based compensation $ 719,733 $ 1,877,754
Restricted Stock Units    
Net reversal of stock-based compensation $ 935,837 $ 4,005
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Payments (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Stock options granted 0   0  
Stock options forfeited 0   0  
Stock options expired 0   0  
Issuances of stock options 0 0 0 0
Stock options outstanding 1,587,081 1,587,081 1,587,081 1,587,081
Stock options outstanding, weighted average exercise price $ 6.81 $ 6.81 $ 6.81 $ 6.81
Stock options exercisable 1,278,748 1,083,748 1,278,748 1,083,748
Stock options exercisable, weighted average exercise price $ 7.30 $ 7.05 $ 7.30 $ 7.05
Stock-based compensation expense $ 343,653 $ 553,540 $ 892,971 $ 1,110,435
Research and Development Expenses        
Restricted stock unit expense 394,527 352,282 790,072 704,289
General and Administrative Expenses        
Restricted stock unit expense $ 313,282 $ 513,649 70,338 1,173,466
Net reversal in stock-based compensation     $ 935,837 $ 4,005
Restricted Stock Units        
Restricted stock units granted 33,184 38,648 286,942 122,373
Restricted stock units granted, weighted average exercise price $ 13.05 $ 9.20 $ 9.41 $ 8.86
Restricted stock units settled 12,031 18,305 31,660 24,436
Restricted stock units settled, weighted average exercise price $ 8.48 $ 9.85 $ 8.82 $ 9.78
Restricted stock units forfeited 0 0 295,524 2,989
Restricted stock units forfeited, weighted average exercise price     $ 7.93 $ 8.78
Restricted stock units outstanding 4,170,278 4,313,750 4,170,278 4,313,750
Restricted stock units vested   891,327 725,313  
Restricted stock unit expense $ 379,165 $ 312,390 $ 173,238 $ 682,877
Net reversal in expenses attributable to RSUs $ 935,837 $ 4,005    
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plan (Details) - Equity Incentive Plan - shares
6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Outstanding, beginning of period 1,083,412 1,300,518
Share reserve increase 0 0
Units granted 286,942 125,762
Units forfeited 295,524 2,989
Units expired 0 0
Outstanding, end of period 1,091,994 1,177,745
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plan (Details Narrative) - 2017 Equity Incentive Plan - shares
6 Months Ended
Jul. 06, 2017
Aug. 31, 2021
Common stock shares reserved for future issuance 3,000,000  
Common stock shares reserved for future issuance annual increase 1,500,000  
Expected life   10 years
Voting power percentage   10
Life of option   5 years
Common stock outstanding shares percentage 5  
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants (Details)
6 Months Ended
Aug. 31, 2021
USD ($)
$ / shares
Warrants 1  
Number of warrants | $ $ 4,714,813
Exercise Price | $ / shares $ 15.00
Expiration date Jul. 29, 2024
Warrants 2  
Number of warrants | $ $ 2,357,407
Exercise Price | $ / shares $ 20.00
Warrants 3  
Number of warrants | $ $ 461,298
Exercise Price | $ / shares $ 11.00
Expiration date Jun. 14, 2022
Warrants 4  
Number of warrants | $ $ 17,180
Exercise Price | $ / shares $ 11.00
Expiration date Aug. 26, 2024
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants (Details Narrative) - Warrants
6 Months Ended
Aug. 31, 2021
$ / shares
shares
Warrants to issue shares of common stock 200,000
Warrants to issue shares of common stock exercise price | $ / shares $ 11.00
Warrant to purchase common stock shares for for consulting services 25,000
Warrant to purchase common stock shares for for consulting services, per share price | $ / shares $ 9.43
Warrants issued 7,550,698
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Interest and Other Financial Costs (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Aug. 31, 2020
Interest and Other Finance Costs        
Interest on long-term debt $ 22,056 $ 19,005 $ 41,890 $ 38,732
Accretion expense 11,046 9,112 21,573 17,658
Loss (gain) on revaluation of foreign exchange contracts 0 (87,022) 0 11,481
Other Interest and finance costs 0 0 226 0
Interest and other finance costs $ 33,102 $ (58,905) $ 63,689 $ 67,871
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Details Narrative) - USD ($)
6 Months Ended
Aug. 31, 2021
Sep. 02, 2020
Commitments and Contingencies    
Cumulative amount paid $ 900,000  
Total amount of Chemtex Agreement   $ 4,300,000
Milestones payments facility   $ 2,150,000
EXCEL 84 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 85 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 86 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 87 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 199 326 1 false 44 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://loopindustries.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://loopindustries.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Sheet http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Statements 5 false false R6.htm 000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 000007 - Disclosure - The Company, Basis of Presentation Sheet http://loopindustries.com/role/TheCompanyBasisOfPresentation The Company, Basis of Presentation Notes 7 false false R8.htm 000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 000009 - Disclosure - Sales Tax, Tax Credits and Other Receivables Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables Sales Tax, Tax Credits and Other Receivables Notes 9 false false R10.htm 000010 - Disclosure - Prepaid Expenses and Deposits Sheet http://loopindustries.com/role/PrepaidExpensesAndDeposits Prepaid Expenses and Deposits Notes 10 false false R11.htm 000011 - Disclosure - Assets held for sale Sheet http://loopindustries.com/role/AssetsHeldForSale Assets held for sale Notes 11 false false R12.htm 000012 - Disclosure - Property, Plant and Equipment Sheet http://loopindustries.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 12 false false R13.htm 000013 - Disclosure - Intangible Assets Sheet http://loopindustries.com/role/IntangibleAssets Intangible Assets Notes 13 false false R14.htm 000014 - Disclosure - Fair Value of Financial Instruments Sheet http://loopindustries.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 14 false false R15.htm 000015 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 15 false false R16.htm 000016 - Disclosure - Joint Venture Sheet http://loopindustries.com/role/JointVenture Joint Venture Notes 16 false false R17.htm 000017 - Disclosure - Long-Term Debt Sheet http://loopindustries.com/role/LongTermDebt Long-Term Debt Notes 17 false false R18.htm 000018 - Disclosure - Related Party Transactions Sheet http://loopindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 000019 - Disclosure - Stockholders' Equity Sheet http://loopindustries.com/role/StockholdersEquity Stockholders' Equity Notes 19 false false R20.htm 000020 - Disclosure - Research and Development Expenses Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpenses Research and Development Expenses Notes 20 false false R21.htm 000021 - Disclosure - General and Administrative Expenses Sheet http://loopindustries.com/role/GeneralAndAdministrativeExpenses General and Administrative Expenses Notes 21 false false R22.htm 000022 - Disclosure - Share-Based Payments Sheet http://loopindustries.com/role/ShareBasedPayments Share-Based Payments Notes 22 false false R23.htm 000023 - Disclosure - Equity Incentive Plan Sheet http://loopindustries.com/role/EquityIncentivePlan Equity Incentive Plan Notes 23 false false R24.htm 000024 - Disclosure - Warrants Sheet http://loopindustries.com/role/Warrants Warrants Notes 24 false false R25.htm 000025 - Disclosure - Interest and Other Finance Costs Sheet http://loopindustries.com/role/InterestAndOtherFinanceCosts Interest and Other Finance Costs Notes 25 false false R26.htm 000026 - Disclosure - Commitments and Contingencies Sheet http://loopindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 26 false false R27.htm 000027 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 000028 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Tables) Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesTables Sales Tax, Tax Credits and Other Receivables (Tables) Tables http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables 28 false false R29.htm 000029 - Disclosure - Prepaid Expenses and Deposits (Tables) Sheet http://loopindustries.com/role/PrepaidExpensesAndDepositsTables Prepaid Expenses and Deposits (Tables) Tables http://loopindustries.com/role/PrepaidExpensesAndDeposits 29 false false R30.htm 000030 - Disclosure - Assets held for sale (Tables) Sheet http://loopindustries.com/role/AssetsHeldForSaleTables Assets held for sale (Tables) Tables http://loopindustries.com/role/AssetsHeldForSale 30 false false R31.htm 000031 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://loopindustries.com/role/PropertyPlantAndEquipment 31 false false R32.htm 000032 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://loopindustries.com/role/FairValueOfFinancialInstruments 32 false false R33.htm 000033 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities 33 false false R34.htm 000034 - Disclosure - Long-Term Debt (Tables) Sheet http://loopindustries.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://loopindustries.com/role/LongTermDebt 34 false false R35.htm 000035 - Disclosure - Stockholders' Equity (Tables) Sheet http://loopindustries.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://loopindustries.com/role/StockholdersEquity 35 false false R36.htm 000036 - Disclosure - Research and Development Expenses (Tables) Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables Research and Development Expenses (Tables) Tables http://loopindustries.com/role/ResearchAndDevelopmentExpenses 36 false false R37.htm 000037 - Disclosure - General and Administrative Expenses (Tables) Sheet http://loopindustries.com/role/GeneralAndAdministrativeExpensesTables General and Administrative Expenses (Tables) Tables http://loopindustries.com/role/GeneralAndAdministrativeExpenses 37 false false R38.htm 000038 - Disclosure - Equity Incentive Plan (Tables) Sheet http://loopindustries.com/role/EquityIncentivePlanTables Equity Incentive Plan (Tables) Tables http://loopindustries.com/role/EquityIncentivePlan 38 false false R39.htm 000039 - Disclosure - Warrants (Tables) Sheet http://loopindustries.com/role/WarrantsTables Warrants (Tables) Tables http://loopindustries.com/role/Warrants 39 false false R40.htm 000040 - Disclosure - Interest and Other Financial Costs (Tables) Sheet http://loopindustries.com/role/InterestAndOtherFinancialCostsTables Interest and Other Financial Costs (Tables) Tables 40 false false R41.htm 000041 - Disclosure - The Company Basis of Presentation (Details Narrative) Sheet http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative The Company Basis of Presentation (Details Narrative) Details 41 false false R42.htm 000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies 42 false false R43.htm 000043 - Disclosure - Sales Tax Tax Credits and Other Receivables (Details) Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails Sales Tax Tax Credits and Other Receivables (Details) Details 43 false false R44.htm 000044 - Disclosure - Prepaid Expenses and Deposits (Details) Sheet http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails Prepaid Expenses and Deposits (Details) Details http://loopindustries.com/role/PrepaidExpensesAndDepositsTables 44 false false R45.htm 000045 - Disclosure - Prepaid Expenses and Deposits (Details Narrative) Sheet http://loopindustries.com/role/PrepaidExpensesAndDepositsDetailsNarrative Prepaid Expenses and Deposits (Details Narrative) Details http://loopindustries.com/role/PrepaidExpensesAndDepositsTables 45 false false R46.htm 000046 - Disclosure - Assets held for sale (Details) Sheet http://loopindustries.com/role/AssetsHeldForSaleDetails Assets held for sale (Details) Details http://loopindustries.com/role/AssetsHeldForSaleTables 46 false false R47.htm 000047 - Disclosure - Assets held for sale (Details Narrative) Sheet http://loopindustries.com/role/AssetsHeldForSaleDetailsNarrative Assets held for sale (Details Narrative) Details http://loopindustries.com/role/AssetsHeldForSaleTables 47 false false R48.htm 000048 - Disclosure - Property Plant and Equipment (Details) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentDetails Property Plant and Equipment (Details) Details 48 false false R49.htm 000049 - Disclosure - Property Plant and Equipment (Details Narrative) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentDetailsNarrative Property Plant and Equipment (Details Narrative) Details 49 false false R50.htm 000050 - Disclosure - Intangible Assets (Details Narrative) Sheet http://loopindustries.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://loopindustries.com/role/IntangibleAssets 50 false false R51.htm 000051 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables 51 false false R52.htm 000052 - Disclosure - Accounts Payable and Accrued Liabilities (Details) Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities (Details) Details http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables 52 false false R53.htm 000053 - Disclosure - Joint Venture (Details Narrative) Sheet http://loopindustries.com/role/JointVentureDetailsNarrative Joint Venture (Details Narrative) Details http://loopindustries.com/role/JointVenture 53 false false R54.htm 000054 - Disclosure - LongTerm Debt (Details) Sheet http://loopindustries.com/role/LongtermDebtDetails LongTerm Debt (Details) Details 54 false false R55.htm 000055 - Disclosure - LongTerm Debt (Details 1) Sheet http://loopindustries.com/role/LongtermDebtDetails1 LongTerm Debt (Details 1) Details 55 false false R56.htm 000056 - Disclosure - LongTerm Debt (Details Narrative) Sheet http://loopindustries.com/role/LongtermDebtDetailsNarrative LongTerm Debt (Details Narrative) Details 56 false false R57.htm 000057 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://loopindustries.com/role/RelatedPartyTransactions 57 false false R58.htm 000058 - Disclosure - Stockholders Equity (Details) Sheet http://loopindustries.com/role/StockholdersEquityDetails Stockholders Equity (Details) Details 58 false false R59.htm 000059 - Disclosure - Stockholders' Equity (Details 1) Sheet http://loopindustries.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) Details http://loopindustries.com/role/StockholdersEquityTables 59 false false R60.htm 000060 - Disclosure - Stockholders Equity (Details Narrative) Sheet http://loopindustries.com/role/StockholdersEquityDetailsNarrative Stockholders Equity (Details Narrative) Details 60 false false R61.htm 000061 - Disclosure - Research and Development Expenses (Details) Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails Research and Development Expenses (Details) Details http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables 61 false false R62.htm 000062 - Disclosure - Research and Development Expenses (Details Narrative) Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetailsNarrative Research and Development Expenses (Details Narrative) Details http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables 62 false false R63.htm 000063 - Disclosure - General and Administrative Expenses (Details) Sheet http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails General and Administrative Expenses (Details) Details http://loopindustries.com/role/GeneralAndAdministrativeExpensesTables 63 false false R64.htm 000064 - Disclosure - General and Administrative Expenses (Details Narrative) Sheet http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative General and Administrative Expenses (Details Narrative) Details http://loopindustries.com/role/GeneralAndAdministrativeExpensesTables 64 false false R65.htm 000065 - Disclosure - Share-based Payments (Details Narrative) Sheet http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative Share-based Payments (Details Narrative) Details 65 false false R66.htm 000066 - Disclosure - Equity Incentive Plan (Details) Sheet http://loopindustries.com/role/EquityIncentivePlanDetails Equity Incentive Plan (Details) Details http://loopindustries.com/role/EquityIncentivePlanTables 66 false false R67.htm 000067 - Disclosure - Equity Incentive Plan (Details Narrative) Sheet http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative Equity Incentive Plan (Details Narrative) Details http://loopindustries.com/role/EquityIncentivePlanTables 67 false false R68.htm 000068 - Disclosure - Warrants (Details) Sheet http://loopindustries.com/role/WarrantsDetails Warrants (Details) Details http://loopindustries.com/role/WarrantsTables 68 false false R69.htm 000069 - Disclosure - Warrants (Details Narrative) Sheet http://loopindustries.com/role/WarrantsDetailsNarrative Warrants (Details Narrative) Details http://loopindustries.com/role/WarrantsTables 69 false false R70.htm 000070 - Disclosure - Interest and Other Financial Costs (Details) Sheet http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails Interest and Other Financial Costs (Details) Details http://loopindustries.com/role/InterestAndOtherFinancialCostsTables 70 false false R71.htm 000071 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://loopindustries.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://loopindustries.com/role/CommitmentsAndContingencies 71 false false All Reports Book All Reports loop_10q.htm loop-20210831.xsd loop-20210831_cal.xml loop-20210831_def.xml loop-20210831_lab.xml loop-20210831_pre.xml loop_ex311.htm loop_ex312.htm loop_ex321.htm loop_ex322.htm loop_10qimg1.jpg http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 90 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "loop_10q.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 199, "dts": { "calculationLink": { "local": [ "loop-20210831_cal.xml" ] }, "definitionLink": { "local": [ "loop-20210831_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "loop_10q.htm" ] }, "labelLink": { "local": [ "loop-20210831_lab.xml" ] }, "presentationLink": { "local": [ "loop-20210831_pre.xml" ] }, "schema": { "local": [ "loop-20210831.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 377, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 31, "http://loopindustries.com/20210831": 6, "http://xbrl.sec.gov/dei/2020-01-31": 7, "total": 44 }, "keyCustom": 54, "keyStandard": 272, "memberCustom": 30, "memberStandard": 14, "nsprefix": "loop", "nsuri": "http://loopindustries.com/20210831", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://loopindustries.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - Prepaid Expenses and Deposits", "role": "http://loopindustries.com/role/PrepaidExpensesAndDeposits", "shortName": "Prepaid Expenses and Deposits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:AssetsHeldForSaletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - Assets held for sale", "role": "http://loopindustries.com/role/AssetsHeldForSale", "shortName": "Assets held for sale", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:AssetsHeldForSaletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - Property, Plant and Equipment", "role": "http://loopindustries.com/role/PropertyPlantAndEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - Intangible Assets", "role": "http://loopindustries.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Fair Value of Financial Instruments", "role": "http://loopindustries.com/role/FairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Accounts Payable and Accrued Liabilities", "role": "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - Joint Venture", "role": "http://loopindustries.com/role/JointVenture", "shortName": "Joint Venture", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - Long-Term Debt", "role": "http://loopindustries.com/role/LongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - Related Party Transactions", "role": "http://loopindustries.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - Stockholders' Equity", "role": "http://loopindustries.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "lang": null, "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - Research and Development Expenses", "role": "http://loopindustries.com/role/ResearchAndDevelopmentExpenses", "shortName": "Research and Development Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - General and Administrative Expenses", "role": "http://loopindustries.com/role/GeneralAndAdministrativeExpenses", "shortName": "General and Administrative Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - Share-Based Payments", "role": "http://loopindustries.com/role/ShareBasedPayments", "shortName": "Share-Based Payments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - Equity Incentive Plan", "role": "http://loopindustries.com/role/EquityIncentivePlan", "shortName": "Equity Incentive Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - Warrants", "role": "http://loopindustries.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - Interest and Other Finance Costs", "role": "http://loopindustries.com/role/InterestAndOtherFinanceCosts", "shortName": "Interest and Other Finance Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - Commitments and Contingencies", "role": "http://loopindustries.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Tables)", "role": "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesTables", "shortName": "Sales Tax, Tax Credits and Other Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - Prepaid Expenses and Deposits (Tables)", "role": "http://loopindustries.com/role/PrepaidExpensesAndDepositsTables", "shortName": "Prepaid Expenses and Deposits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:SummarizesCostOfAssetsHeldForSaletabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - Assets held for sale (Tables)", "role": "http://loopindustries.com/role/AssetsHeldForSaleTables", "shortName": "Assets held for sale (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:SummarizesCostOfAssetsHeldForSaletabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - Property, Plant and Equipment (Tables)", "role": "http://loopindustries.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, Plant and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "role": "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - Long-Term Debt (Tables)", "role": "http://loopindustries.com/role/LongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - Stockholders' Equity (Tables)", "role": "http://loopindustries.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ResearchAndDevelopmentExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - Research and Development Expenses (Tables)", "role": "http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables", "shortName": "Research and Development Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ResearchAndDevelopmentExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:GeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - General and Administrative Expenses (Tables)", "role": "http://loopindustries.com/role/GeneralAndAdministrativeExpensesTables", "shortName": "General and Administrative Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:GeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - Equity Incentive Plan (Tables)", "role": "http://loopindustries.com/role/EquityIncentivePlanTables", "shortName": "Equity Incentive Plan (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - Warrants (Tables)", "role": "http://loopindustries.com/role/WarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "role": "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfInterestAndOtherFinancialCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000040 - Disclosure - Interest and Other Financial Costs (Tables)", "role": "http://loopindustries.com/role/InterestAndOtherFinancialCostsTables", "shortName": "Interest and Other Financial Costs (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:ScheduleOfInterestAndOtherFinancialCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_IndoramaLoopTechnologiesLlcMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000041 - Disclosure - The Company Basis of Presentation (Details Narrative)", "role": "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative", "shortName": "The Company Basis of Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_IndoramaLoopTechnologiesLlcMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:ResearchAndDevelopmentExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:ResearchAndDevelopmentExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock", "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValueAddedTaxReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000043 - Disclosure - Sales Tax Tax Credits and Other Receivables (Details)", "role": "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails", "shortName": "Sales Tax Tax Credits and Other Receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock", "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValueAddedTaxReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:PrepaidMachineryAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000044 - Disclosure - Prepaid Expenses and Deposits (Details)", "role": "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails", "shortName": "Prepaid Expenses and Deposits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "loop:PrepaidExpensesAndDepositsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:PrepaidMachineryAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2020-03-01to2020-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForOtherDeposits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000045 - Disclosure - Prepaid Expenses and Deposits (Details Narrative)", "role": "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetailsNarrative", "shortName": "Prepaid Expenses and Deposits (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2020-03-01to2020-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForOtherDeposits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "loop:SummarizesCostOfAssetsHeldForSaletabletextblock", "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000046 - Disclosure - Assets held for sale (Details)", "role": "http://loopindustries.com/role/AssetsHeldForSaleDetails", "shortName": "Assets held for sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "loop:SummarizesCostOfAssetsHeldForSaletabletextblock", "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireLand", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000047 - Disclosure - Assets held for sale (Details Narrative)", "role": "http://loopindustries.com/role/AssetsHeldForSaleDetailsNarrative", "shortName": "Assets held for sale (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "loop:AssetsHeldForSaletextblock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireLand", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000048 - Disclosure - Property Plant and Equipment (Details)", "role": "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepreciationExpenseOnReclassifiedAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000049 - Disclosure - Property Plant and Equipment (Details Narrative)", "role": "http://loopindustries.com/role/PropertyPlantAndEquipmentDetailsNarrative", "shortName": "Property Plant and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepreciationExpenseOnReclassifiedAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2020-02-29_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited)", "role": "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "shortName": "Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2020-02-29_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000050 - Disclosure - Intangible Assets (Details Narrative)", "role": "http://loopindustries.com/role/IntangibleAssetsDetailsNarrative", "shortName": "Intangible Assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Liabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000051 - Disclosure - Fair Value of Financial Instruments (Details)", "role": "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails", "shortName": "Fair Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-02-28_us-gaap_LongTermDebtMember_us-gaap_FairValueInputsLevel2Member", "decimals": "0", "lang": null, "name": "us-gaap:Liabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000052 - Disclosure - Accounts Payable and Accrued Liabilities (Details)", "role": "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2020-03-01to2020-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000053 - Disclosure - Joint Venture (Details Narrative)", "role": "http://loopindustries.com/role/JointVentureDetailsNarrative", "shortName": "Joint Venture (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2020-03-01to2020-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtNoncurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000054 - Disclosure - LongTerm Debt (Details)", "role": "http://loopindustries.com/role/LongtermDebtDetails", "shortName": "LongTerm Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_InvestissementQuebecFinancingFacilityMember", "decimals": "0", "lang": null, "name": "us-gaap:LongTermDebtNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000055 - Disclosure - LongTerm Debt (Details 1)", "role": "http://loopindustries.com/role/LongtermDebtDetails1", "shortName": "LongTerm Debt (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfLongTermDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000056 - Disclosure - LongTerm Debt (Details Narrative)", "role": "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "shortName": "LongTerm Debt (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-26_loop_InvestissementQuebecFinancingFacilityMember", "decimals": "0", "lang": null, "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2018-07-01to2018-07-13_loop_PresidentAndChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000057 - Disclosure - Related Party Transactions (Details Narrative)", "role": "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2018-07-01to2018-07-13_loop_PresidentAndChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000058 - Disclosure - Stockholders Equity (Details)", "role": "http://loopindustries.com/role/StockholdersEquityDetails", "shortName": "Stockholders Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-05-31_loop_CommonStock1Member", "decimals": "0", "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:AggregatePurchasePriceNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000059 - Disclosure - Stockholders' Equity (Details 1)", "role": "http://loopindustries.com/role/StockholdersEquityDetails1", "shortName": "Stockholders' Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "loop:AggregatePurchasePriceNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000060 - Disclosure - Stockholders Equity (Details Narrative)", "role": "http://loopindustries.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ResearchAndDevelopmentExpensesTableTextBlock", "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000061 - Disclosure - Research and Development Expenses (Details)", "role": "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails", "shortName": "Research and Development Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ResearchAndDevelopmentExpensesTableTextBlock", "loop:DisclosureResearchAndDevelopmentExpensesTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationTaxCreditsResearch", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000062 - Disclosure - Research and Development Expenses (Details Narrative)", "role": "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetailsNarrative", "shortName": "Research and Development Expenses (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationTaxCreditsResearch", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000063 - Disclosure - General and Administrative Expenses (Details)", "role": "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "shortName": "General and Administrative Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:GeneralAndAdministrativeExpensesTableTextBlock", "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31_loop_EmployeeCompensationMember", "decimals": "0", "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000064 - Disclosure - General and Administrative Expenses (Details Narrative)", "role": "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "shortName": "General and Administrative Expenses (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000065 - Disclosure - Share-based Payments (Details Narrative)", "role": "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "shortName": "Share-based Payments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-02-28_loop_EquityIncentiveplanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000066 - Disclosure - Equity Incentive Plan (Details)", "role": "http://loopindustries.com/role/EquityIncentivePlanDetails", "shortName": "Equity Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-02-28_loop_EquityIncentiveplanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2017-07-06_loop_TwoThousandSeventeenEquityIncentivePlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000067 - Disclosure - Equity Incentive Plan (Details Narrative)", "role": "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative", "shortName": "Equity Incentive Plan (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2017-07-06_loop_TwoThousandSeventeenEquityIncentivePlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_WarrantsOneMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000068 - Disclosure - Warrants (Details)", "role": "http://loopindustries.com/role/WarrantsDetails", "shortName": "Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_WarrantsOneMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000069 - Disclosure - Warrants (Details Narrative)", "role": "http://loopindustries.com/role/WarrantsDetailsNarrative", "shortName": "Warrants (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "loop:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "AsOf2021-08-31_loop_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - The Company, Basis of Presentation", "role": "http://loopindustries.com/role/TheCompanyBasisOfPresentation", "shortName": "The Company, Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfInterestAndOtherFinancialCostsTableTextBlock", "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseLongTermDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000070 - Disclosure - Interest and Other Financial Costs (Details)", "role": "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails", "shortName": "Interest and Other Financial Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "loop:ScheduleOfInterestAndOtherFinancialCostsTableTextBlock", "loop:InterestAndOtherFinancialCostsDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-06-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseLongTermDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForLossesAndLossAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000071 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://loopindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForLossesAndLossAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Sales Tax, Tax Credits and Other Receivables", "role": "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables", "shortName": "Sales Tax, Tax Credits and Other Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "loop_10q.htm", "contextRef": "From2021-03-01to2021-08-31", "decimals": null, "first": true, "lang": "en-US", "name": "loop:SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 44, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://loopindustries.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "loop_AccretionExpenseBorrowings": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accretion expense" } } }, "localname": "AccretionExpenseBorrowings", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_AdditionalPaidInCapitalWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital -Warrants [Member]" } } }, "localname": "AdditionalPaidInCapitalWarrantsMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "loop_AdditionalPaidInCapitalwarrants": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional paid-in capital - Warrants (Note 18)" } } }, "localname": "AdditionalPaidInCapitalwarrants", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "loop_AggregatePurchasePriceNetOfIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate purchase price, net of issuance costs" } } }, "localname": "AggregatePurchasePriceNetOfIssuanceCosts", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1" ], "xbrltype": "monetaryItemType" }, "loop_AssetsHeldForSaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets held for sale [Member]" } } }, "localname": "AssetsHeldForSaleMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "domainItemType" }, "loop_AssetsHeldForSaletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "5. Assets held for sale" } } }, "localname": "AssetsHeldForSaletextblock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSale" ], "xbrltype": "textBlockItemType" }, "loop_CommonStock1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStock1Member", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "loop_CommonStockOutstandingSharesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock outstanding shares percentage" } } }, "localname": "CommonStockOutstandingSharesPercentage", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "stringItemType" }, "loop_CommonStockSharesReservedForFutureIssuanceAnnualIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares reserved for future issuance annual increase" } } }, "localname": "CommonStockSharesReservedForFutureIssuanceAnnualIncrease", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "sharesItemType" }, "loop_DebtDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt discount" } } }, "localname": "DebtDiscount", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_DebtInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued interest" } } }, "localname": "DebtInstrumentAccruedInterest", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "loop_DirectorsAndOfficersInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Directors and officers insurance [Member]" } } }, "localname": "DirectorsAndOfficersInsuranceMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_DisbursementFromFinancingFacility": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Disbursement from financing facility" } } }, "localname": "DisbursementFromFinancingFacility", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_DisclosureResearchAndDevelopmentExpensesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "14. Research and development expenses" } } }, "localname": "DisclosureResearchAndDevelopmentExpensesTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpenses" ], "xbrltype": "textBlockItemType" }, "loop_EmployeeCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Compensation [Member]", "verboseLabel": "Employee Compensation [Member]" } } }, "localname": "EmployeeCompensationMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_EquityIncentiveplanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Equity Incentive Plan]", "verboseLabel": "Equity Incentive Plan" } } }, "localname": "EquityIncentiveplanMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "loop_ExternalEngineeringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "External Engineering [Member]" } } }, "localname": "ExternalEngineeringMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_FairValueOfWarrant": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrant" } } }, "localname": "FairValueOfWarrant", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_FirstDisbursementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Disbursement Warrant [Member]" } } }, "localname": "FirstDisbursementWarrantMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_FirstTrancheWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Tranche Warrants [Member]", "verboseLabel": "First Tranche Warrants [Member]" } } }, "localname": "FirstTrancheWarrantsMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_ForeignCurrencyTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Foreign currency translation" } } }, "localname": "ForeignCurrencyTranslation", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_GainLossOnRevaluationOfForeignExchangeContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss (gain) on revaluation of foreign exchange contracts" } } }, "localname": "GainLossOnRevaluationOfForeignExchangeContracts", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails" ], "xbrltype": "monetaryItemType" }, "loop_GeneralAndAdministrativeExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpensesTableTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesTables" ], "xbrltype": "textBlockItemType" }, "loop_GrossProceedsFromIssuanceOfSharesWithWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gross proceeds from issuance of shares with warrants" } } }, "localname": "GrossProceedsFromIssuanceOfSharesWithWarrants", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_IncreaseDecreaseLossOnRevaluationOfForeignExchangeContracts": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss on revaluation of foreign exchange contracts (Note 19)" } } }, "localname": "IncreaseDecreaseLossOnRevaluationOfForeignExchangeContracts", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_IncreaseDecreasesalesTaxAndTaxCreditsReceivable": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sales tax and tax credits receivable (Note 3)" } } }, "localname": "IncreaseDecreasesalesTaxAndTaxCreditsReceivable", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_IncreasedecreaseIndepositsOnMachineryAndEquipment": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deposits on machinery and equipment (Note 4)" } } }, "localname": "IncreasedecreaseIndepositsOnMachineryAndEquipment", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_IndoramaLoopTechnologiesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indorama Loop Technologies, LLC [Member]" } } }, "localname": "IndoramaLoopTechnologiesLlcMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_InterestAndOtherFinanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest and other finance costs" } } }, "localname": "InterestAndOtherFinanceCosts", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails" ], "xbrltype": "monetaryItemType" }, "loop_InterestAndOtherFinancialCostsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "19. Interest and Other Finance Costs" } } }, "localname": "InterestAndOtherFinancialCostsDisclosureTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinanceCosts" ], "xbrltype": "textBlockItemType" }, "loop_InterestAndOtherFinancialExpensesNote19": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest and other financial expenses (Note 19)" } } }, "localname": "InterestAndOtherFinancialExpensesNote19", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_InvestissementQuebecFinancingFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investissement Qu?bec Financing Facility [Member]" } } }, "localname": "InvestissementQuebecFinancingFacilityMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_InvestmentInJointVenture": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.", "label": "Investment in joint venture (Note 10)" } } }, "localname": "InvestmentInJointVenture", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "loop_IssuanceOfCommonSharesAndWarrantsForCashNetOfShareIssuanceCostsNote13Amount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), amount" } } }, "localname": "IssuanceOfCommonSharesAndWarrantsForCashNetOfShareIssuanceCostsNote13Amount", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_IssuanceOfCommonSharesAndWarrantsForCashNetOfShareIssuanceCostsNote13Shares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), shares" } } }, "localname": "IssuanceOfCommonSharesAndWarrantsForCashNetOfShareIssuanceCostsNote13Shares", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "loop_IssuanceOfSharesUponTheVestingOfRestrictedStockUnitsNote16Amount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of shares upon the vesting of restricted stock units (Note 16), amount" } } }, "localname": "IssuanceOfSharesUponTheVestingOfRestrictedStockUnitsNote16Amount", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_IssuanceOfSharesUponTheVestingOfRestrictedStockUnitsNote16Shares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares upon the vesting of restricted stock units (Note 16), shares" } } }, "localname": "IssuanceOfSharesUponTheVestingOfRestrictedStockUnitsNote16Shares", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "loop_IssuanceOfWarrantsForFinancingFacilityNotes11And18": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of warrants for financing facility (Notes 11 and 18)" } } }, "localname": "IssuanceOfWarrantsForFinancingFacilityNotes11And18", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_LoanFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loan fees" } } }, "localname": "LoanFees", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_MilestonesPaymentsFacility": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Milestones payments facility.", "label": "Milestones payments facility" } } }, "localname": "MilestonesPaymentsFacility", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_NetProceedsFromIssuanceOfSharesWithWarrant": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net proceeds from issuance of shares with warrant" } } }, "localname": "NetProceedsFromIssuanceOfSharesWithWarrant", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_NetReversalInExpensesAttributableToRsus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net reversal in expenses attributable to RSUs", "label": "Net reversal in expenses attributable to RSUs" } } }, "localname": "NetReversalInExpensesAttributableToRsus", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_NetReversalInStockBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net reversal in stock-based compensation.", "label": "Net reversal in stock-based compensation" } } }, "localname": "NetReversalInStockBasedCompensation", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_NumberOfInstallments": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of monthly installments" } } }, "localname": "NumberOfInstallments", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "integerItemType" }, "loop_OfficeEquipmentAndFurnitureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Office Equipment and Furniture [Member]" } } }, "localname": "OfficeEquipmentAndFurnitureMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "loop_OtherInterestAndFinanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Interest and finance costs" } } }, "localname": "OtherInterestAndFinanceCosts", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails" ], "xbrltype": "monetaryItemType" }, "loop_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Other [Member]]", "verboseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_OtherResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other [Member]" } } }, "localname": "OtherResearchAndDevelopmentExpenseMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_PlantAndLaboratoryOperatingExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plant and Laboratory Operating Expenses [Member]" } } }, "localname": "PlantAndLaboratoryOperatingExpensesMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_PrepaidExpensesAndDepositsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "4. Prepaid Expenses and Deposits" } } }, "localname": "PrepaidExpensesAndDepositsDisclosureTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/PrepaidExpensesAndDeposits" ], "xbrltype": "textBlockItemType" }, "loop_PrepaidMachineryAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deposits on machinery and equipment" } } }, "localname": "PrepaidMachineryAndEquipment", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "loop_PresidentAndChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "President and Chief Executive Officer" } } }, "localname": "PresidentAndChiefExecutiveOfficerMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_ProfessionalFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Professional fees [Member]" } } }, "localname": "ProfessionalFeesMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "domainItemType" }, "loop_PropertyPlantAndEquipmentNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, net [Member]" } } }, "localname": "PropertyPlantAndEquipmentNetMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "domainItemType" }, "loop_ResearchAndDevelopmentExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a", "label": "[Research and development expenses 1]", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpenses", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "loop_ResearchAndDevelopmentExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Research and development expenses]", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpensesTableTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables" ], "xbrltype": "textBlockItemType" }, "loop_RestrictedStockUnitsIssuedForServicesNote16": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Restricted stock units issued for services (Note 16)" } } }, "localname": "RestrictedStockUnitsIssuedForServicesNote16", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_SalesTaxResearchAndDevelopmentTaxCreditsAndOtherReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sales tax, research and development tax credits and other receivables" } } }, "localname": "SalesTaxResearchAndDevelopmentTaxCreditsAndOtherReceivables", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "loop_SalesTaxTaxCreditsAndOtherReceivablesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "3. Sales Tax, Tax Credits and Other Receivables" } } }, "localname": "SalesTaxTaxCreditsAndOtherReceivablesTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables" ], "xbrltype": "textBlockItemType" }, "loop_ScheduleOfInterestAndOtherFinancialCostsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and other financial costs" } } }, "localname": "ScheduleOfInterestAndOtherFinancialCostsTableTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsTables" ], "xbrltype": "textBlockItemType" }, "loop_ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales tax, tax credits and other receivables" } } }, "localname": "ScheduleOfSalesTaxTaxCreditsAndOtherReceivablesTableTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "loop_ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity incentive plan" } } }, "localname": "ScheduleOfShareBasedCompensationEquityIncentivePlanActivityTableTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanTables" ], "xbrltype": "textBlockItemType" }, "loop_SecondDisbursementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Disbursement Warrant [Member]" } } }, "localname": "SecondDisbursementWarrantMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_SecondTrancheWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Tranche Warrants [Member]", "verboseLabel": "Second Tranche Warrants [Member]" } } }, "localname": "SecondTrancheWarrantsMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_SeriesAPreferredStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A, Preferred Stock" } } }, "localname": "SeriesAPreferredStocksMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "loop_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "loop_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSettledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units settled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSettledInPeriod", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "loop_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSettledInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units settled, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSettledInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "loop_SkgcInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SKGC Investment [Member]" } } }, "localname": "SkgcInvestmentMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_StockOptionsIssuedForServicesNote16": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock options issued for services (Note 16)" } } }, "localname": "StockOptionsIssuedForServicesNote16", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_StockbasedCompensationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-based compensation" } } }, "localname": "StockbasedCompensationPolicyTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "loop_SummarizesCostOfAssetsHeldForSaletabletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summarizes cost of assets held for sale" } } }, "localname": "SummarizesCostOfAssetsHeldForSaletabletextblock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleTables" ], "xbrltype": "textBlockItemType" }, "loop_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_ThirdTrancheWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Tranche Warrants [Member]", "verboseLabel": "Third Tranche Warrants [Member]" } } }, "localname": "ThirdTrancheWarrantsMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_TwoThousandSeventeenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2017 Equity Incentive Plan" } } }, "localname": "TwoThousandSeventeenEquityIncentivePlanMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_WarrantIssuedForServicesNote18": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrant issued for services (Note 18)" } } }, "localname": "WarrantIssuedForServicesNote18", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "loop_WarrantTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant term" } } }, "localname": "WarrantTerm", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "durationItemType" }, "loop_WarrantToPurchaseCommonStockSharesForForConsultingServicesPerSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant to purchase common stock shares for for consulting services, per share price" } } }, "localname": "WarrantToPurchaseCommonStockSharesForForConsultingServicesPerSharePrice", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "loop_WarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "18. Warrants" } } }, "localname": "WarrantsDisclosureTextBlock", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "loop_WarrantsFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants 4" } } }, "localname": "WarrantsFourMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "loop_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Warrants]", "verboseLabel": "Warrants" } } }, "localname": "WarrantsMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "loop_WarrantsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants 1" } } }, "localname": "WarrantsOneMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "loop_WarrantsThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants 3" } } }, "localname": "WarrantsThreeMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "loop_WarrantsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants 2" } } }, "localname": "WarrantsTwoMember", "nsuri": "http://loopindustries.com/20210831", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r114", "r168", "r169", "r282", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r114", "r168", "r169", "r282", "r321", "r322" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities (Note 9)" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r300", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "[Accounts Payable and Accrued Liabilities]", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "9. Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "auth_ref": [ "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r152", "r153" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "[Accretion Expense]", "verboseLabel": "Accretion expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrentAndNoncurrent": { "auth_ref": [ "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.", "label": "Accrued employee compensation" } } }, "localname": "AccruedBonusesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued engineering fees" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": { "auth_ref": [ "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.", "label": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r25", "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "[Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment]", "negatedLabel": "Less: accumulated depreciation, write-down and impairment" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r19", "r41", "r42", "r43", "r312", "r327", "r328" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "[Accumulated Other Comprehensive Income (Loss), Net of Tax]", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r40", "r43", "r44", "r75", "r76", "r77", "r223", "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r17", "r205" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r75", "r76", "r77", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r67", "r136", "r139" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r73", "r103", "r106", "r112", "r122", "r221", "r224", "r228", "r296", "r310" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r38", "r73", "r122", "r221", "r224", "r228" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "auth_ref": [ "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets classified as held for sale.", "label": "Total Assets held for sale" } } }, "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [ "r143" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.", "label": "Assets held for sale (Note 5)" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r185", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type Axis" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://loopindustries.com/role/WarrantsDetails", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingImprovementsMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building and Land Improvements [Member]" } } }, "localname": "BuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r181", "r182", "r217", "r218" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Aggregate purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill in a business combination.", "label": "Summarizes the allocation of the aggregate purchase price" } } }, "localname": "BusinessCombinationSegmentAllocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.", "label": "Issued and outstanding common stock, contribution" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r4", "r74", "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "1. The Company, Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/TheCompanyBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r23", "r69" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Net increase (decrease) in cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in CCYY-MM-DD format.", "label": "Expiration date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r166", "r184" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant exercise price", "verboseLabel": "Exercise Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Warrant to purchase common stock shares for for consulting services" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to issue shares of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r154", "r155", "r156", "r157" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "20. Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common stock shares reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r75", "r76" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock par value $0.0001: 250,000,000 shares authorized; 47,160,164 shares issued and outstanding (February 28, 2021 - 42,413,691) (Note 13)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Voting power percentage" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r170", "r171", "r183", "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "17. Equity Incentive Plan" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlan" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r46", "r48", "r49", "r52", "r303", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and Other Finance Costs" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r12", "r13", "r14", "r297", "r298", "r309" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument Axis" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r14", "r159", "r298", "r309" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Loan amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r242", "r243" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Total amount of Chemtex Agreement" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r33", "r161", "r242" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Discount rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Loan, interest rate description" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r34", "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Monthly repayment of loan" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Loan, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r241", "r243" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "[Debt Instrument, Unamortized Discount]", "negatedLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expenses and Deposits" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Prepaid expenses" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PrepaidExpensesAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r213", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Research and development tax credits" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r67", "r146" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization (Notes 6 and 7)", "verboseLabel": "Depreciation and amortization (Notes 6 and 7)" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationExpenseOnReclassifiedAssets": { "auth_ref": [ "r144", "r145" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For the asset that is reclassified back to held and use from held-for-sale, the depreciation expense recognized when the asset is reclassified. This represents the difference between the carrying value at the time the decision to reclassify is made and the carrying amount that the asset would have had if it had never been classified as held for sale (including consideration of depreciation expense).", "label": "Depreciation expense" } } }, "localname": "DepreciationExpenseOnReclassifiedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payments" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsPolicyTextBlock": { "auth_ref": [ "r1", "r3", "r71" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.", "label": "Discontinued Operations, Policy [Policy Text Block]", "verboseLabel": "Assets held for sale" } } }, "localname": "DiscontinuedOperationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and Diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r71", "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net earnings (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCash": { "auth_ref": [ "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of effect of exchange rate changes on cash balances held in foreign currencies. Excludes cash equivalents.", "label": "Effect of exchange rate changes" } } }, "localname": "EffectOfExchangeRateOnCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Stock-based compensation expense" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Incentive Plan" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r75", "r76", "r77", "r79", "r84", "r86", "r92", "r124", "r163", "r165", "r202", "r203", "r204", "r215", "r216", "r234", "r235", "r236", "r237", "r238", "r239", "r323", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership, percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentQuotedMarketValue": { "auth_ref": [ "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.", "label": "Equity method investment, carrying value" } } }, "localname": "EquityMethodInvestmentQuotedMarketValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/JointVentureDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Joint Venture" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "10. Joint Venture" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/JointVenture" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r180", "r227", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level Axis" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r172", "r173", "r178", "r180", "r227", "r255" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r180", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r118", "r119", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "8. Fair Value of Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r138", "r283" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, net (Note 7)", "verboseLabel": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Additions to intangible assets" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r229", "r230", "r231", "r232" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign exchange loss (gain)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r71", "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currency translations and transactions" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative (Note 15)", "verboseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative Expenses" } } }, "localname": "GeneralAndAdministrativeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "verboseLabel": "General and Administrative Expenses" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets held for sale" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location Axis" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "auth_ref": [ "r212" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Research and development, tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income tax paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]", "verboseLabel": "Accounts payable and accrued liabilities (Note 9)" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "auth_ref": [ "r66" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.", "label": "Accretion and accrued interest expenses (Note 19)" } } }, "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r66" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Prepaid expenses (Note 4)" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "7. Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r304" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "[Interest and Dividend Income, Operating]", "negatedLabel": "Interest income" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseBorrowings": { "auth_ref": [ "r305" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of interest expense on all borrowings.", "label": "Interest expense" } } }, "localname": "InterestExpenseBorrowings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseLongTermDebt": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of interest paid or due on all long-term debt.", "label": "Interest on long-term debt" } } }, "localname": "InterestExpenseLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "[Interest Paid, Including Capitalized Interest, Operating and Investing Activities]", "verboseLabel": "Interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r58", "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Interest paid" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred." } } }, "localname": "InterimPeriodCostsNotAllocableDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r55", "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment in joint venture" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/JointVentureDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandPurchaseOptionsDescription": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Describes contracts, agreements and arrangements that give the entity unilateral rights to purchase the land covered by the option for a specified period of time.", "label": "Land acquired descriprtion" } } }, "localname": "LandPurchaseOptionsDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31", "r73", "r107", "r122", "r222", "r224", "r225", "r228" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total liabilities", "verboseLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r22", "r73", "r122", "r228", "r299", "r314" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r32", "r73", "r122", "r222", "r224", "r225", "r228" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Mximum financing facility" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Ramaining financing facility" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Represents the assets held for sale.", "label": "Long Lived Assets Held-for-sale by Asset Type [Axis]" } } }, "localname": "LongLivedAssetsHeldForSaleByAssetTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongLivedAssetsHeldForSaleDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "A description of the assets to be disposed of and the facts and circumstances leading to the expected disposal, and the expected manner and timing of the disposal (generally no more than 12 months from the date of the balance sheet).", "label": "Assets Held-for-sale, Description" } } }, "localname": "LongLivedAssetsHeldForSaleDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongLivedAssetsHeldForSaleNameDomain": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A name of the assets to be disposed." } } }, "localname": "LongLivedAssetsHeldForSaleNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r14", "r160", "r298", "r311" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Principal amount", "verboseLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Term Debt" } } }, "localname": "LongTermDebtAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Thereafter" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "February 28, 2026" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "February 28, 2025" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "February 29, 2024" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "February 28, 2023" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and capital lease obligation maturing in the remainder of the fiscal year following the latest fiscal year ended.", "label": "February 28, 2022" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Current portion of long-term debt (Note 11)", "negatedLabel": "Less: current portion" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/LongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Fair value of the loan for the disbursement" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt (Note 11)", "verboseLabel": "Long-term debt, net of current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/LongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.", "label": "Interest rate on loan" } } }, "localname": "LongTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "11. Long-Term Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "verboseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfExpenseAxis": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cost or expense.", "label": "Nature Of Expense Axis" } } }, "localname": "NatureOfExpenseAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net cash (used) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "[Net Cash Provided by (Used in) Investing Activities]", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r63", "r65", "r68" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r45", "r47", "r51", "r68", "r73", "r78", "r80", "r81", "r82", "r83", "r85", "r86", "r87", "r103", "r105", "r108", "r111", "r113", "r122", "r228", "r302", "r318" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "terseLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "The Company, Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other.", "label": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r39", "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r64", "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Cumulative amount paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForOtherDeposits": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for deposits classified as other.", "label": "Non refundable deposits on machinery and equipment" } } }, "localname": "PaymentsForOtherDeposits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r58" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "[Payments to Acquire Intangible Assets]", "negatedLabel": "Additions to intangible assets (Note 7)" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInterestInJointVenture": { "auth_ref": [ "r57" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.", "label": "[Payments to Acquire Interest in Joint Venture]", "negatedLabel": "Investment in joint venture (Note 10)" } } }, "localname": "PaymentsToAcquireInterestInJointVenture", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLand": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.", "label": "Land acquired for cash, amount" } } }, "localname": "PaymentsToAcquireLand", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r58" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "[Payments to Acquire Property, Plant, and Equipment]", "negatedLabel": "Additions to property, plant and equipment (Notes 5 and 6)" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r185", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Series A preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Series A preferred stock, share authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Series A preferred stock, share issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Series A preferred stock, share outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r15" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r134", "r135" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and deposits (Note 4)", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInterestReceived": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest received on loans and other debt instruments during the current period.", "label": "Interest received" } } }, "localname": "ProceedsFromInterestReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": { "auth_ref": [ "r60" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).", "label": "Proceeds from issuance of long-term debt (Note 11)" } } }, "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Warrants issued to purchase common stock, amount" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r59", "r201" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from sale of common shares and warrants, net of share issuance costs (Note 13)" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAssetsHeldForSaleDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets held for sale (Details)" } } }, "localname": "PropertyPlantAndEquipmentAssetsHeldForSaleDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r25", "r149" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type Axis" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r151", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "6. Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r24", "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r149", "r315" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, plant and equipment, net (Note 6)", "verboseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r10", "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r10", "r147" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales Tax, Tax Credits and Other Receivables" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r179", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r179", "r246", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative", "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative", "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r179", "r246", "r248", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r244", "r245", "r247", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "12. Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r61" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "[Repayments of Long-term Debt]", "negatedLabel": "Repayment of long-term debt (Note 11)", "verboseLabel": "Repayment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r210", "r211" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research And Development Arrangement Contract To Perform For Others By Type Axis" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r210", "r211" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred": { "auth_ref": [ "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.", "label": "Research and development, government grants" } } }, "localname": "ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r209", "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "[Research and Development Expense]", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "verboseLabel": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentInProcess": { "auth_ref": [], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.", "label": "Research and development (Note 14)" } } }, "localname": "ResearchAndDevelopmentInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r26", "r71", "r140", "r141", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research and development expenses" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted stock unit expense" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units", "verboseLabel": "Restricted Stock Units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r165", "r205", "r313", "r326", "r328" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r75", "r76", "r77", "r79", "r84", "r86", "r124", "r202", "r203", "r204", "r215", "r216", "r323", "r325" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r50", "r73", "r101", "r102", "r104", "r109", "r110", "r114", "r115", "r116", "r122", "r228", "r307" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Shares of common stock sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in common stock outstanding.", "label": "Common stock" } } }, "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Long-term debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Principal repayments" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Summarizes the warrants of granted" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r71", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "15. General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/GeneralAndAdministrativeExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r66" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation expense (Note 16)", "verboseLabel": "Net reversal of stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Restricted stock units forfeited", "verboseLabel": "Units forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Restricted stock units forfeited, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Restricted stock units granted, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.", "label": "Share reserve increase" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Restricted stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Restricted stock units granted", "terseLabel": "Warrants issued", "verboseLabel": "Units granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r187", "r189" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Restricted stock units outstanding", "periodEndLabel": "Outstanding, end of period", "periodStartLabel": "Outstanding, beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Stock options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price]", "terseLabel": "Stock options exercisable, weighted average exercise price", "verboseLabel": "Warrant exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Stock options expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Stock options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Warrants issued to purchase common stock, shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/LongtermDebtDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Shares granted", "verboseLabel": "Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r188", "r200" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Stock options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Stock options outstanding, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r184", "r186" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://loopindustries.com/role/WarrantsDetails", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Warrants to issue shares of common stock exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Closing price per share" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r199", "r206" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Life of option" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r167", "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "16. Share-Based Payments" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPayments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "http://loopindustries.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Offering price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "2. Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r36", "r75", "r76", "r77", "r79", "r84", "r86", "r92", "r124", "r163", "r165", "r202", "r203", "r204", "r215", "r216", "r234", "r235", "r236", "r237", "r238", "r239", "r323", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components Axis" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails", "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative", "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative", "http://loopindustries.com/role/WarrantsDetails", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows (Unaudited)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r75", "r76", "r77", "r92", "r282" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/AssetsHeldForSaleDetails", "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "http://loopindustries.com/role/EquityIncentivePlanDetails", "http://loopindustries.com/role/EquityIncentivePlanDetailsNarrative", "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetails", "http://loopindustries.com/role/GeneralAndAdministrativeExpensesDetailsNarrative", "http://loopindustries.com/role/LongtermDebtDetails", "http://loopindustries.com/role/LongtermDebtDetailsNarrative", "http://loopindustries.com/role/PropertyPlantAndEquipmentDetails", "http://loopindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails", "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative", "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetails1", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://loopindustries.com/role/TheCompanyBasisOfPresentationDetailsNarrative", "http://loopindustries.com/role/WarrantsDetails", "http://loopindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r16", "r163", "r165" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of shares for cash, shares", "verboseLabel": "Issuance of shares for cash, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Issuances of stock options" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/ShareBasedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r163", "r165" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Issuance of shares upon settlement of restricted stock units, shares", "verboseLabel": "Issuance of shares upon the vesting of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails", "http://loopindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r15", "r16", "r163", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of shares for cash, amount" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r15", "r16", "r163", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Issuance of shares upon settlement of restricted stock units, amount" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Stock Options [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r20", "r21", "r73", "r117", "r122", "r228" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityUnaudited", "http://loopindustries.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity", "verboseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets", "http://loopindustries.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r72", "r165", "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "13. Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r118", "r119", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails", "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r93", "r94", "r95", "r96", "r97", "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValueAddedTaxReceivable": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.", "label": "Sales tax" } } }, "localname": "ValueAddedTaxReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Sales tax, tax credits and other receivables (Note 3)" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Number of warrants" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/WarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "[Weighted Average Number of Shares Outstanding, Basic and Diluted]", "verboseLabel": "Basic and Diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://loopindustries.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2459-110228" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r156": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.7,8)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.8)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=121568667&loc=d3e29293-110302" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r334": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r336": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r337": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r338": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r339": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" } }, "version": "2.1" } ZIP 91 0001654954-21-011107-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-21-011107-xbrl.zip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